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ACh. Acetilcolina 
ATP: Adenosín trifosfato 
BH4: Tetrahidrobiopterina 
CaM: Calmodulina 
cAMP: Adenosín monofosfato cíclico 
cGMP: Guanosín monofosfato cíclico 
CGRP: Péptido relacionado con el gen de la 
calcitonina 
CL: Calcitonin-like receptor 
COMT: Catecol-metil transferasa 
COX: Ciclooxigenasa  
DAG: Diacilglicerol 
DEA-NO: Dietilamina NONOato 
EE: Estimulación eléctrica 
eNOS: Óxido nítrico sintasa endotelial 
FAD: dinucleótido de flavina y adenina 
FMN: mononucleótido de flavina 
iNOS: Óxido nítrico sintasa inducible 
IP3: Inositol – 1,4,5- trifosfato 
KATP: Canales de potasio dependientes de 
ATP 
L-NAME: N
ω
-nitro-L-arginina metil éster 
LPS: Lipopolisacárido 
MAO: Monoamino oxigenasa 
NA: Noradrenalina 
NADPH: nicotinamida adenina 
dinucleótido fosfato 
NANC: Nervios no colinérgicos no 
adrenérgicos 
NKA: Neuroquinina A 
nNOS: Óxido nítrico sintasa neuronal 
NO: Óxido nítrico 
NPY: Neuropéptido Y 
O2
.-
: Anión superóxido 
ONOO
-
: Anión peroxinitrito 
PGE2: Prostaglandina E2 
PGI2: Prostaciclina 
PIP2: Fosfatidil inositol -4, 5-bifosfato 
PKA: Proteína quinasa A 
PKC: Proteína quinasa C 
PKG: Proteína quinasa G 
PLC: Fosfolipasa C 
RAMP1: receptor activity modifying 
protein 1 
RCP: Receptor component protein 
ROS: Especies reactivas de oxígeno 
SHR: Ratas espontáneamente hipertensas 
SNP: Nitroprusiato sódico 
SP: Sustancia P 
TXA2: Tromboxano A2 
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Resultados previos han puesto de manifiesto alteraciones en la función de la inervación 
perivascular en arteria mesentérica superior en distintas situaciones fisiológicas y 
patológicas, como en hipertensión, cirrosis y envejecimiento.  
El objetivo de este trabajo ha sido analizar los posibles cambios en la participación de la 
inervación perivascular simpática, nitrérgica y sensitiva en esta arteria en las situaciones 
fisiológicas: gestación y lactancia; y patológicas: hipertensión portal, hipertensión en 
descendencia adulta de madres diabéticas y efectos del lipopolisácarido (LPS). 
Asimismo se analizado si el ejercicio físico moderado revierte o previene las 
alteraciones en la función de la inervación perivascular en ratas espontáneamente 
hipertensas (SHR) y ratas sometidas a una dieta rica grasa, respectivamente. 
Adicionalmente se ha valorado el efecto de distintos estabilizadores de células cebadas, 
ketotifen y tranilast, sobre la función neuronal en dicha arteria; así como del tranilast 
sobre la función endotelial en arterias mesentéricas de resistencia.  
Los resultados obtenidos en arteria mesentérica superior de rata son: 
1. En ratas gestantes, día 20 de gestación, se produce una disminución en la 
respuesta vasoconstrictora inducida por estimulación eléctrica (EE) que es 
resultado neto de una disminución tanto en la liberación como en la respuesta a 
noradrenalina (NA); y un incremento en la liberación de óxido nítrico (NO) 
neuronal mientras que la respuesta vasodilatadora al donante de NO, dietilamina 
NONOato (DEA-NO), no se modifica. La inervación sensitiva no participa en 
esta respuesta ni se modifica con la gestación. 
2. En ratas madre tras 21 de lactancia, aumenta la respuesta contráctil inducida por 
EE. Este incremento está mediado por una mayor liberación de ATP desde las 
terminaciones simpáticas, mientras que no se modifica ni la liberación ni la 
respuesta a NA; junto a una disminución en la liberación de NO aunque la 
respuesta vasodilatadora a DEA-NO es similar. No se observa participación ni 
alteraciones en la inervación sensitiva. 
3. En hipertensión portal inducida por triple ligadura de la vena porta a corto plazo, 
1 mes, se observa una disminución en la respuesta vasoconstrictora inducida por 
EE que está mediada por una diminución en la liberación de NA mientras que su 
respuesta contráctil no se modifica; y un incremento tanto en la liberación de  
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NO como del péptido relacionado con el gen de la calcitonina (CGRP), mientras 
que sus respuestas vasodilatadoras no se modifican. A largo plazo, 21 meses, no 
se producen ninguna de las alteraciones observadas a corto plazo. 
4. En ratas macho adultas, descendientes de madres diabéticas, se incrementa la 
respuesta contráctil inducida por EE. Este incremento está mediado por un 
aumento en la liberación de NA y ATP junto a un incremento en la liberación de 
NO. Las respuestas vasomotoras a NA y DEA-NO no se modifican. La 
inervación sensitiva no está implicada en este efecto. 
5. El ejercicio físico moderado (8 semanas, 5 días/semana, 50 min) revierte la 
incrementada respuesta vasoconstrictora observada en SHR. En este efecto están 
implicados una disminución en la liberación de NA y un aumento en su 
respuesta contráctil; y un incremento en la liberación y biodisponibilidad de NO. 
La inervación sensitiva participa en la respuesta contráctil aunque esta 
participación no se modifica con el ejercicio físico. 
6. En ratas alimentadas con una dieta rica en grasa (8 semanas), se observa un 
incremento en la respuesta vasoconstrictora inducida por EE. El ejercicio físico 
moderado (8 semanas, 5 días/semana, 50 min) realizado de forma simultánea 
con la dieta previene el incremento observado. Este efecto está mediado por un 
con una disminución en la liberación de NA junto a incremento en la liberación 
de NO y ATP, mientras que las respuestas vasomotoras a NA y DEA-NO no se 
modifican. La inervación sensitiva no participa en ninguna de estas respuestas. 
7. La incubación con LPS produjo alteraciones que fueron dependientes del tiempo 
de exposición. A corto plazo, 2 horas, se incrementa la respuesta 
vasoconstrictora inducida por EE mediada por a una incrementada respuesta a 
NA junto con una menor liberación de NO. A largo plazo, 5 horas, disminuye 
este incremento debido a una restauración en la función simpática y el 
mantenimiento en la reducción de la función nitrérgica. 
8. Los fármacos estabilizadores de células cebadas modifican la respuesta 
contráctil inducida por EE de forma opuesta. El ketotifen la incrementa a través 
de una disminución en la liberación de NO y un aumento en la respuesta a DEA-
NO, sin modificar la función adrenérgica; mientras que el tranilast la disminuye 
mediante una diminución en la respuesta a NA junto con una menor liberación 
de NO. 
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9. En vasos de resistencia, el tranilast altera la función endotelial incrementando la 
relajación inducida por acetilcolina (ACh). En este efecto no están implicados el 
NO ni prostanoides derivados de la ciclooxigenasa (COX), sino a una mayor 
participación del factor hiperpolarizante derivado de endotelio (EDHF) cuyo 
efecto está mediado a través de canales de potasio dependientes de calcio de baja 
conductancia. 
La amplitud de resultados obtenidos en esta tesis doctoral nos permite realizar varias 
consideraciones globales: 
 La existencia de inervación nitrérgica funcional en el control del tono 
vascular en la arteria mesentérica superior de todas las cepas analizadas. 
 La inervación sensitiva no participa en la respuesta contráctil inducida por 
EE en situaciones fisiológicas, mientras que en las distintas situaciones 
patológicas analizadas sólo contribuye a la vasodilatación esplácnica 
asociada a la hipertensión portal. 
 Los mecanismos por los cuales se incrementa o disminuye la respuesta 
vasoconstrictora inducida por EE no son homogéneos y difieren en función 
de la situación experimental analizada. 
 El incremento en la respuesta vasoconstrictora inducida por la liberación de 
los distintos neurotransmisores en arteria mesentérica superior no se ve 
afectada por la disfunción endotelial. 
 No parece existir una interacción entre la inervación nitrérgica y adrenérgica. 
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El sistema cardiovascular está formado por el corazón que impulsa la sangre a través de 
los vasos sanguíneos a los distintos órganos. Tiene como función principal satisfacer las 
necesidades nutricionales, metabólicas, hormonales e inmunes de los tejidos 
manteniendo así, la homeostasis del organismo. Para ello, el corazón bombea la sangre a 
través de las arterias y ésta retorna por medio de las venas. Aunque la circulación de 
cada tejido concreto tiene características peculiares, podemos aplicar ciertos principios 
generales a toda la circulación. Así, la estructura y diámetro de los vasos van a depender 
de la localización y función que lleven a cabo, se distinguen en: 
 Arterias: transportan la sangre a los tejidos bajo presiones elevadas. 
 Arteriolas: ramas terminales de las arterias que actúan como válvulas de control 
del flujo hacia los capilares. 
 Capilares: su función es intercambiar sustancias entre la sangre y el líquido 
intersticial. 
 Vénulas: recogen la sangre de los capilares, para ir confluyendo en venas cada 
vez de mayor calibre, hasta retornar al corazón. 
La circulación esplácnica es la parte de la circulación sistémica que irriga la porción 
abdominal del tubo digestivo, así como el bazo, el páncreas y el hígado. Recibe 
aproximadamente una cuarta parte del gasto cardíaco, participando en la regulación de 
la resistencia periférica y consecuentemente de la presión arterial. La contracción o 
relajación de los vasos de la circulación esplácnica le permite actuar como un sistema de 
adaptación que garantiza la redistribución de la sangre desde el territorio abdominal 
hacia la circulación general, con el fin de mantener el flujo sanguíneo adecuado en los 
órganos vitales. Este mecanismo permite el control de la presión sanguínea sistémica y 
regulación del flujo sanguíneo tisular (Gourley y Gering, 2005) 
Embriológicamente, los vasos mesentéricos tienen su origen en el segmento ventral 
primitivo, siendo la decimotercera arteria la que da origen a la arteria mesentérica 
superior (Rosenblum y cols., 1997); la cual forma parte de circulación esplácnica. La 
arteria mesentérica superior emerge desde la aorta y es la fuente principal de irrigación 
intestinal. 
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Características generales de la pared arterial 
Es un sistema dinámico, cuyos componentes se modifican o reorganizan en respuesta a 
estímulos fisiológicos y/o patológicos. En la pared vascular se distinguen tres capas 
concéntricas: la interna o túnica íntima, la capa media y la externa o túnica adventicia 
(Figura 1). 
1. Túnica íntima 
Es la capa interna de la pared arterial y está constituida por un epitelio simple y plano de 
células endoteliales orientadas longitudinalmente y unidas estrechamente a una lámina 
basal y tejido conjuntivo subendotelial; está separada de la túnica media por la lámina 
elástica interna. Las células endoteliales son capaces de detectar cambios físicos, como 
en el flujo sanguíneo y presión arterial; y químicos como hipoxia. Como respuesta 
producen múltiples sustancias vasoactivas que actúan de forma exocrina, paracrina y 
autocrina; y que tienen un papel primordial en la regulación del tono vascular; procesos 
de inflamación, crecimiento de células vasculares lisas, agregación plaquetaria y 
coagulación plasmática (Barton y Haudenschild, 2001; Vanhoutte y cols., 2009). Entre 
estos mediadores vasoactivos, se incluyen vasodilatadores como óxido nítrico (NO), 
prostaciclina (PGI2) (Furchgott y Vanhoutte, 1989) y el factor hiperpolarizante derivado 
de endotelio (EDHF) (Rubanyi 1991). Los principales factores vasoconstrictores 
liberados por el endotelio son la endotelina 1, prostanoides vasoconstrictores como 
tromboxano A2 (TXA2) y prostaglandina E2 (PGE2) y especies reactivas de oxígeno 
(ROS) (Tang y Vanhoutte 2009). 
2. Túnica media 
Es la capa intermedia de la pared vascular, está formada por capas concéntricas de 
células musculares lisas entre las que se interponen cantidades variables de matriz 
extracelular. La túnica media está separada de la túnica adventicia por una segunda capa 
de fibras elásticas, la lámina elástica externa. 
Las fibras musculares lisas de la túnica media son las responsables del mantenimiento 
de la tensión muscular, regulando el diámetro de la luz del vaso, siendo capaces de 
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contraerse y relajarse en respuesta a diferentes estímulos. Los componentes de la matriz 
extracelular, principalmente elastina y colágeno, van a determinan la distensibilidad de 
la arteria (Guyton 1991). 
 
 
 
Figura 1: Estructura general de la pared vascular. Tomado de 
http://www.lab.anhb.uwa.edu.au/mb140/corepages/vascular/vascular.htm 
 
3. Túnica adventicia 
Es la capa más externa compuesta por tejido conjuntivo con fibras de colágeno tipo I, y 
fibras elásticas; diversos tipos celulares como fibroblastos, adipocitos, macrófagos y 
mastocitos; una red de pequeños vasos sanguíneos que suplen a vasos de mayor tamaño 
o vasa vasorum; (Gutterman 1999; Stenmark y cols., 2013) y terminaciones nerviosas 
que liberan distintos neurotransmisores (Loesch 2002;  Cardinali y Dvorkin, 1999) 
Históricamente ha sido considerada como una capa poco organizada formada por 
múltiples tipos celulares. En los últimos años se ha demostrado que tiene una estructura 
compleja y dinámica que libera sustancias reguladoras tanto de la función como de la 
estructura vascular (Stenmark y cols., 2013). 
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El tono vascular está regulado por distintos mecanismos, sustancias vasoactivas 
liberadas desde las células endoteliales y musculares lisas, además de factores 
hormonales, metabólicos y neuronales. La respuesta vasomotora neta depende del grado 
de participación de cada uno de ellos. 
Inervación perivascular de la arteria mesentérica 
Las terminaciones nerviosas perivasculares liberan neurotransmisores vasoconstrictores 
y vasodilatadores, que regulan el tono vascular y el flujo sanguíneo. No todas las 
arterias poseen los mismos tipos de inervación, depende del lecho vascular analizado 
(Loesch 2002). En la arteria mesentérica se han descrito tres tipos de inervación: 
simpática, nitrérgica y sensitiva. 
1. Inervación simpática 
En el sistema nervioso periférico, la rama simpática emerge de la médula espinal 
torácica y de los dos o tres primeros segmentos lumbares. Estas neuronas 
preganglionares alcanzan los distintos ganglios paravertebrales y prevertebrales; entre 
estos últimos se encuentran los ganglios mesentéricos, que dan origen a fibras 
postganglionares que inervan los órganos de la región abdominal y pelviana así como 
los vasos mesentéricos (Cardinali y Dvorkin, 1999). Las terminaciones simpáticas 
liberan noradrenalina (NA) como neurotransmisor principal y los cotransmisores 
adenosina trifosfato (ATP) y neuropéptido Y (NPY) (Donoso y cols., 1997). 
Componente adrenérgico 
La NA es una catecolamina que se sintetiza a partir de la tirosina. La enzima tirosina 
hidroxilasa produce L-DOPA (L-dihidroxifenialanina) a partir de la tirosina, que por 
medio de la enzima dopadescarboxilasa, se convierte en dopamina. La enzima 
dopamina β-hidroxilasa, en presencia de oxígeno y ácido ascórbico, transforma en NA 
la dopamina (Cardinali y Dvorkin, 1999). 
La NA se almacena en las vesículas sinápticas y se libera al espacio sináptico por 
exocitosis. Una vez en la hendidura sináptica, actúa sobre dos tipos de receptores 
específicos, receptores α y β-adrenérgicos, tanto pre como postsinápticos, que 
pertenecen a la superfamilia de receptores acoplados a proteína G (Guimaraes y Moura, 
2001):
Introducción 
 
20 
 α1-postsinápticos: en el músculo liso vascular, que activan a la fosfolipasa C 
(PLC). Esta enzima cataliza la hidrólisis del fosfatidilinositol bifosfato (PIP2) en 
inositol trifosfato (IP3) y diacilglicerol (DAG), ambos compuestos actúan como 
segundos mensajeros provocando la liberación de calcio intracelular y 
consecuente vasoconstricción (García-Sáinz y cols., 2000).  
 α2-presinápticos: se localizan en las terminaciones nerviosas simpáticas 
(homorreceptores) y no simpáticas (heterorreceptores), su activación inhibe la 
liberación de NA (Enero y cols., 1972) o modula la liberación de otros 
neurotransmisores (Marín y Balfagón, 1998),  respectivamente. 
 β1-postsinápticos: en el músculo liso vascular, que activan a su vez la adenilato 
ciclasa, produciendo un incremento de adenosín monofosfato cíclico (cAMP), el 
cual activa la proteína quinasa A (PKA) y provoca la disminución en los niveles 
de calcio intracelular, originando la relajación del músculo liso vascular 
(Werstiuk y Lee, 2000). Asimismo se ha descrito la presencia de receptores β-
adrenérgicos en endotelio, cuya activación provoca la liberación de óxido nítrico 
(NO) (Arribas y cols., 1994). 
 β2- presinápticos: localizados en las terminaciones nerviosas, a través de los 
cuales se facilita la liberación de NA (Marín y Balfagón, 1998). La activación de 
estos receptores en las terminaciones nerviosas nitrérgicas produce un 
incremento en la liberación de NO (Marín y Balfagón, 1998).   
La NA posee mayor afinidad por los receptores α que por los β, y debido al predominio 
de los receptores α en las células musculares lisas, el efecto vasomotor producido por la 
NA liberada desde las terminaciones nerviosas adrenérgicas es vasoconstrictor 
(Vanhoutte 1981), participando en la regulación de la resistencia y el tono vascular. 
La acción de NA finaliza por recaptación retrógrada, donde se incorpora a nuevas 
vesículas sinápticas, y degradación mediante las enzimas monoaminooxidasa (MAO) o 
catecol-O-metil transferasa (COMT) (Hein 2006). 
Componente purinérgico 
El cotransmisor purinérgico ATP se sintetiza en las terminaciones nerviosas simpáticas 
y se almacena en vesículas distintas a las que contienen NA. Una vez liberado actúa 
sobre receptores purinérgicos tanto pre como postsinápticos (Burnstock y Ralevic, 
2013). Se metaboliza por ectonucleotidasas situadas en la superficie de las células 
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musculares lisas y endoteliales (Zimmermann y cols., 2012) hasta adenosina (Burnstock 
y Ralevic, 2013). 
Los receptores purinérgicos se dividen en dos tipos: P1 y P2. Los P1 son selectivos para 
adenosina, mientras que los P2 son selectivos para nucleótidos y han sido divididos en 
P2X y P2Y (Abbracchio y Burnstock, 1994). El efecto vasoconstrictor del ATP en 
arteria mesentérica procedente de la inervación simpática está mediado por receptores 
P2X (Ralevic y Burnstock, 1988), y aunque hay evidencias de la expresión de ambos 
tipos en el músculo liso vascular, no se ha asociado un papel fisiológico a los receptores 
P2Y. Los receptores P2X son de tipo ionotrópico, su activación por ATP produce una 
rápida respuesta debida a la entrada de cationes al interior celular produciendo una 
despolarización de membrana y un flujo de calcio a través de canales de calcio voltaje-
dependientes de tipo L (Burnstock y Ralevic, 2013; Rummery y cols., 2007).  
Además del efecto vasoconstrictor, la NA y el ATP actúan sinérgicamente 
disminuyendo la neurotransmisión simpática presinápticamente a través de receptores 
α2 y P1 (Burnstock 2009). 
El cotransmisor NPY tiene un papel menor sobre el músculo liso y actúa 
fundamentalmente como neuromodulador disminuyendo la liberación de NA y ATP 
presinápticamente y/o amplificando postsinápticamente las respuestas adrenérgica y 
purinérgica (Burnstock 2009). Aunque se han estudiado las vías de señalización, sigue 
sin aclararse totalmente como el NPY contribuye al control vasomotor en condiciones 
fisiológicas (Westcott y Segal, 2013b). 
2. Inervación nitrérgica 
La existencia de inervación nitrérgica perivascular desde la que se libera NO y la 
posibilidad de que tuviera un papel fisiológico o patológico se cuestionó durante mucho 
tiempo (Toda y Okamura, 2003; Amerini y cols., 1993). Actualmente se ha demostrado 
su existencia en numerosos lechos vasculares, entre los que se encuentra la arteria 
mesentérica (Toda y Okamura, 2015). 
La síntesis de NO (Figura 2) se lleva a cabo por distintas isoformas de la enzima óxido 
nítrico sintasa (NOS): 
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 NOS1 o neuronal (nNOS) está presente en sistema nervioso central y periférico 
(Ayajiki y cols., 2002), también se ha descrito su expresión en glándula adrenal, 
en células epiteliales de varios órganos y musculares lisas vasculares 
(Förstermann y cols., 1994). 
 NOS3 o endotelial (eNOS) se expresa principalmente en células endoteliales 
aunque también ha sido detectada en miocitos cardíacos y plaquetas 
(Förstermann y cols., 1994), su función está modulada por factores humorales 
y/o mecánicos (Schulz y cols., 1992;  Fisher y cols., 2001). 
Entre estas dos isoformas existen numerosas similitudes. Ambas son constitutivas y 
dependientes de la concentración de calcio para unir calmodulina (CaM). La actividad 
de ambas enzimas está regulada por procesos de fosforilación mediada por diferentes 
quinasas y fosfatasas (Rafikov y cols., 2011; Zhou y Zhu, 2009). Contienen múltiples 
regiones sensibles a fosforilación, aunque las más estudiadas son; para nNOS en la 
serina 1412 y serina 847 (Zhou y Zhu, 2009) que van a determinar una mayor o menor 
activación, respectivamente; y para eNOS de forma similar en la serina 1177 y treonina 
495 (Rafikov y cols., 2011). Ambas participan, a través de su efecto vasodilatador en el 
control del tono vascular en situaciones fisiológicas y patológicas, modificando su 
expresión, activación y acoplamiento. 
 NOS2 o inducible (iNOS) fue identificada inicialmente en macrófagos, aunque 
puede inducirse su expresión en la mayoría de células y tejidos (Förstermann y 
cols., 1994). Esta isoforma tiene una alta afinidad por la CaM, siendo su unión 
independiente de las concentraciones de calcio, generando mayores cantidades 
de NO en situaciones patológicas (Moncada 1997; Schulz y Triggle, 1994). 
Al ser estimulada la terminación nerviosa nitrérgica se libera NO, que al ser un gas, 
difunde a través de las membranas del músculo liso. Está implicado, dado su efecto 
vasodilatador, en la regulación del tono vascular y la resistencia vascular periférica El 
NO produce relajación en el músculo liso vascular por la activación de la enzima 
guanilato ciclasa soluble, incrementando los niveles de guanosín monofosfato cíclico 
(cGMP) (Toda y Okamura, 2003; Webb 2003). El cGMP activa a la proteína quinasa G 
(PKG) que activa a su vez a la bomba de calcio (Ca
2+
-ATPasa) del retículo 
endoplásmico reduciendo la concentración de calcio intracelular (Yoshida y cols., 
1991). 
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El NO se metaboliza a través de la oxidación producida por especies reactivas de 
oxígeno (ROS) (Beckman y Koppenol, 1996). Esto implica que la generación de ROS 
por el metabolismo celular se relaciona estrechamente con el metabolismo de NO y su 
incremento se ha vinculado con alteraciones en el papel de este neurotransmisor en 
distintas patologías cardiovasculares (Cai y Harrison, 2000; Wolin 2000). Entre las ROS 
destacan los aniones superoxido (O2
.-
), los cuales reaccionan con el NO de manera 
espontánea e irreversible (Huie y Padmaja, 1993), dando como resultado el anión 
peroxinitrito (ONOO
-
) altamente oxidante, que afecta a proteínas, lípidos y ácidos 
nucleicos (Pacher y cols., 2007). 
 
 
 
Figura 2. Representación esquemática de la estructura de la óxido nítrico sintasa neuronal y 
síntesis de NO. Los monónomeros contienen un dominio oxigenasa (N-terminal), una región central de 
unión a calmodulina (CaM) y un dominio reductasa (C-terminal). El dominio reductasa contiene regiones 
de unión a nicotinamida adenina dinucleótido fosfato (NADPH), dinucleótido de flavina y adenina (FAD) 
y mononucleótido de flavina (FMN); y el dominio oxigenasa contiene regiones de unión para L-arginina 
y tetrahidrobiopterina (BH4) y un grupo Fe-hemo. Los electrones (e-) son donados por el NADPH 
reducido y son transferidos desde el dominio reductasa hacia el dominio oxigenasa vía FMN y FAD y se 
produce la oxidación de la L-arginina en NO y L-citrulina. Adaptado de Zhou y Zhu, 2009.  
 
3. Inervación sensitiva 
El núcleo de estas fibras se localiza en los ganglios dorsales de la médula espinal, 
localizándose las terminaciones nerviosas entre la adventicia y media de los vasos 
sanguíneos, principalmente arterias (Gulbenkian y cols., 1993; Saetrum Opgaard y 
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cols., 1995). Liberan diversos neuropéptidos, siendo el principal el péptido relacionado 
con el gen de la calcitonina (CGRP), liberando también los cotransmisores sustancia P 
(SP) y neuroquinina A (NKA) pricipalmente (Lundberg y cols., 1985). 
El CGRP pertenece a la superfamilia de péptidos de la calcitonina, formada por la 
calcitonina, adrenomedulina, amilina y CGRP (α y β) (Wimalawansa 1996). Se sintetiza 
en el soma neuronal y se almacena en vesículas, que lo transportan a través del axón 
hasta el terminal para liberarlo. Una vez liberado, actúa a través de receptores 
específicos y su acción finaliza mediante mecanismos de recaptación por los terminales 
sensitivos (Sams-Nielsen y cols., 2001), metabolismo y transporte hacia el flujo 
sanguíneo. Estos receptores se componen de tres subunidades: un receptor acoplado a 
proteína G, calcitonin-like receptor (CL) (Poyner y cols., 2002); una proteína que 
modifica la actividad del receptor, receptor activity modifying protein 1 (RAMP1) 
(Poyner y cols., 2002) y otra proteína necesaria para la unión a proteína G y la 
transducción de la señal, receptor component protein (RCP) (Prado y cols., 2002). La 
interacción entre el receptor CL y RAMP1 es necesaria para constituir el receptor de 
CGRP funcional, mientras que otras combinaciones originan receptores para otros 
péptidos de la misma familia (Kawasaki y cols., 2003). 
El CGRP liberado desde las terminaciones nerviosas de la pared vascular participa en la 
regulación de la resistencia periférica, ejerciendo un efecto vasodilatador. Dicha 
vasodilatación está mediada por la unión del CGRP a su receptor específico localizado 
tanto en células endoteliales como células musculares lisas (Wimalawansa 1996). En 
células del músculo liso vascular la activación del receptor de CGRP activa la enzima 
adenilato ciclasa, que incrementa los niveles de cAMP y activa a PKA que favorece la 
apertura de canales de potasio dependientes de ATP (KATP) y disminuye los niveles de 
calcio intracelular (Nelson y cols., 1990; Brain y Grant, 2004; Figura 3). Asimismo se 
ha descrito que el efecto vasodilatador del CGRP sobre músculo liso vascular está 
mediado por el cGMP (Wimalawansa 1996; Balfagón y cols., 2004). La respuesta 
dependiente de endotelio está mediada por la producción de NO a través del incremento 
de cAMP y PKA (Wimalawansa 1996; Brain y Grant, 2004). El NO difunde a la célula 
muscular lisa donde produce relajación. (Figura 3). Al igual que lo que se observa en 
otros tipos de terminaciones nerviosas el CGRP regula su propia liberación a través de 
un mecanismo de retroalimentación negativa, estimulando receptores presinápticos para 
CGRP (Nuki y cols., 1994). 
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Figura 3: Mecanismos de vasodilatación mediada por CGRP. Izquierda: vasodilatación independiente 
de endotelio. La activación del receptor de CGRP en la célula muscular lisa está unida a la activación de 
la enzima adenilato ciclasa y producción de cAMP. El incremento en la concentración de cAMP estimula 
a la proteína quinasa A (PKA)  que activa canales de potasio y disminuye la concentración de calcio 
intracelular, produciendo la relajación del músculo liso. Derecha: vasodilatación dependiente de 
endotelio. La activación del receptor de CGRP produce un incremento en la producción de NO por la 
activación de la óxido nítrico sintasa endotelial (eNOS) mediada por el incremento en cAMP y PKA. El 
NO difunde a las células del músculo liso donde activa a la guanilato ciclasa produciendo relajación. 
Adaptado de Brain y Grant, 2004. 
 
Antecedentes 
Resultados previos observados en nuestro laboratorio han demostrado que la 
participación de los distintos tipos de inervación perivascular mesentérica se modifica 
en situaciones tanto fisiológicas como patológicas. 
Las modificaciones de los distintos tipos de inervación están implicadas en la génesis y 
mantenimiento de las alteraciones vasculares asociadas a múltiples situaciones 
fisiopatológicas, como envejecimiento o hipertensión arterial. Estas modificaciones 
pueden ser debidas tanto a cambios en la liberación de los neurotransmisores 
correspondientes, como a alteraciones en la respuesta de las células del músculo liso 
vascular a dichos neurotransmisores. 
Hipertensión 
El incremento del tono vascular observado en hipertensión se ha asociado con 
disfunción endotelial, estrés oxidativo y remodelado de la pared vascular, entre otros 
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(Montezano y cols., 2015). La disfunción endotelial se ha vinculado a alteraciones en la 
formación de NO endotelial y/o mayor metabolismo por ROS, así como una mayor 
producción y respuesta a sustancias vasoconstrictoras (Paravicini y Touyz, 2006; 
Félétou y cols., 2010).  
La participación de la inervación adrenérgica en el desarrollo de la hipertensión ha sido 
extensamente estudiada, se ha demostrado que se produce un incremento en la actividad 
simpática así como alteraciones tanto en la regulación presináptica de la liberación 
como en los mecanismos de recaptación de la NA (Westfall y cols., 2013). Sin embargo 
se han descrito resultados contradictorios en cuanto a la respuesta vasoconstrictora a NA 
(Marín 1993; Tabernero y cols., 1996; Dickhout y Lee, 1997), las diferencias parecen 
deberse a las alteraciones en la estructura de la pared vascular observada en 
hipertensión.  
Por otra parte, son escasos los trabajos sobre el posible papel de la inervación nitrérgica 
en el desarrollo de hipertensión, con resultados controvertidos. Se ha descrito tanto una 
disminución (Quadri y cols., 1999; Hauser y cols., 2005) como un incremento (Piech y 
cols., 2003; Hojna y cols., 2007) en la expresión de nNOS en sistema nervioso central. 
Resultados similares han sido observados a nivel periférico y en diferentes lechos 
vasculares, incluido el mesentérico (Rabelo y cols., 2001; Ferrer y cols., 2003). 
En nuestro laboratorio hemos observado que en ratas macho espontáneamente 
hipertensas (SHR) se produce un incremento en la liberación de NA y una disminución 
en la respuesta vasoconstrictora a dicho neurotransmisor, así como un incremento en la 
participación de la inervación nitrérgica caracterizada por un aumento en la liberación 
de NO, mediada por la mayor actividad de la proteína quinasa C (PKC), y en la 
respuesta vasodilatadora a donantes de NO (Marín y cols., 2000). Adicionalmente 
hemos observado en ratas macho SHR que la aldosterona incrementa la expresión de la 
subunidad RAMP1 del receptor de CGRP, mecanismo por el cual incrementa la 
respuesta vasodilatadora a CGRP (Balfagón y cols., 2004; Márquez-Rodas y cols., 
2006). Por otra parte, en el modelo de hipertensión inducido por ouabaína, la función de 
la inervación adrenérgica no está alterada, mientras que se incrementa la liberación de 
NO mediada por la mayor expresión de nNOS y no se modifica la respuesta 
vasodilatadora a nitroprusiato sódico (SNP) (Xavier y cols., 2004). En SHR hembras, 
sin embargo, la función adrenérgica no se modifica, mientras que se disminuye la 
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liberación de NO, mediada por una menor expresión de nNOS; y se incrementa tanto la 
liberación de CGRP como su respuesta vasodilatadora (del Campo y cols., 2004). 
Estos resultados obtenidos en machos sugieren que las alteraciones en la inervación 
adrenérgica en hipertensión difieren dependiendo del modelo experimental utilizado, 
mientras que las modificaciones en la función de la inervación nitrérgica son similares, 
un incremento en su participación, sugiriendo que actúa como un mecanismo 
compensador. 
Sin embargo en hembras observamos el proceso contrario en cuanto a la liberación de 
NO, disminuye mientras que no se modifica la función adrenérgica, indicando la 
existencia de dimorfismo sexual en las alteraciones de la inervación perivascular de la 
arteria mesentérica en hipertensión.  
Diabetes 
La diabetes es una enfermedad metabólica caracterizada por hiperglucemia, en la que se 
observan diferentes alteraciones vasculares, que son la causa más común de morbilidad 
y mortalidad. Se ha demostrado el desarrollo de disfunción endotelial tanto en pacientes 
como en modelos animales (Johnstone y cols., 1993; Pieper 1999) lo cual se ha sugerido 
que constituye el origen de estas alteraciones en diferentes lechos vasculares (Bertoluci 
y cols., 2015). La disfunción endotelial no es un proceso homogéneo en sus 
características y distribución, sino que varía con la duración de la exposición a la 
hiperglucemia y el lecho vascular analizado (Davel y cols., 2011), lo cual facilita la 
progresión de las alteraciones vasculares en diabetes. La característica más notable de la 
disfunción endotelial en diabetes es la disminución de la liberación y/o 
biodisponibilidad del NO, lo cual se ha asociado tanto al incremento del estrés oxidativo 
como al déficit de sustrato y/o cofactores cruciales para la actividad de eNOS (Akamine 
y cols., 2006) aunque también se ha relacionado con la liberación de diferentes 
sustancias vasoconstrictoras como prostanoides derivados de la ciclooxigenasa (COX) 
(Bagi y cols., 2006). 
A pesar del control de los niveles de glucosa en pacientes diabéticos, éstos mantienen 
un alto riesgo de sufrir enfermedades cardiovasculares, siendo las neuropatías una de las 
mayores complicaciones en diabetes. Datos epidemiológicos indican que el 50% de los 
pacientes diabéticos sufren alteraciones en la función neuronal (Boulton y cols., 2005). 
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Con respecto a las posibles alteraciones en la inervación simpática se ha descrito que no 
existen modificaciones (Weber y MacLeod, 1994; Speirs y cols., 2006) y una reducción 
(Hart y cols., 1988; Ralevic y cols., 1995) en la vasoconstricción inducida por EE. Estas 
diferencias en los resultados se han asociado a los distintos tiempos de exposición a la 
hiperglucemia y al lecho vascular analizado (Johansen y col., 2013). 
Sobre la posible alteración de la inervación nitrérgica los datos son escasos, salvo en la 
disfunción eréctil en la cual la disminución de su función se asocia tanto a una menor 
liberación de NO como a un incremento de su metabolismo. Estudios recientes asocian 
esa disfunción al desacoplamiento de nNOS en arterias peneanas mediado por una 
disminución de l-arginina y/o del cofactor tetrahidrobiopterina (BH4) (Sánchez y cols., 
2012). Al igual que en la disfunción endotelial, diversos trabajos han sugerido que la 
evolución de esta neuropatía es dependiente del tiempo (Cellek y cols., 2003). Los 
resultados obtenidos en nuestro laboratorio en un modelo de diabetes inducido por 
estreptozotocina muestran en arteria mesentérica un incremento en la liberación de NO 
neuronal mediado por la activación de PKC; asimismo se ha observado una mayor 
función simpática mediada por un incremento en la liberación de NA (Ferrer y cols., 
2000). Siendo el resultado neto un incremento en la respuesta vasoconstrictora a la EE. 
Estos datos tomados en su conjunto indican que en diabetes se producen alteraciones en 
la función de la inervación perivascular y que estas alteraciones dependen del lecho 
vascular analizado y del tiempo de evolución. 
Cirrosis 
La cirrosis hepática es una patología frecuente que se sitúa dentro de las 10 causas más 
comunes de muerte en los países desarrollados (Stewart y Day, 2003). Esta patología 
cursa con el desarrollo de hipertensión portal y circulación esplácnica hiperdinámica, 
cuyos efectos acaban afectando tanto a la circulación hepática y esplácnica, como a la 
circulación cardiaca, pulmonar, renal y cerebral (Lockwood y cols., 1991; Palma y 
Fallon, 2006). Los mecanismos fisiopatológicos implicados en estos cambios 
cardiovasculares son complejos, ya que se ha descrito la participación de factores origen 
neurogénico, humoral y endotelial (Al-Hamoudi 2010; Xavier y cols., 2010), cuyas 
modificaciones difieren en función del lecho vascular analizado, así se observa una 
intensa vasoconstricción intrahepática y una marcada vasodilatación esplácnica. 
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En el lecho esplácnico se ha descrito un incremento en la liberación y sensibilidad de 
factores vasodilatadores como NO
 
(Morales-Ruiz y cols., 1996; Iwakiri 2007) y PGI2
 
(Vaughan y cols., 2005); así como una disminución en la respuesta a factores 
vasoconstrictores como NA (Battaglia y cols., 2006) y angiotensina II (Hennenberg y 
col., 2009), induciendo alteraciones hemodinámicas que agravan y prolongan la 
enfermedad e incluso ser causa de muerte (Groszmann 1994). 
En nuestro laboratorio, en un modelo de cirrosis inducido por administración oral de 
tetracloruro de carbono, los resultados obtenidos en arteria mesentérica superior 
confirman la diminución en la función simpática, mediada tanto por una menor 
liberación como respuesta a NA, y el incremento en la función nitrérgica mediada por 
un aumento en la expresión de nNOS y liberación de NO (datos no publicados). 
Adicionalmente, se observa un incremento en la liberación de CGRP y de su respuesta 
vasodilatadora debida a un incremento en la apertura de canales KATP, jugando, por 
tanto, un papel en la vasodilatación esplácnica observada en cirrosis (Blanco-Rivero y 
cols., 2011).  
Además de la valoración de las alteraciones en la función de la inervación perivascular 
mesentérica en situaciones patológicas, en nuestro grupo también se han analizado 
posibles modificaciones en  situaciones fisiológicas.  
Envejecimiento 
El envejecimiento se asocia con cambios morfológicos y funcionales en distintos 
sistemas, incluido el sistema cardiovascular, donde la incidencia de distintas patologías 
se encuentra incrementada. 
Entre los factores implicados en el incremento de riesgo cardiovascular asociado a la 
edad, destacan la disfunción endotelial (Seals y cols., 2011) y el remodelado vascular 
(Barodka y cols., 2011). En modelos animales se ha descrito un aumento, disminución y 
no modificación de la expresión/activación de eNOS (Durrant y cols., 2009; van der 
Loo y cols., 2000; Rippe y cols., 2010), asimismo se ha implicado el incremento del 
estrés oxidativo (Lesniewski y cols., 2009; Durrant y cols., 2009) y disminución de la 
capacidad antioxidante (Wang y Shah, 2015) así como a una menor respuesta a 
prostaglandinas vasodilatadoras (Singh y cols., 2002). 
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La actividad del sistema renina-angiotensina y el incremento en la actividad nerviosa 
simpática, producen alteraciones en la proliferación de células musculares lisas (Wang y 
Shah, 2015; Dinenno y cols., 2000), participando en el desarrollo del remodelado 
vascular y en la respuesta vascular a vasoconstrictores. Los datos con respecto a la 
respuesta a sustancias vasoconstrictoras son contradictorios, con disminución (Seals y 
Dinenno, 2004) y aumento (Dinenno y cols., 2000).  
El papel de la inervación perivascular en los cambios vasculares asociados a la edad es 
escasamente conocido. En nuestro laboratorio, en arteria mesentérica de ratas con 22-24 
meses se ha observado una mayor respuesta vasoconstrictora a NA, mientras que la 
liberación no se modifica. En el caso de la inervación nitrérgica, se produce una 
disminución en la función, debido a una menor liberación de NO sin alteraciones en el 
metabolismo y sensibilidad del músculo al NO (Ferrer y Balfagón, 2001). Estudios 
recientes han descrito una menor función de los nervios sensitivos en el lecho 
mesentérico (Westcott y Segal, 2013a), sin embargo en nuestro modelo la inervación 
sensitiva no parece estar implicada en las alteraciones asociadas con la edad. 
Estos resultados, en su conjunto, indican que la inervación adrenérgica juega un papel 
relevante en el mantenimiento del tono vasomotor de la arteria mesentérica, y que se 
altera su función en diversas situaciones fisiopatológicas, participando en el desarrollo 
y/o mantenimiento de las mismas. Estos datos cuestionan la idea de que la inervación 
nitrérgica, aunque exista no tiene un papel en el control vascular y de que sólo el NO de 
origen endotelial participa en la regulación del tono vascular periférico como han 
sugerido algunos autores (Toda y Okamura, 2003; Amerini y cols., 1993) y refuerzan al 
NO procedente de la inervación nitrérgica como un elemento más en la regulación del 
tono vascular. Este importante papel de la inervación nitrérgica se ha puesto de 
manifiesto en humanos donde el inhibidor específico de la nNOS, S-metil-L-
tiocitrulina, redujo el flujo sanguíneo basal en el antebrazo y en la circulación coronaria. 
(Melikian y col., 2009). 
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Estos resultados, tomados en su conjunto, nos indican que la función de la inervación 
perivascular en la arteria mesentérica superior se modifica tanto en situaciones 
fisiológicas como patológicas y que los mecanismos implicados tanto en el incremento 
como en la disminución de la respuesta inducida por estimulación eléctrica varían según 
el modelo experimental. 
Se ha descrito que el flujo de la circulación esplácnica se modifica o altera en distintas 
situaciones. En la gestación y la lactancia materna, con el fin de adaptarse a las nuevas 
demandas del organismo (Melchiorre y cols., 2012; Svennersten-Sjaunja y Olsson, 
2005); en la hipertensión portal se produce el síndrome de circulación hiperdinámica 
asociada a una gran vasodilatación en este lecho (Bosch y cols., 2015) y durante la 
sepsis y shock séptico asociada a una disminución en la resistencia vascular y una 
anómala redistribución del flujo sanguíneo (Landry y Oliver, 2001). Los trabajos que 
han abordado el estudio de los mecanismos implicados en estas modificaciones por 
diversos grupos de investigación se han centrado preferentemente en el estudio de las 
alteraciones de la función endotelial (Magness y cols., 1996; Levy y cols., 2010; Iwakiri 
2014) siendo menos conocido el papel de los distintos neurotransmisores. Aunque se ha 
sugerido la participación de la inervación en situaciones fisiológicas y patológicas como 
gestación (van Drongelen y cols., 2012) e hipertensión portal (Iwakiri 2014), es un 
aspecto prácticamente inexplorado. 
Asimismo, se ha observado que la descendencia macho adulta de madres diabéticas 
desarrolla hipertensión. Se ha descrito que alteraciones tanto en la función endotelial 
(Ramos-Alves y cols., 2012a, 2012b) en vasos mesentéricos como en la función renal 
(Rocha y cols., 2005) están implicados en este proceso. Previamente ya hemos descrito 
las alteraciones en la función perivascular en diversos modelos de hipertensión (Marín y 
cols., 2000; Márquez-Rodas y cols., 2006; Xavier y cols., 2004). Consecuentemente, en 
este modelo de programación fetal podrían producirse alteraciones en la función de la 
inervación perivascular. 
El sedentarismo constituye un factor de riesgo en el desarrollo de enfermedades 
cardiovasculares. La práctica regular de ejercicio físico ha demostrado tener efectos 
beneficiosos en el sistema cardiovascular (Belardinelli y cols., 1999; Phillips y cols., 
2015). Se ha descrito que el ejercicio físico influye sobre la función de la inervación 
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simpática (Leosco y cols., 2013), sin embargo no son conocidos sus efectos sobre la 
inervación nitrérgica y sensitiva.  
Se ha demostrado la existencia de comunicación entre neuronas del tracto 
gastrointestinal y células cebadas de la cavidad abdominal (Van Nassauw y cols., 2007). 
La localización de los mastocitos o células cebadas en la túnica adventicia sugiere una 
interacción entre éstas y la inervación perivascular. Por lo tanto, la activación o 
estabilización de las células cebadas pueden afectar a la función de esta inervación y del 
endotelio vascular. 
Por lo tanto, nuestro objetivo ha sido analizar la implicación de las 
modificaciones/alteraciones en la función de la inervación perivascular simpática, 
nitrérgica y sensitiva de la arteria mesentérica superior en:  
1. Gestación y Lactancia 
2. Hipertensión Portal 
3. Descendencia adulta de madres diabéticas 
4. Efecto del LPS sobre la función neuronal. 
5. Efectos del ejercicio físico sobre la función neuronal en hipertensión y obesidad 
inducida por una dieta rica en grasa 
6. Efecto de los estabilizadores de células cebadas, ketotifen y tranilast, en arteria 
mesentérica superior. 
7. Efecto del tranilast sobre la función endotelial de arteria mesentérica de 
resistencia. 
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Abstract
Background and Purpose
We investigated whether pregnancy was associated with changed function in components
of perivascular mesenteric innervation and the mechanism/s involved.
Experimental Approach
We used superior mesenteric arteries from female Sprague-Dawley rats divided into two
groups: control rats (in oestrous phase) and pregnant rats (20 days of pregnancy). Modifica-
tions in the vasoconstrictor response to electrical field stimulation (EFS) were analysed in
the presence/absence of phentolamine (alpha-adrenoceptor antagonist) or L-NAME (nitric
oxide synthase-NOS- non-specific inhibitor). Vasomotor responses to noradrenaline (NA),
and to NO donor DEA-NO were studied, NA and NO release measured and neuronal NOS
(nNOS) expression/activation analysed.
Key Results
EFS induced a lower frequency-dependent contraction in pregnant than in control rats.
Phentolamine decreased EFS-induced vasoconstriction in segments from both experimen-
tal groups, but to a greater extent in control rats. EFS-induced vasoconstriction was in-
creased by L-NAME in arteries from both experimental groups. This increase was greater in
segments from pregnant rats. Pregnancy decreased NA release while increasing NO re-
lease. nNOS expression was not modified but nNOS activation was increased by pregnan-
cy. Pregnancy decreased NA-induced vasoconstriction response and did not modify DEA-
NO-induced vasodilation response.
PLOS ONE | DOI:10.1371/journal.pone.0126017 May 7, 2015 1 / 18
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Conclusions and Implications
Neural control of mesenteric vasomotor tone was altered by pregnancy. Diminished sympa-
thetic and enhanced nitrergic components both contributed to the decreased vasoconstric-
tion response to EFS during pregnancy. All these changes indicate the selective
participation of sympathetic and nitrergic innervations in vascular adaptations produced
during pregnancy.
Introduction
Pregnancy is associated with a decrease in systemic vascular resistance that, despite the marked
increase in blood volume and cardiac output, maintains or reduces maternal blood pressure, in
both experimental animals and humans. Adaptations to pregnancy have been studied in several
vascular beds, but the mechanisms underlying the altered vessel function are complex and only
partially understood.
Vascular adaptations to pregnancy include both an endothelium-dependent pathway asso-
ciated with increased production of vasodilators [1] and an endothelium-independent pathway
associated with altered vasomotor smooth muscle cell responses to different vasoactive sub-
stances [2,3,4], that decrease myogenic reactivity [5] and increase vascular compliance [6].
However, activation of additional endothelium-independent pathways has been strongly sug-
gested [7]. Perivascular innervation has a significant influence on peripheral vascular resistance
involving the sympathetic, cholinergic, nitrergic, peptidergic and/or sensory innervations,
which are specific to the vascular bed under consideration.
The mesenteric artery plays a pivotal role in global peripheral resistance in rats, especially in
pregnancy; during this physiological process, mesenteric perfusion is strongly increased. These
arteries are innervated by sympathetic nerves, which mediate vasoconstriction mainly via nor-
adrenaline (NA) release, but also by nitrergic innervation, which induces vasodilatation by ni-
tric oxide (NO) release, and sensory innervation through release of the vasodilator calcitonin
gene-related peptide neuropeptide (CGRP) [8,9,10]. Electric field stimulation (EFS) produces a
vasomotor response that is the integrated result of the effect of these different neurotransmit-
ters [10]. The alterations in the functional roles of these components have been associated with
changes in synthesis, release, response and/or metabolism of the different neurotransmitters in
several physiological and pathological circumstances [11,12,13,14].
Neuronal adaptation to pregnancy by mesenteric arteries it has been reported to be time-de-
pendent. In late pregnancy diminished sympathetic nerve-mediated constriction has been as-
sociated with a decreased vasoconstrictor response to NA [7], while possible changes in NA
release have been suggested but not investigated [4]. No changes have been reported in sensory
innervation [4] but there is an increased vasodilation to CGRP [7,15,16]. It is widely known
that estrogens modulate vascular tone activating endothelial nitric oxide synthase (eNOS) and
several studies have reported that vascular adaptation in pregnancy is associated with an in-
crease in eNOS protein expression [17,18,19]. In previous studies we have observed that
changes in levels of sex steroids are associated with changes in nitrergic innervation function
[14,20]. However, to the best of our knowledge, the possible role of nitrergic innervation in vas-
cular adaptations to pregnancy remains unexplored.
Taking these data into account, we considered it relevant to study possible simultaneous
changes in the different kinds of perivascular innervation during pregnancy, consequently the
aim of this work is to analyze whether the possible functional changes in sympathetic, nitrergic
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and sensory innervations in late pregnancy could be associated with the decreased vascular re-
sistance observed in the mesenteric artery, as well as the mechanisms that may be implicated.
Materials and Methods
Animals
Female Sprague-Dawley rats (4–6 months old) were obtained from the Animal Quarters and
housed in the Animal Facility of the Universidad Autónoma de Madrid (registration number
EX-021U) in accordance with guidelines 609/86 of the E.E.C., R.D. 233/88 of the Ministerio de
Agricultura, Pesca y Alimentación of Spain, and the Guide for the Care and Use of Laboratory
Animals published by the United States National Institute of Health [NIH publication No. 85–
23, revised 1996]. All experimental procedures involving animal use were approved by the Eth-
ics Committee of the Universidad Autónoma de Madrid. Rats were housed at a constant room
temperature, humidity, and light cycle (12:12 h light-dark) with free access to tap water and fed
with standard rat chow ad libitum, and were divided into two groups: Control (virgin females
in oestrous phase) and pregnant rats (20 days of pregnancy). The stage of the oestrous cycle was
determined by examination of vaginal smears; oestrous females exhibited the presence of corni-
fied cells. The day when a vaginal plug was found was considered to be day 1 of pregnancy.
Animals were sacrificed by CO2 inhalation followed by decapitation; superior mesenteric ar-
tery was carefully dissected, cleaned of connective tissue and placed in Krebs-Henseleit solution
(KHS, in mmol/L: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4.7H2O 1.2, NaHCO3 25;
glucose 11.1; Na2EDTA 0.03) at 4°C. For protein expression analysis, some segments were rap-
idly frozen in liquid nitrogen and kept at -80°C until the day of analysis.
Vascular reactivity
The method used for isometric tension recording has been described in full elsewhere [10,21].
Two parallel stainless steel pins were introduced through the lumen of the vascular segment:
one was fixed to the bath wall, and the other connected to a force transducer (Grass FTO3C;
Quincy, MA, USA); this, in turn, was connected to a model 7D Grass polygraph. For EFS ex-
periments, segments were mounted between two platinum electrodes 0.5 cm apart and con-
nected to a stimulator (Grass, model S44) modified to supply adequate current strength.
Segments were suspended in an organ bath containing 5 mL of KHS at 37°C and continuously
bubbled with a 95% O2 to 5% CO2 mixture (pH of 7.4). Some experiments were performed in
endothelium-denuded segments to eliminate the main source of vasoactive substances, includ-
ing endothelial NO. This avoided possible actions by different drugs on endothelial cells that
could lead to misinterpretation of results. Endothelium was removed by gently rubbing the lu-
minal surface of the segments with a thin wooden stick. The segments were subjected to a ten-
sion of 0.5 g, which was readjusted every 15 min during a 90-min equilibration period before
drug administration. After this, vessels were exposed to 75 mmol/L KCl to check their func-
tional integrity. After a washout period, the presence/absence of vascular endothelium was test-
ed by the ability/inability of 10 μmol/L acetylcholine (ACh) to relax segments precontracted
with NA (1 μmol/L).
Vasodilator response to ACh (0.1 nmol/L- 10 μmol/L) was tested in endothelium-intact ar-
teries precontracted with NA (1μmol/L) from all experimental groups.
Frequency-response curves to EFS (1, 2, 4 and 8 Hz) were performed in endothelium-intact
and endothelium-denuded mesenteric segments from all experimental groups. The parameters
used for EFS were 200 mA, 0.3 ms, 1–8 Hz, for 30 s with an interval of 1 min between each
stimulus [10], the time required to recover basal tone. Two successive frequency-response
curves separated by 1-hour intervals produced similar contractile responses. To evaluate the
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neural origin of the EFS-induced contractile response, the nerve impulse propagation blocker,
tetrodotoxin (TTX, 0.1 μmol/L) was added to the bath 30 min before the second frequency-re-
sponse curve was performed.
To determine the participation of the adrenergic component of sympathetic innervation in
EFS-induced responses in endothelium-denuded segments from control and pregnant rats,
1 μmol/L phentolamine, an alpha-adrenoceptor antagonist was added to the bath 30 min be-
fore performing the frequency-response curve. Additionally, the vasoconstrictor response to
exogenous NA (1 nmol/L- 10 μmol/L) was tested in segments from both experimental groups.
The method to deplete sympathetic innervation has been used previously by our group in
this artery [22]. Briefly, endothelium-denuded mesenteric segments from control and pregnant
rats were incubated at room temperature for 10 minutes in KHS (NaHCO3 and NaH2PO4
were omitted, unbuffered solution) containing 0.02 mmol/L glutathione and 1.46 mmol/L of
the neurotoxin 6-hydroxydopamine (6-OHDA). The pH of this solution was adjusted to 4.9
with 0.05 mmol/L NaOH and then the solution was covered with paraffin oil. Subsequently,
the arteries were immersed in normal KHS and EFS-induced contraction experiments were
performed. After EFS-contraction experiments mesenteric segments from control and preg-
nant rats were exposed to 75 mmol/L KCl to check that their functional integrity was not af-
fected by 6-OHDA.
To study the possible participation of sensory innervation in EFS-induced responses in en-
dothelium-denuded segments from control and pregnant rats, 0.5 μmol/L CGRP (8–37), a
CGRP receptor antagonist was added to the bath 30 min before performing the second fre-
quency-response curve.
To analyse the participation of NO in the EFS-induced response in endothelium-denuded
segments from control and pregnant rats, 0.1 mmol/L Nω-nitro-L-arginine methyl ester
(L-NAME), a non-specific inhibitor of nitric oxide synthase (NOS), was added to the bath 30
min before performing the second frequency-response curve. The vasodilator response to the
NO donor, diethylamine NONOate (DEA-NO, 0.1 nmol/L-0.1 mmol/L) was determined in
NA-precontracted arteries from both experimental groups. To assess the participation of super-
oxide anion in DEA-NO-induced vasodilation, 0.1 mmol/L tempol, a superoxide anion scaven-
ger, was added to the bath before the frequency-response curve to DEA-NO was performed.
Noradrenaline release
Endothelium-denuded mesenteric segments from control and pregnant rats were preincubated
for 30 min in 5 mL of KHS at 37°C and continuously gassed with a 95% O2-5% CO2 mixture
(stabilisation period). This was followed by two washout periods of 10 min in a bath of 0.4 mL
of KHS. Then, the medium was collected to measure basal release. Next, the organ bath was re-
filled, and cumulative EFS periods of 30 s at 1, 2, 4 and 8 Hz were applied at 1 min intervals. Af-
terwards, the medium was collected to measure EFS-induced neurotransmitter release. The
EFS-induced NA release was calculated by subtracting basal NA release from that evoked by
EFS. Mesenteric segments were weighed in order to normalise the results.
NA release was measured using the Noradrenaline Research EIA (Labor Diagnostica Nord,
Gmbh and Co., KG, Nordhon, Germany). The assay was performed following the manufactur-
er’s instructions. Results were expressed as ng NA/mL mg tissue.
Nitric Oxide release
NO release was measured using fluorescence emitted by the fluorescent probe 4,5-diamino-
fluorescein (DAF-2) [23]. Endothelium-denuded mesenteric arteries from control and preg-
nant rats were subjected to a 60-minute equilibration period in HEPES buffer (in mmol/L:
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NaCl 119; HEPES 20; CaCl2 1.2; KCl 4.6; MgSO4 1; KH2PO4 0.4; NaHCO3 5; glucose 5.5;
Na2HPO4 0.15; pH 7.4) at 37°C. Arteries were incubated with 2 μmol/L DAF-2 for 30 min. The
medium was then collected to measure basal NO release. Once the organ bath was refilled, cu-
mulative EFS periods of 30 s at 1, 2, 4 and 8 Hz were applied at 1 min intervals. Afterwards, the
medium was collected to measure EFS-induced NO release. The fluorescence of the medium
was measured at room temperature using a spectrofluorometer (LS50 Perkin Elmer Instru-
ments, FL WINLAB Software, Whaltmann, MA, USA) with excitation wavelength set at 492
nm and emission wavelength at 515 nm. Mesenteric segments were weighed in order to nor-
malize the results.
The EFS-induced NO release was calculated by subtracting basal NO release from that
evoked by EFS. Also, blank samples were collected in the same way from segment-free medium
in order to subtract the background emission. Some assays were performed in the presence of
0.1 mmol/L L-NAME, 0.1 mmol 7-nitroindazol (7-NI), the specific nNOS inhibitor, 1 μmol/L
1400W, the specific iNOS inhibitor, or 0.1 μmol/L TTX. The amount of NO released was ex-
pressed as arbitrary units/mg tissue.
Detection of O2
.-
O2
.- levels were measured using lucigenin chemiluminescence [24]. Endothelium-denuded
mesenteric segments from control and pregnant rats were rinsed in KHS for 30 min, equilibrat-
ed for 30 min in HEPES buffer at 37°C, transferred to test tubes that contained 1 mL HEPES
buffer (pH 7.4) with lucigenin (5 μmol/L) and then kept at 37°C. The luminometer was set to
report arbitrary units of emitted light; repeated measurements were collected for 5 min at 10 s
intervals and averaged. 4,5-Dihydroxy-1,3-benzene-disulphonic acid “Tiron” (10 mmol/L), a
cell-permeant, non-enzymatic O2
.-scavenger, was added to quench the O2
.-dependent chemilu-
minescence. Some segments were preincubated with 0.3 mmol/L apocinin, a NADPH oxidase
inhibitor, or 0.1 mmol/L allopurinol, a xanthine oxidase inhibitor. Also, blank samples were
collected in the same way without mesenteric segments to subtract background emission.
nNOS and P-nNOS Expression
Western blot analysis of nNOS and phosphorylated nNOS (P-nNOS) expression was per-
formed in endothelium-denuded mesenteric segments from control and pregnant rats, as pre-
viously described [23,24]. For these experiments, we used mouse monoclonal nNOS antibody
(1:1000, Abcam, Cambridge, UK), rabbit polyclonal phospho1417-nNOS antibody (1:1000,
Abcam, Cambridge, UK), and monoclonal anti-β-actin-peroxidase antibody (1:50000, Sigma-
Aldrich, Spain). Rat brain homogenates were used as a positive control.
Drugs used
L-NA hydrochloride, ACh chloride, diethylamine NONOate diethylammonium salt, CGRP
(8–37), TTX, L-NAME hydrochloride, 7-NI, 1400W, phentolamine, apocinin, allopurinol, luci-
genin, tiron, tempol and DAF-2 (Sigma-Aldrich, Madrid, Spain) were used. Stock solutions (10
mmol/L) of drugs were made in distilled water, except for NA, which was dissolved in a NaCl
(0.9%)-ascorbic acid (0.01% w/v) solution. These solutions were kept at -20°C and appropriate
dilutions were made in KHS on the day of the experiment.
Data analysis
The responses elicited by EFS and NA were expressed as a percentage of the initial contraction
elicited by 75 mmol/L KCl for comparison between control and pregnant rats. The relaxation
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induced by ACh or DEA-NO was expressed as a percentage of the initial contraction elicited
by NA (Control: 1373 ± 178.4 mg; pregnant: 1366 ± 126.5 mg; P>0.05). For concentration-re-
sponse curves, non-linear regression and Emax and—log EC50 were performed. Results are
given as mean ± S.E.M. Statistical analysis was done by comparing the curve obtained in the
presence of the different substances with the previous or control curve by means of repeated
measure analysis of variance (ANOVA) followed by the Bonferroni post-hoc test using Graph-
Pad Prism 5.0 software (CA, USA). Some results were expressed as differences of area under
the curve (dAUC) for EFS obtained in segments from control and pregnant rats. AUC were cal-
culated from the individual concentration-response plots. For dAUC, NO, O2
.- and NA release
data, the statistical analysis was done using one-way ANOVA followed by Newman-Keuls’
post-hoc test. P<0.05 was considered significant.
Results
Vasomotor response to KCl
In endothelium-intact mesenteric segments, the vasoconstrictor response to 75 mmol/L KCl
was similar in mesenteric segments from control and pregnant rats (Control: 1421 ± 114 mg;
pregnant; 1538 ± 67.3 mg; P>0.05). Endothelium removal did not alter KCl-induced vasocon-
striction (Control: 1677 ± 63.5 mg; pregnant: 1788 ± 54 mg; P>0.05).
Vasodilator response to ACh
Vasodilator response to ACh was similar in NA-precontracted segments from both experimen-
tal groups (Fig 1, Table 1).
Vascular responses to EFS
The application of EFS induced a frequency-dependent contractile response in both endotheli-
um-intact and endothelium-denuded mesenteric segments from both experimental groups.
This vasoconstriction was lower in segments from pregnant rats compared to control animals
(Fig 2A and 2B). Endothelium removal increased the EFS-induced contractile response to a
similar extent in segments from control and pregnant rats (Fig 2A and 2B, Table 2). EFS-in-
duced contractions were practically abolished by preincubation with neurotoxin TTX
(0.1 μmol/L), indicating the neuronal origin of the factors inducing this response (Table 3).
Effect of pregnancy on the sympathetic component of vascular
responses to EFS in endothelium-denuded mesenteric segments
Preincubation with the alpha-adrenergic antagonist phentolamine (1 μmol/L) decreased the
vasoconstrictor response induced by EFS in segments from both experimental groups (Fig 3A
and 3B). This decrease was lower in arteries from pregnant rats (Table 4). The phentolamine-
resistant contractile response to EFS was lower in segments from pregnant rats (Table 5). Pre-
incubation with 6-OHDA practically abolished the EFS-induced contraction in segments from
control and pregnant rats (Table 3). After 6-OHDA preincubation, vasomotor response to KCl
was similar in mesenteric segments from both experimental groups (Control: 1501 ± 95.4 mg;
pregnant; 1622 ± 109 mg; P>0.05).
The contractile response elicited by exogenous NA (1 nmol/L-10 μmol/L) was reduced in
segments from pregnant rats (Fig 3C, Table 1). Additionally, EFS-induced NA release was
lower in segments from pregnant rats (Fig 3D).
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Effect of pregnancy on the sensory component of vascular responses to
EFS in endothelium-denuded mesenteric segments
Preincubation with the CGRP receptor antagonist CGRP (8–37) (0.5 μmol/L) did not alter the
EFS-induced contraction in any experimental group, indicating that sensory innervation did
not contribute to the observed effects (Fig 4A and 4B).
Fig 1. Vasodilator response to ACh. ACh-induced vasodilation in endothelium-intact mesenteric segments from control and pregnant rats. Results (mean
±SEM) were expressed as a percentage of the previous tone elicited by exogenous NA. n = 6 animals each group.
doi:10.1371/journal.pone.0126017.g001
Table 1. Emax (%) and log EC50 (mmol/L) values of vasodilator responses to Ach and DEA-NO or vasoconstrictor responses to NA in mesenteric ar-
teries from control and pregnant rats.
Control Pregnant
Emax -logEC50 Emax -logEC50
ACh 95.09±3.07 6.84±0.08 90.58±2.76 6.72±0.07
NA 167.4±10.2 7.26±0.12 129.7±8.44* 7.23±0.2
DEA-NO 101.8±2.11 6.83±0.06 94.27±3.15 7.21±0.11
Results are expressed as mean±SEM.
*P<0.05 vs. Control.
n = 7 animals each group.
doi:10.1371/journal.pone.0126017.t001
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Effect of pregnancy on the nitrergic component of vascular responses to
EFS in endothelium-denuded mesenteric segments
Preincubation with the unspecific NOS inhibitor L-NAME (0.1 mmol/L) significantly in-
creased the EFS-contractile response at all frequencies in segments from control and pregnant
rats (Fig 5A and 5B). This increase was greater in arteries from pregnant animals (Fig 5C).
Fig 2. Vasoconstrictor response to EFS. EFS-induced vasoconstriction in endothelium intact (A) and endothelium-denuded (B) mesenteric segments from
control and pregnant rats. Results (mean±SEM) were expressed as a percentage of the initial contraction elicited by KCl. ANOVA P<0.05 Control vs.
pregnant in both endothelium intact (A) and endothelium-denuded (B). *P<0.05 vs. control animals at each frequency (Bonferroni test). n = 10 animals
each group.
doi:10.1371/journal.pone.0126017.g002
Table 2. EFS potentiation after endothelium removal in superior mesenteric artery from control and
pregnant rats.
1 Hz 2 Hz 4 Hz 8 Hz
Control 12.51±2.61 18.19±2.79 19.38±3.05 17.23±3.32
Pregnant 11.55±2.92 17.39±3.85 20.26±4.37 19.79±4.26
Percentage (%) of potentiation in EFS-induced contraction after endothelium removal. Calculations are
performed taking KCl-induced contraction as 100% of the contractile response. Results are expressed as
mean ± SEM. n = 10 animals each group.
doi:10.1371/journal.pone.0126017.t002
Table 3. Effect of preincubation with tetrodotoxin (TTX, 0.1μmol/L) or 6-hydroxydopamine (6-OHDA,
1.46 mmol/L) on the frequency—contraction curves performed in mesenteric segments of control and
pregnant rats.
1 Hz 2 Hz 4 Hz 8 Hz
Control 21.31±2.23 34.10±2.56 52.41±2.22 69.28±3.91
TTX 0 0 0 0.5±0.06
6-OHDA 0 0 0.1±0.02 0.2±0.04
Pregnant 16.42±2.72 25.9±3.58 39.28±4.04 53.75±3.99
TTX 0 0 0 0.4±0.05
6-OHDA 0 0 0.1±0.01 0.3±0.05
Results (means ± S.E.M.) are expressed as percentages of the response elicited by 75 mM KCl; zeros are
used when contraction was not detected. n = 7 animals each group.
doi:10.1371/journal.pone.0126017.t003
Pregnancy Modifies Mesenteric Innervation
PLOS ONE | DOI:10.1371/journal.pone.0126017 May 7, 2015 8 / 18
EFS-induced NO release was significantly greater in segments from pregnant rats (Fig 6A).
Preincubation with 0.1 mmol L-NAME, 0.1 mmol 7-NI or 0.1 μmol/L TTX abolished EFS-in-
duced NO release in both experimental groups (Fig 6A), while preincubation with 1 μmol/L
1400W did not modify this release (Fig 6A). Pregnancy did not modify nNOS expression but
did increase P-nNOS expression (Fig 6B).
In segments precontracted with NA, vasodilator response elicited by the exogenous NO
donor DEA-NO (0.1 nmol/L- 10 μmol/L) was similar in mesenteric segments from both exper-
imental groups (Fig 7A, Table 2). Preincubation with 0.1 mmol/L tempol augmented
DEA-NO-induced vasodilation similarly in segments from control and pregnant rats (Fig 7B
and 7C). On the other hand, after subtracting the lucigenin chemiluminescence obtained in the
presence of tiron from that obtained in its absence, superoxide anion formation was greater in
Fig 3. Effect of pregnancy on sympathetic innervation function. Effect of preincubation with 1 μmol/L phentolamine on vasonstriction response induced
by EFS in endothelium-denuded mesenteric segments from control (A) and pregnant rats (B). Results (mean±SEM) were expressed as a percentage of the
initial contraction elicited by KCl. ANOVA P<0.05 vs. conditions without phentolamine in both experimental groups. *P<0.05 vs. conditions without
phentolamine at each frequency (Bonferroni test). n = 8 animals per group. (C) Vasoconstriction response to NA in segments of control and pregnant rats.
Results (mean±SEM) were expressed as a percentage of the initial contraction elicited by KCl. ANOVA P<0.05 Control vs. pregnant. *P<0.05 vs. control
animals at each concentration (Bonferroni test). n = 8 animals per group. (D) EFS-induced NA release in mesenteric segments of control and pregnant rats.
Results expressed as ng NA/mL mg tissue. *P<0.05 vs. Control. n = 6 animals per group.
doi:10.1371/journal.pone.0126017.g003
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Table 4. Effect of preincubation with phentolamine (0.1 μmol/L) on the frequency—contraction curves performed in mesenteric segments from
control and pregnant rats.
1 Hz 2 Hz 4 Hz 8 Hz
Control 24.1±3.23 41.06±2.84 59.14±2.22 77.76±3.90
Phentolamine inhibition 23.79±4.01* 38.88±3.08* 52.90±2.74* 62.63±3.47*
Pregnant 17.53±3.71 27.17±5.84 40.14±5.42 54.03±5.96
Phentolamine inhibition 16.96±5.55* 25.54±6.42*# 36.13±6.39*# 42.97±4.12*#
Percentage (%) of inhibition in EFS-induced contraction after preincubation with phentolamine. Calculations are performed taking KCl-induced contraction
as 100% of the contractile response. Results are expressed as mean ± SEM.
*P<0.05 vs. conditions without phentolamine at each frequency (Bonferroni test).
#P<0.05 vs. Control.
n = 8 animals per group.
doi:10.1371/journal.pone.0126017.t004
Table 5. Remnant vasoconstriction after preincubation with phentolamine (0.1 μmol/L) on the frequency—contraction curves performed inmesen-
teric segments of control and pregnant rats.
1 Hz 2 Hz 4 Hz 8 Hz
Control 24.1±3.23 41.06±2.84 59.14±2.22 77.76±3.90
Phentolamine Remnant 0.40±0.19* 2.17±0.88* 7.98±1.38* 18.35±5.54*
Pregnant 17.53±3.71 27.17±5.84 40.14±5.42 54.03±5.96
Phentolamine Remnant 0.61±0.4* 1.63±0.56* 3.72±2.06*# 9.97±3.63*#
Results (means ± S.E.M.) are expressed as percentages of the response elicited by 75 mM KCl.
*P<0.05 vs. conditions without phentolamine at each frequency (Bonferroni test).
#P<0.05 vs. Control.
n = 8 animals per group.
doi:10.1371/journal.pone.0126017.t005
Fig 4. Effect of pregnancy on sensory innervation. Effect of preincubation with 0.5 μmol/L CGRP (8–37) on the vasoconstrictor response induced by EFS
in mesenteric segments from (A) control and (B) pregnant rats. Results (mean±SEM) are expressed as a percentage of the previous contraction elicited by
KCl. n = 8 animals per group.
doi:10.1371/journal.pone.0126017.g004
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arteries from pregnant rats (Fig 7D). Preincubation with apocinin decreased superoxide anion
formation significantly in mesenteric segments of pregnant rats, while allopurinol did not
modify this formation in any experimental group (Fig 7D)
Discussion
The present study shows that pregnancy diminished the vasoconstrictor response due to stimu-
lation of perivascular innervation in mesenteric artery through an endothelium-independent
mechanism. This effect is associated with a reduction in sympathetic innervation function me-
diated by a decreased NA release and vasoconstrictor response and an increased nitrergic func-
tion associated with increased neuronal NO release. Sensory innervation did not participate in
any experimental conditions.
When analyzing the vasoconstrictor response induced by EFS in endothelium-intact seg-
ments, we observed that EFS produced a frequency-dependent contraction in segments from
both control and pregnant rats that was lower in segments from pregnant rats, as previously re-
ported [4,25,26]. The fact that in our experimental conditions the vasoconstrictor response to
Fig 5. Effect of pregnancy on nitrergic innervation. Effect of preincubation with 0.1 mmol/L L-NAME on the vasoconstrictor response induced by EFS in
mesenteric segments from (A) control and (B) pregnant rats. Results (mean±SEM) are expressed as a percentage of the previous contraction elicited by KCl.
ANOVA P<0.05 vs. conditions without L-NAME in both experimental groups. *P<0.05 vs. conditions without L-NAME for each frequency (Bonferroni test).
n = 8 animals per group. (C) Differences of area under curve (dAUC) in the absence or presence of 0.1 mmol/L L-NAME, dAUC values are expressed as
arbitrary units.*P<0.05 Control vs. pregnant rats.
doi:10.1371/journal.pone.0126017.g005
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KCl remained unmodified by pregnancy, as has been previously reported in this artery [4,27],
indicates the maintenance of vasoconstrictor capacity, ruling out possible changes in the intrin-
sic contractile machinery of smooth muscle cells.
It has been widely described that endothelium affects the response to several vasomotor sub-
stances, including neurotransmitters [28], and since pregnancy could affect the production of
endothelial factors [29] it would consequently affect these responses. In our experimental con-
ditions ACh-induced vasodilation was not modified by pregnancy as also reported by Ralevic
and Burnstock at late-term pregnancy [4]. Endothelium removal increased vasoconstrictor re-
sponse to EFS similarly in both groups, indicating that the modulating role of endothelium in
the EFS vasoconstrictor response is unaltered by pregnancy so the decreased contractile re-
sponse would be due to modifications in perivascular innervation function produced by an en-
dothelium-independent mechanism. Taking into account these results, we performed the
following experiments only in endothelium-denuded mesenteric segments. The abolishment of
EFS-induced vasoconstriction in the presence of TTX indicates that the response to EFS is due
to neurotransmitter release. Sympathetic and nitrergic innervation involvement in the vasomo-
tor response to EFS in rat superior mesenteric artery has been widely reported [9,10], while sen-
sory innervation participation only appears in several pathological situations [13,30,31,32,33].
A decreased participation of sympathetic innervation in splanchnic blood flow as an adapta-
tion to pregnancy has been demonstrated previously and associated with decreased vasocon-
strictor response to NA [7]. However the possibility that the NA release was also affected by
Fig 6. Effect of pregnancy on neuronal NO synthesis. (A) Effect of 0.1 mmo/L L-NAME or 0.1 mmol/L 7-NI or 0.1 μmol/L TTX on EFS-induced NO release
in segments from control and pregnant rats. Results (mean±SEM) were expressed as arbitrary (A.U.)/mg tissue. *P<0.05 vs. Control; #P<0.05 compared
with conditions without specific inhibitor; n = 8 animals per group. (B) Effect of pregnancy on nNOS and P-nNOS expression. The blot is representative of four
separate segments from each group. Rat brain homogenates were used as a positive control. Lower panel shows relation between P-nNOS or nNOS
expression and β-actin. Results (mean±SEM) are expressed as ratio of the signal obtained for each protein and the signal obtained for β-actin. *P<0.05
Control vs. pregnant rats.
doi:10.1371/journal.pone.0126017.g006
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pregnancy has been also suggested but not measured [3,4]. Preincubation with the alpha-adre-
noceptor antagonist phentolamine significantly diminished the vasoconstrictor response to
EFS in mesenteric segments from both experimental groups. This decrease was less marked in
mesenteric segments from pregnant rats, indicating a decreased participation by the adrenergic
component from sympathetic innervation in the lower vasoconstrictor response to EFS in
pregnant rats, similarly to results described by Ralevic and Burnstock [4]. The differences in
the vasoconstrictor response to EFS could be associated with changes in neurotransmitter re-
lease and/or vasomotor response to NA. The results obtained demonstrate that late pregnancy
decreases the vasoconstrictor response to NA and simultaneously decreases NA release in
mesenteric artery. It is well known that there is a decrease in vasomotor responses to contractile
Fig 7. Effect of pregnancy on DEA-NO vasodilation and superoxide anion production. (A) Vasodilator response to NO donor DEA-NO in segments
from control and pregnant rats. Effect of preincubation with tempol (0.1 mmol/L) on vasodilator response to NO donor DEA-NO in segments from (B) control
and (C) pregnant rats. Results (mean±SEM) are expressed as a percentage of the previous tone elicited by exogenous NA. ANOVA P<0.05 vs. conditions
without tempol in both experimental groups. *P<0.05 vs. conditions without tempol for each concentration (Bonferroni test). n = 7 animals per group. Insert
graph shows differences of area under curve (dAUC) in the absence or presence of 0.1 mmol/L tempol; dAUC values are expressed as arbitrary units. (D)
Effect of 0.3 mmol/L apocinin or 0.1 mmol/L allopurinol on superoxide anion release in mesenteric segments from control and pregnant rats. Results (mean
±SEM) are expressed as chemoluminiscence units (U)/min mg tissue. *P<0.05 vs. Control; #P<0.05 compared with conditions without specific inhibitor; n = 7
animals per group.
doi:10.1371/journal.pone.0126017.g007
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substances in pregnancy, although the mechanisms implicated are not well known. No changes
in alpha-adrenoceptor affinity in pregnancy [34], decreased alpha(1)-adrenoceptor expression
[35] and modifications in the regulation of Ca(2+) mobilization and Ca(2+) sensitivity in alpha
(1)-adrenoceptor-mediated contractions [36] have all been described. While the decrease in
NA release could be associated with changes in sympathetic nerve density due to estrogens,
previous studies have report that pregnancy produces no change [37], increased [38] and de-
creased [39] sympathetic nerve density, depending on the tissue studied. We have reported
that the remnant vasoconstriction after preincubation with phentolamine is due to the release
of sympathetic cotransmitter ATP in mesenteric segments from female rats [14]. Preincubation
with the neurotoxine 6-OHDA practically abolished EFS-induced contraction in both experi-
mental groups while the remnant vasoconstriction after preincubation with phentolamine was
decreased in mesenteric segments of pregnant rats, suggesting a minor role for ATP in late
pregnancy. The diminished sympathetic innervation function could, by itself, explain the de-
creased EFS-induced vasoconstriction observed in mesenteric segments from pregnant rats.
However, the participation of other neural components cannot be ruled out.
We have previously reported that sensory innervation does not participate in vasomotor re-
sponse induced by EFS in control Sprague Dawley rats [14]. However, the participation of this
innervation is increased in several pathological conditions such as hypertension, cirrhosis and
diabetes [20,30,31,32]. Important variations in serum levels of the vasodilator CGRP have been
reported in humans and rats during pregnancy [40,41]. Additionally, in rat mesenteric arteries,
both early and late pregnancy are associated with a rise in the vascular sensitivity to CGRP in
selected areas of the vascular bed without a concomitant increase in vascular CGRP production
and release [15,16,42]. This observation led us to study the possible role of sensory innervation
in the decreased EFS vasoconstriction observed in pregnant rats. Preincubation with the CGRP
receptor antagonist CGRP (8–37) did not alter EFS-induced vasoconstriction in any experi-
mental group, indicating that in late pregnancy sensory innervation does not participate in the
vasoconstrictor response to EFS. This result contrasts with those of Ralevic and Burnstock [4],
who observed a participation of sensory innervation in the EFS-mediated relaxation, and this
response was not modified by pregnancy. Nevertheless, Lanlua et al. [43] reported no effect
from CGRP (8–37) in the EFS-mediated relaxation of small mesenteric arteries in pregnancy.
It has also been suggested an involvement by NO in the decreased vasoconstrictor response
to EFS in conductance and resistance mesenteric arteries during pregnancy [4,25] since there is
increased NO production and release by endothelial cells. However, the fact that the unspecific
inhibition of NO synthesis also affects neuronal NO does not rule out the participation of nitrer-
gic perivascular innervation, especially when NO released from nitrergic innervation has been
demonstrated to have a vasodilator role that contributes to decreasing the vasomotor response
to EFS [10]. Previously, we have demonstrated that both the non-selective NOS inhibitor
L-NAME and the specific nNOS inhibitor 7-NI decrease EFS-induced NO release to a similar
extent [23]. However, in vascular reactivity experiments, preincubation with 7-NI also decreased
the vasoconstrictor response to NA, making the analysis of EFS-induced contractions very com-
plex, and leading to result misinterpretation [23,44]. For that reason, we used L-NAME instead
of 7-NI in vascular reactivity experiments. Vasoconstriction induced by EFS was increased in
L-NAME incubated segments from both groups of rats, suggesting an involvement by NO in
this response, as previously described in this rat strain [10]. The greater effect of L-NAME ob-
served in segments from pregnant rats suggests an increased role of neuronal NO in EFS-in-
duced vasoconstriction related to increases in NO release and/or increases in the vasodilator
response. EFS-induced NO release was higher in segments from pregnant animals, confirming
our hypothesis. Production of NO in neural tissue can have two sources: nNOS and iNOS
[22,44,45]. EFS-induced NO release was abolished by preincubation with L-NAME, 7-NI or
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TTX in both experimental groups, confirming that EFS induced NO release from nitrergic in-
nervation. Additionally, in the present study, the specific iNOS inhibitor 1400W did not change
EFS-induced NO release in segments from the two experimental groups, ruling out the partici-
pation of this inducible isoform in our experimental approach, as previously reported [22,46].
The differences in NO release observed in our experimental conditions could be dependent
on nNOS expression and/or activity. We found that nNOS protein expression was not modi-
fied by pregnancy, whereas P-nNOS, the active form of nNOS was increased, suggesting in-
creased nNOS activity. Estrogens are reported to regulate constitutive nitric oxide synthases
and this regulation could be implicated in changes occurring in pregnancy [47]. Additionally
Martini et al. [48] have reported an increase in nNOS expression correlated with increased fe-
male sex hormone levels, suggesting a complex action by female sex hormones in nNOS ex-
pression; therefore the increased nNOS activity could be due to the estrogens as has been
reported previously [49].
Thus, increased NO release participates in the diminished response to EFS in segments
from pregnant rats. However, altered smooth muscle cell sensitivity to NO cannot be ruled out
since measurements of oxidative stress markers in maternal blood and urine show that preg-
nancy itself is a state of oxidative stress due to the high metabolic activity of the placenta and
maternal metabolism [50], and this could alter NO bioavailability. First, we confirmed that su-
peroxide anion production is increased in mesenteric segments from pregnant rats. Oxidative
stress in pregnancy is regulated differently depending on the organ analysed [51]. It is well
known that NADPH oxidase is the main source of superoxide anion in vessels [52]. Taking
this into account, we have measured superoxide anion production in the presence of the
NADPH oxidase inhibitor apocinin and the xanthine oxidase inhibitor allopurinol. Preincuba-
tion with apocinin significantly decreased superoxide anion production only in mesenteric seg-
ments of pregnant rats, but allopurinol did not modify superoxide anion production in any
experimental group. These results confirm NADPH oxidase as the principal source of oxidative
stress in superior mesenteric artery in late pregnancy. However, the vasodilator response to
DEA-NO was similar in segments from both experimental groups. Additionally, preincubation
with the superoxide anion scavenger tempol increased vasodilator response to DEA-NO to a
similar extent in mesenteric segments from both control and pregnant rats. These results sug-
gest that, despite the increased superoxide anion levels observed, the oxidation process is un-
able to affect the NO metabolism enough to significantly affect vasodilator response.
In conclusion, our results show that neural control of mesenteric vasomotor tone was al-
tered by pregnancy. Diminished sympathetic and enhanced nitrergic components both con-
tributed to a decreased vasoconstriction response to EFS. The sensory innervation did not
participate in these modifications. All these changes indicate the simultaneous implication of
different components of perivascular innervation in vascular adaptations to pregnancy.
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Abstract
Objectives: The aim of this study was to investigate in rat mesenteric artery whether breast feeding (BF) affects the
vasomotor response induced by electrical field stimulation (EFS), participation by different innervations in the EFS-induced
response and the mechanism/s underlying these possible modifications.
Methods: Experiments were performed in female Sprague-Dawley rats (3 months old), divided into three groups: Control (in
oestrous phase), mothers after 21 days of BF, and mothers that had recovered their oestral cycle (After BF, in oestrous
phase). Vasomotor response to EFS, noradrenaline (NA) and nitric oxide (NO) donor DEA-NO were studied. Neuronal NO
synthase (nNOS) and phosphorylated nNOS (P-nNOS) protein expression were analysed and NO, superoxide anion (O2
.–), NA
and ATP releases were also determined.
Results: EFS-induced contraction was higher in the BF group, and was recovered after BF. 1 mmol/L phentolamine
decreased the response to EFS similarly in control and BF rats. NA vasoconstriction and release were similar in both
experimental groups. ATP release was higher in segments from BF rats. 0.1 mmol/L L-NAME increased the response to EFS
in both control and BF rats, but more so in control animals. BF decreased NO release and did not modify O2
.– production.
Vasodilator response to DEA-NO was similar in both groups, while nNOS and P-nNOS expressions were decreased in
segments from BF animals.
Conclusion: Breast feeding increases EFS-induced contraction in mesenteric arteries, mainly through the decrease of
neuronal NO release mediated by decreased nNOS and P-nNOS expression. Sympathetic function is increased through the
increased ATP release in BF rats.
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Introduction
Breast feeding is characterised by strict hormonal control
mediated by oestrogen, progesterone, prolactin and oxytocin,
associated with increases in gastrointestinal blood flow and cardiac
output [1,2] to provide the udder with nutrients and hormones
that regulate milk synthesis and secretion. Some hormones
implicated in the lactation process (prolactin, oxytocin) have been
reported to alter vascular function [3,4].
Vascular tone is determined by an equilibrium among several
mechanisms, including hormonal, metabolic and neuronal factors.
This neural regulation involves sympathetic, cholinergic, nitrergic,
peptidergic and/or sensory innervations that are specific to the
vascular bed considered [5,6]. In rat mesenteric arteries, vascular
tone is mediated by the integrated action of different neurotrans-
mitters, mainly noradrenaline (NA) and ATP from sympathetic
nerve terminals, neuronal nitric oxide (NO) from nitrergic
innervation and calcitonin gene-related peptide (CGRP) from
sensory nerves [7,8,9,10]. Several experimental and pathophysi-
ological circumstances including ageing, hypertension and diabe-
tes, have been shown to alter the functional role of these
components [11,12,13].
We have previously reported that sex steroids modulate the
synthesis and/or sensitivity to these neurotransmitters in rat
mesenteric arteries [14,15]. Reports of the effects of breast feeding
on sympathetic activity are contradictory, with increased and
decreased sympathetic tone being described [16,17,18]. On the
other hand, increased serum nitrite and nitrate concentrations [19]
and ROS generation [20] have been reported in breast-feeding
mothers. These findings indicate that the functional role of
adrenergic and nitrergic innervations could be affected in breast
feeding and this would affect peripheral vascular resistance.
Therefore, the aim of this study was to investigate whether
breast feeding affects neurotransmitter release or EFS-induced
vasomotor response in rat mesenteric arteries, the participation of
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different innervations in the EFS-induced response and the
mechanism/s underlying these possible modifications.
Methods
Animals
Female Sprague-Dawley rats (3 months-old) were obtained from
the Animal Quarters of the Universidad Auto´noma de Madrid
and housed in the Animal Facility of the Universidad Auto´noma
de Madrid (Registration number EX-021U) in accordance with
guidelines 609/86 of the E.E.C., R.D. 233/88 of the Ministerio de
Agricultura, Pesca y Alimentacio´n of Spain, and Guide for the Care and
Use of Laboratory Animals published by the United States
National Institute of Health [NIH publication No. 85.23, revised
1985]. All experimental procedures involving animal use were
approved by the Ethics Committee of the Universidad Auto´noma de
Madrid. Rats were housed during treatment at a constant room
temperature, humidity, and light cycle (12:12 h light-dark) with
free access to tap water and fed with standard rat chow ad libitum.
Rats were divided into three groups: Control (virgin females in
oestrous phase), mothers after 21 days of breast feeding (BF), and
mothers that had recovered their oestral cycle (After BF, in
oestrous phase).
Animals were sacrificed by CO2 inhalation; the first branch of
the mesenteric artery was carefully dissected, cleaned of connective
tissue and placed in Krebs-Henseleit solution (KHS, in mmol/L:
NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4. 7H2O 1.2,
NaHCO3 25, glucose 11.1, Na2EDTA 0.03) at 4uC. For protein
expression analysis, some arteries were rapidly frozen in liquid
nitrogen and kept at 280uC until the day of analysis.
Vascular Reactivity
The method used for isometric tension recording has been
described in full elsewhere [9,21]. Two parallel stainless steel pins
were introduced through the lumen of the vascular segment: one
was fixed to the bath wall and the other connected to a force
transducer (Grass FTO3C; Quincy, Mass., USA); this, in turn, was
connected to a model 7D Grass polygraph. For EFS experiments,
segments were mounted between two platinum electrodes 0.5 cm
apart and connected to a stimulator (Grass, model S44) modified
to supply adequate current strength. Segments were suspended in
an organ bath containing 5 mL of KHS at 37uC and continuously
bubbled with a 95% O2 to 5% CO2 mixture (pH 7.4). Some
experiments were performed in endothelium-denuded segments to
eliminate the main source of vasoactive substances, including
endothelial NO. This avoided possible actions by different drugs
on endothelial cells that could lead to misinterpretation of results.
Endothelium was removed by gently rubbing the luminal surface
of the segments with a thin wooden stick. The segments were
subjected to a tension of 0.5 g, which was readjusted every 15 min
during a 90-min equilibration period before drug administration.
After this, the vessels were exposed to 75 mmol/L KCl, to check
their functional integrity. Endothelium removal did not alter the
contractions elicited by 75 mmol/L KCl. After a washout period,
the presence/absence of vascular endothelium was tested by the
ability/inability of 10 mmol/L acetylcholine (ACh) to relax
segments precontracted with NA (1 mmol/L).
Vasodilator response to ACh (0.1 nmol/L-10 mmol/L) was
tested in endothelium-intact arteries from all experimental groups.
Frequency-response curves to EFS (1, 2, 4, 8 and 16 Hz) were
performed in endothelium-intact and endothelium-removed mes-
enteric segments from all experimental groups. The parameters
used for EFS were 200 mA, 0.3 ms, 1–16 Hz, for 30 s with an
interval of 1 min between each stimulus, the time required to
recover basal tone. A washout period of at least 1 h was necessary
to avoid desensitisation between consecutive curves. Two succes-
sive frequency-response curves separated by 1-hour intervals
produced similar contractile responses. To evaluate the neural
origin of the EFS-induced contractile response, the nerve impulse
propagation blocker, tetrodotoxin, (TTX, 0.1 mmol/L) was added
to the bath 30 min before the second frequency-response curve
was performed.
To determine the participation of sympathetic innervation in
the EFS-induced response in endothelium-denuded segments from
control and BF rats, 1 mmol/L phentolamine, an a-adrenoceptor
antagonist, or phentolamine plus 0.1 mmol/L suramin, a non-
specific P2 purinergic receptor antagonist, were added to the bath
30 min before performing the frequency-response curve. Addi-
tionally, the vasoconstrictor response to exogenous NA (1 nmol/L-
10 mmol/L) was tested in segments from both experimental
groups.
To study the possible participation of sensitive innervation in
EFS-induced response in endothelium-denuded segments from
control and BF rats, 0.5 mmol/L CGRP (8–37), a CGRP receptor
antagonist, was added to the bath 30 min before performing the
second frequency–response curve.
To analyse the participation of NO in the EFS- induced
response in endothelium-denuded segments from control and BF
rats, 0.1 mmol/L Nv-nitro-L-arginine methyl ester (L-NAME), a
non-specific inhibitor of nitric oxide synthase (NOS), was added to
the bath 30 min before performing the second frequency–response
curve. The vasodilator response to the NO donor, diethylamine
NONOate, (DEA-NO, 0.1 nmol/L–0.1 mmol/L) was determined
in NA-precontracted arteries from both experimental groups.
Noradrenaline and ATP Release
Endothelium-denuded segments of rat mesenteric arteries from
control and BF rats were preincubated for 30 minutes in 5 mL of
KHS at 37uC and continuously gassed with a 95% O2–5% CO2
mixture (stabilisation period). This was followed by two washout
periods of 10 min in a bath of 0.4 mL KHS. Then the medium
was collected to measure basal release. Next, the organ bath was
refilled and cumulative EFS periods of 30 s at 1, 2, 4, 8 and 16 Hz
were applied at 1 min intervals. Afterwards, the medium was
collected to measure EFS-induced neurotransmitter release.
Mesenteric segments were weighed in order to normalise the
results.
NA and ATP releases were measured using Noradrenaline
Research EIA (Labor Diagnostica Nord, Gmbh and Co., KG,
Nordhon, Germany) or an ATP Colorimetric/Fluorometric Assay
kit (Abcam, Cambridge, UK). The assays were performed
following the manufacturers’ instructions. Results were expressed
as ng NA/mL mg tissue, or nmol ATP/mL mg tissue.
Nitric Oxide Release
NO release was measured using fluorescence emitted by the
fluorescent probe 4,5-diaminofluorescein (DAF-2). Endothelium-
denuded mesenteric arteries from control and BF rats were
subjected to a 60-minute equilibration period in HEPES buffer (in
mmol/L: NaCl 119; HEPES 20; CaCl2 1.2; KCl 4.6; MgSO4 1;
KH2PO4 0.4; NaHCO3 5; glucose 5.5; Na2HPO4 0.15; pH 7.4) at
37uC. Arteries were incubated with 2 mmol/L DAF-2 for 30 min.
The medium was then collected to measure basal NO release.
Once the organ bath was refilled, cumulative EFS periods of 30 s
at 1, 2, 4, 8 and 16 Hz were applied at 1 min intervals.
Afterwards, the medium was collected to measure EFS-induced
NO release. The fluorescence of the medium was measured at
room temperature using a spectrofluorometer (LS50 Perkin Elmer
Mesenteric Innervation in Breast Feeding Adult Rat
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Instruments, FL WINLAB Software, Whaltmann, MA, USA) with
excitation wavelength set at 492 nm and emission wavelength at
515 nm.
The EFS-induced NO release was calculated by subtracting
basal NO release from that evoked by EFS. Also, blank sample
measures were collected in the same way from segment-free
medium in order to subtract background emission. Some assays
were performed in the presence of 0.1 mmol//L TTX or 1 mmol/
L 1400W, the specific iNOS inhibitor. The amount of NO
released was expressed as arbitrary units/mg tissue.
Detection of O2
.–
O2
.– levels were measured using lucigenin chemiluminescence.
Endothelium-denuded mesenteric segments from control and BF
rats were rinsed in KHS for 30 min, equilibrated for 30 min in
HEPES buffer at 37uC, transferred to test tubes that contained
1 mL HEPES buffer (pH 7.4) containing lucigenin (5 mmol/L)
and then kept at 37uC. The luminometer was set to report
arbitrary units of emitted light; repeated measurements were
collected for 5 min at 10 s intervals and averaged. 4,5-Dihydroxy-
1,3-benzene-disulphonic acid ‘‘Tiron’’ (10 mmol/L), a cell-per-
meant, non-enzymatic O2
.– scavenger, was added to quench the
O2
.–dependent chemiluminescence. Also, blank samples were
collected in the same way without mesenteric segments to subtract
background emission.
nNOs and P-nNOS Expression
Western blot analysis of nNOS and phosphorylated nNOS (P-
nNOS) expression was performed in endothelium-denuded
mesenteric segments from control and BF rats, as previously
described [22]. For these experiments, we used mouse monoclonal
nNOS antibody (1:1000, Transduction Laboratories), rabbit
polyclonal P-nNOS antibody (1:2000, Abcam, Cambridge, UK),
and monoclonal anti-ß -actin-peroxidase antibody (1:50000,
Sigma-Aldrich, Spain). Rat brain homogenates were used as
positive control.
Drugs Used
L -NA hydrochloride, ACh chloride, diethylamine NONOate
diethylammonium salt, CGRP (8–37), suramin hexasodium salt,
TTX, L -NAME hydrochloride, 1400W, phentolamine, lucigenin,
tiron and DAF-2 (Sigma-Aldrich, Madrid, Spain) were used. Stock
solutions (10 mmol/L) of drugs were made in distilled water,
except for NA, which was dissolved in a NaCl (0.9%)-ascorbic acid
(0.01% w/v) solution. These solutions were kept at –20uC and
appropriate dilutions were made in KHS on the day of the
experiment.
Data Analysis
The responses elicited by EFS and NA were expressed as a
percentage of the initial contraction elicited by 75 mmol/L KCl
for comparison between control and BF rats. The relaxation
induced by ACh or DEA-NO was expressed as a percentage of the
initial contraction elicited by NA (Control: 1070.5464.6 mg; BF:
1096.9265.1 mg; after BF: 1054.1768.5; P.0.05). For concen-
tration-response curves, non-linear regression and Emax and –log
EC50 were performed. Results are given as mean6SEM.
Statistical analysis was done by comparing the curve obtained in
the presence of the different substances with the previous or
control curve by means of repeated measure analysis of variance
(ANOVA) followed by Bonferroni post-hoc test, using GraphPad
Prism 5.0 software (CA, USA). Some results were expressed as
differences of area under the curve (dAUC) of EFS obtained in
segments from control and BF animals. AUC were calculated from
the individual concentration-response plots. For dAUC, NO, O2
.,
ATP and NA release data, the statistical analysis was done using
one-way ANOVA followed by Newman-Keuls post-hoc test.
P,0.05 was considered significant.
Results
Vasomotor Response to KCl
In endothelium-intact mesenteric segments, the vasoconstrictor
response to 75 mmol/l KCl was similar in all experimental groups
(Control: 1393689.65 mg; BF: 14456164.85 mg; After BF:
14126120.54 mg; P.0.05). Endothelium removal did not alter
KCl-induced vasoconstriction (Control: 1348697.95 mg; BF:
1354685.77 mg; After BF: 13956124.46 mg; P.0.05).
Vasodilator Response to ACh
Vasodilator response to ACh was similar in all experimental
groups (Figure 1, Table 1).
Vascular Responses to EFS
The application of EFS induced a frequency-dependent
contractile response in endothelium-intact mesenteric segments
from all experimental groups. This vasoconstriction was greater in
segments from BF rats compared to control and after BF animals
(Figure 2A). Endothelium removal increased EFS-induced con-
tractile response similarly in segments from all experimental
groups (Figure 2B, Table 2). EFS-induced contractions were
practically abolished in segments from all experimental groups by
the neurotoxin TTX (0.1 mmol/L), indicating the neuronal origin
of the factors inducing this response (Results not shown).
Since the differences appear only between control and BF rats,
and both endothelial and neuronal function are reversed to control
situation in after BF rats, we performed the following experiments
only in mesenteric segments from control and BF animals.
Figure 1. Vasodilator response to ACh. ACh-induced vasodilation
in endothelium-intact mesenteric segments from control, breast-
feeding (BF) and after BF rats. Results (mean6SEM) were expressed as
a percentage of the previous tone elicited by exogenous NA. n = 6
animals each group.
doi:10.1371/journal.pone.0053802.g001
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Effect of BF on Sympathetic Component of Vascular
Responses to EFS
Preincubation with the a-adrenergic antagonist phentolamine
(1 mmol/L) decreased the vasoconstrictor response induced by
EFS in segments from both experimental groups to the same
extent (Figure 3A, 3B and 3C). In agreement with these results, the
contraction elicited by exogenous NA (1 nmol/L-10 mmol/L) was
similar in segments from both experimental groups (Figure 4A,
Table 3). Additionally, EFS-induced NA release was similar in
segments from both experimental groups (Figure 4B).
Nevertheless, the remnant vasoconstriction induced by EFS
after phentolamine preincubation was greater in segments from
BF animals. Preincubation with phentolamine plus 0.1 mmol/L
suramin, a non-specific P2 purinergic receptor antagonist,
decreased EFS-induced contraction in segments from both
experimental groups. This decrease was greater in segments from
BF animals (Figure 3A, 3B and 3D). In line with this, EFS-induced
ATP release was increased in segments from BF rats (Figure 4C).
Effect of BF on Sensory Component of Vascular
Responses to EFS
Preincubation with the CGRP receptor antagonist CGRP (8–
37) (0.5 mmol/L) did not alter the EFS-induced contraction in any
experimental group (Results not shown).
Effect of BF on Nitrergic Component of Vascular
Responses to EFS
EFS-induced NO release was significantly lower in segments
from BF rats (Figure 5A). Preincubation with 0.1 mmol/L TTX
abolished EFS-induced NO release, while preincubation with
1 mmol/L of the specific iNOS inhibitor 1400W did not modify it
(Results not shown). Both nNOS and P-nNOS expression were
diminished in segments from BF rats (Figure 5B). In segments
precontracted with NA, vasodilator response elicited by the
exogenous NO donor DEA-NO (0.1 nmol/L-10 mmol/L) was
similar in mesenteric segments from both experimental groups
(Figure 5C, Table 3). Additionally, after subtracting the lucigenin
chemiluminescence obtained in the presence of Tiron from that
obtained in its absence, superoxide anion formation was similar in
segments from both experimental groups (Figure 5D).
In line with these results, preincubation with the unspecific NO
synthase inhibitor L-NAME (0.1 mmol/L) significantly increased
the EFS-contractile response in segments from both experimental
groups. This increase was lower in segments from BF rats
(Figure 6).
Table 1. Emax (%) and log EC50 (mmol/L) values of vasodilator
responses to ACh in mesenteric arteries from control, BF and
after BF female rats.
Control BF After BF
Emax 101.566.7 96.2067.4 98.9264.5
2log EC50 6.9460.2 7.1060.3 7.1060.1
Results are expressed as means6S.E.M. n = 6 animals each group.
doi:10.1371/journal.pone.0053802.t001
Figure 2. Vasoconstrictor response to EFS. EFS-induced vasoconstriction in endothelium-intact (A) and endothelium-removed (B) mesenteric
segments from control, breast feeding (BF) and after BF rats. Results (Mean6S.E.M.) were expressed as a percentage of the initial contraction elicited
by KCl. ANOVA P,0.05 Control vs. BF; ANOVA P,0.05 BF vs. After BF in both endothelium intact (A) and endothelium-removed (B) arteries. *P,0.05
vs. control animals at each frequency; #P,0.05 vs. BF group at each frequency (Bonferroni test). n = 10 animals each group.
doi:10.1371/journal.pone.0053802.g002
Table 2. EFS potentiation after endothelium removal.
1 Hz 2 Hz 4 Hz 8 Hz 16 Hz
Control 16.963.5 19.262.1 22.462.3 18.162.5 15.762.9
BF 21.263.1 22.461.8 24.363.4 21.762.7 18.361.7
After BF 17.662.9 20.761.7 21.962.9 19.263.1 17.662.1
Percentage (%) of potentiation in EFS-induced contraction after endothelium
removal. Calculations are performed taking KCl-induced contraction as 100% of
the contractile response. Results are expressed as mean 6 SEM. n = 10 animals
each group.
doi:10.1371/journal.pone.0053802.t002
Mesenteric Innervation in Breast Feeding Adult Rat
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e53802
Discussion
The vasoconstrictor response to EFS is increased by breast
feeding and is restored after this physiological process. This
increase is endothelium-independent, and is mediated by at least
two mechanisms: an increase in ATP release and a decrease in
neuronal NO release.
Important differences in vascular reactivity to different agonists
have been described in several physiological processes associated
to changes in hormone levels. Previous results have been
contradictory, since changes as well as no changes have both
been reported in the vasoconstrictor response to KCl associated
with modifications in sexual hormone levels [23,24,25]. In our
experimental conditions the vasoconstrictor response to KCl
remained unmodified by breast feeding.
When analysing the vasoconstrictor response induced by EFS in
endothelium-intact segments, we observed that EFS produced a
frequency-dependent contraction in segments from all experimen-
tal groups. Mesenteric arteries from breast-feeding rats showed an
increased response to EFS. This increase was abolished after
breast feeding, and was not attributable to changes in the intrinsic
contractile machinery as was demonstrated by the similar
vasoconstrictor response to KCl in all experimental groups.
Endothelium removal increased vasoconstrictor response to EFS
to the same extent in the three experimental groups, indicating
that the modulating role of endothelium is not modified by breast
feeding. The fact that ACh-induced vasodilation was not modified
in any experimental group reinforces this observation. Therefore,
these results indicate that the increment observed during breast
feeding is due to modifications in perivascular innervation
function, as was confirmed by the abolishment of EFS-induced
vasoconstriction in the presence of TTX. Additionally, since both
endothelial and neuronal function are not different when
comparing control and after BF rats, we performed the following
experiments only in mesenteric segments from control and BF
animals.
Hence, this effect could be associated with changes in
neurotransmitter release and/or vasomotor response to the
neurotransmitter/s. In order to clarify this aspect, our next
objective was to determine possible differences in the participation
of sympathetic innervation between control and breast-feeding
experimental groups. The participation of sympathetic innervation
in splanchnic blood flow adaptation to different situations has been
demonstrated previously [26]. Sympathetic innervation releases
mainly NA and ATP when electrically stimulated. The results of
several studies are inconclusive regarding whether or not sexual
hormones affect sympathetic activity [27,28,29], but both increas-
es and decreases have been reported during breast feeding
[16,17,18]. The fact that the a-adrenoceptor antagonist phentol-
amine significantly diminished the vasoconstrictor response to EFS
in mesenteric segments from both experimental groups confirms
that this response appears to be mediated mainly by the release of
NA from sympathetic nerve terminals. In our study the decreases
in EFS vasoconstriction induced by phentolamine, NA release and
exogenous NA-induced vasoconstriction were similar in both
experimental groups, indicating the non-participation of the
adrenergic component from sympathetic innervation in the
increased vasoconstrictor response to EFS in breast-feeding rats.
Figure 3. Effect of breast feeding on sympathetic innervation function. Effect of preincubation with 1 mmol/L phentolamine or 1 mmol/L
phentolamine plus 0.1 mmol/L suramin on the vasoconstrictor response induced by EFS in endothelium-denuded mesenteric segments from control
(A) and breast-feeding (BF) rats (B). Results (Mean6S.E.M.) are expressed as a percentage of the previous contraction elicited by KCl. n = 6 animals
each group. ANOVA P,0.05 vs. conditions without phentolamine in both experimental groups. *P,0.05 vs. conditions without phentolamine at
each frequency (Bonferroni test). ANOVA P,0.05 phentolamine vs. phentolamine plus suramin in both experimental groups.# P,0.05 phentolamine
vs. phentolamine plus suramin at each frequency (Bonferroni test). (C) Representation of remnant vasoconstriction after preincubation with 0.1 mmol/
L phentolamine, expressed as area under curve (AUC). *P,0.05 control vs. BF. Differences of area under curve (dAUC) in the absence or presence of
01 mmol/L phentolamine (D) or in the absence or presence of 1 mmol/L phentolamine plus 0.1 mmol/L suramin (E). dAUC values are expressed as
arbitrary units. *P,0.05 control vs. BF.
doi:10.1371/journal.pone.0053802.g003
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It should also be mentioned that in both groups there was a
substantial contractile response that was phentolamine-resistant.
This remnant vasoconstriction was higher in segments from breast
feeding animals. In mesenteric arteries we have previously
demonstrated that this remnant vasoconstriction is due to ATP
release from sympathetic nerve endings [30]. Based on this
information, we analysed EFS-induced contraction after simulta-
neous preincubation with phentolamine plus the non-specific P2
purinergic receptor antagonist suramin. In these conditions, the
contractile response to EFS was reduced in both experimental
groups, but the reduction was greater in segments from BF than in
control rats, indicating a higher ATP participation in this response
during BF. In line with these results, EFS-induced ATP release
was higher in mesenteric segments from BF than control rats.
Taken together, these results indicate that the greater EFS-
induced vasoconstriction observed in mesenteric segments from
breast-feeding rats might be due to an increase in sympathetic
function through increased ATP release. However, the participa-
tion of other kinds of innervation cannot be ruled out.
We have previously reported that CGRP released from sensory
innervation does not participate in the vasoconstrictor response to
EFS in our experimental conditions [22,30]. However, we have
also demonstrated that in several situations, such as hypertension
and diabetes [11,15,33], CGRP does begin to be functional. Since
sex hormones have been shown to modulate CGRP release [31],
we analyzed the possibility that breast feeding might produce
changes in sensory innervation function in rat mesenteric
innervation. The non-modification of EFS-induced vasoconstric-
tion obtained after preincubation with CGRP receptor antagonist
CGRP (8–37) indicates that breast feeding does not modify the
participation of sensory innervation-derived CGRP in vasomotor
response to EFS.
Figure 4. Effect of breast feeding on NA vasoconstriction and release, and ATP release. (A) Vasoconstrictor response to exogenous NA in
segments from control and breast-feeding (BF) rats. Results (Mean6S.E.M.) are expressed as a percentage of the previous contraction elicited by KCl.
n = 8 animals each group. (B) EFS-induced NA release in mesenteric segments from control and breast-feeding (BF) rats. Results (Mean6S.E.M.) are
expressed as ng NA/mL mg tissue. n = 6 animals per group. (C) EFS-induced ATP release in mesenteric segments from control and breast-feeding (BF)
rats. Results (Mean6S.E.M.) are expressed as mmol ATP/mL mg tissue. *P,0.05 vs control. n = 7 animals per group.
doi:10.1371/journal.pone.0053802.g004
Table 3. Emax (%) and log EC50 (mmo/L) values of
vasoconstrictor response to NA or vasodilator response to
DEA-NO in mesenteric arteries from control and BF rats.
Control BF
Emax 2log EC50 Emax –log EC50
NA 226.3655.3 7.660.8 242.4645.2 7.3760.5
DEA-NO 100.963.4 6.0460.1 108.168.9 5.8960.2
Results are expressed as means6S.E.M. n = 7–8 animals each group.
doi:10.1371/journal.pone.0053802.t003
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The participation of neuronal NO released from perivascular
nitrergic innervation in the EFS-induced response has been
exhaustively studied by our group [13,22,30,32]. In the experi-
mental conditions presented in this study, the involvement of
neuronal NO in the EFS-induced response is demonstrated by the
increased response to EFS in segments from both experimental
groups after preincubation with the unspecific NOS inhibitor L-
NAME. This increase was greater in segments from breast-feeding
rats, indicating that this condition could induce differences in the
neuronal NO pathway. Previous studies have reported increased
nitrite and nitrate levels in breast-feeding mother’s serum [19],
suggesting an increase in NO release, which could be originated
from different sources, such as endothelium and innervation.
However, in our experimental conditions, EFS-induced NO
release was significantly decreased by breast feeding. NO
production in neural tissue can have two sources: nNOS or iNOS
[22,30,32,34]. The fact that preincubation with TTX abolished
EFS-induced NO release in segments from both groups of rats,
and that preincubation with the specific iNOS inhibitor 1400W
did not alter NO release, confirms the neural origin and rules out
the inducible origin of the NO. Since we have previously
demonstrated in this vascular bed that NO released from nerve
endings is synthesized through nNOS [22,30], our next objective
was to determine whether this decrease was due to alterations in
nNOS expression and/or activation. We observed by Western blot
analysis that both nNOS and P-nNOS expression were diminished
in mesenteric segments from breast-feeding rats compared to
controls, indicating that the local decrease of neuronal release in
Figure 5. Effect of breast feeding on neuronal NO synthesis and vasodilation. (A) EFS-induced NO release in segments from control and
breast-feeding (BF) rats. Results (Mean6S.E.M.) are expressed as arbitrary units (A.U.)/mg tissue. *P,0.05 vs. Control; n = 8 animals per group. (B)
Effect of breast feeding (BF) on nNOS and P-nNOS expression. The blot is representative of four separate segments from each group. Rat brain
homogenates were used as positive control. Lower panel shows relation between P-nNOS or nNOS expression and ß-actin. Results (Mean6S.E.M.) are
expressed as the ratio of the signal obtained for each protein and the signal obtained for ß-actin. *P,0.05 vs. control. (C) Vasodilator response to NO
donor DEA-NO in segments from control and breast-feeding (BF) rats. Results (Mean6S.E.M.) are expressed as a percentage of the previous tone
elicited by exogenous NA. n = 7 animals each group. (D) Superoxide anion release in mesenteric segments from control and breast-feeding (BF) rats.
Results (Mean6S.E.M.) are expressed as chemiluminiscence units (U)/min mg tissue. n = 4 animals per group.
doi:10.1371/journal.pone.0053802.g005
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breast-feeding rats is caused by decreased nNOS expression and
activation.
Increased ROS generation has been described specially at the
end of gestation and the beginning of lactation [20]. Thus, the
involvement of ROS in the vascular response cannot be ruled out,
since it would alter the neuronal NO metabolism and consequently
affect the bioavailability of neuronal NO. Superoxide anion
release was similar in segments from both control and breast-
feeding rats. Additionally, the vasodilator response to the NO
donor DEA-NO was similar in segments from both experimental
groups confirming that the diminished function of the nitrergic
innervation is due to a decreased neuronal NO release and not to
changes in the vasodilator response and/or metabolism of
neuronal NO.
In conclusion, breast feeding increases the contractile response
induced by EFS in mesenteric arteries and this increase appears to
be mainly mediated by a decrease in the neuronal NO release
mediated by decreased nNOS and P-nNOS expression. Addition-
ally, sympathetic innervation function is increased through
increased ATP release. These alterations might have relevance
when mothers develop hypertension during the breast feeding
period.
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A B S T R A C T
In the present study, we analysed possible alterations in adrenergic, nitrergic and sensory
functioning in mesenteric arteries from rats at 1 and 21 months after partial portal vein ligation,
and the mechanisms involved in these alterations, if any. For this purpose, we analysed the
vasoconstrictor response to EFS (electrical field stimulation) and the effect of the α-antagonist
phentolamine, the NOS (nitric oxide synthase) inhibitor L-NAME (NG-nitro-L-arginine methyl
ester) and the CGRP (calcitonin gene-related peptide) receptor antagonist CGRP-(8–37) in
mesenteric segments from ST (short-term; 1 month) and LT (long-term; 21 months) SO (sham-
operated) and pre-hepatic PH (portal hypertensive) rats. The vasomotor responses to NA
(noradrenaline), the NO donor DEA-NO (diethylamine NONOate) and CGRP were analysed.
NA, NO and CGRP releases were measured. Phospho-nNOS (neuronal NOS) expression was
studied. The vasoconstrictor response to EFS was decreased in STPH animals. Phentolamine
decreased this vasoconstrictor response more strongly in SO animals. Both L-NAME and CGRP-
(8–37) increased vasoconstrictor response to EFS more strongly in PH than SO segments. PH
did not modify vasomotor responses to NA, DEA-NO or CGRP, but it decreased NA release
while increasing those of NO and CGRP. Phospho-nNOS expression was increased by PH. In
LTPH, no differences were observed in vasoconstrictor response to EFS, vasomotor responses
or neurotransmitter release when compared with age-matched SO animals. In conclusion, the
mesenteric innervation may participate in the development of the characteristic hyperdynamic
circulation observed in STPH through the joint action of decreased adrenergic influence, and
increased nitrergic and sensory innervations influences. The participation of each innervation
normalizes under conditions of LTPH.
INTRODUCTION
PH (portal hypertension) is a clinical syndrome defined,
among other factors, by a pathologically altered
splanchnic and systemic blood flow brought about by
an increased vasodilation associated with endothelial
factor alterations [1,2]. This increased vasodilation is
also present when PH is maintained for a long time
Key words: aging, calcitonin gene-related peptide (CGRP), mesenteric innervation, nitric oxide, noradrenaline, portal hypertension.
Abbreviations: ACh, acetylcholine; CGRP, calcitonin gene-related peptide; DEA-NO, diethylamine NONOate; EFS, electrical
field stimulation; HRP, horseradish peroxidase; KHS, Krebs–Henseleit solution; l-NAME, NG-nitro-l-arginine methyl ester; LT,
long-term; NA, noradrenaline; NOS, nitric oxide synthase; iNOS, inducible NOS; nNOS, neuronal NOS; PH, portal hypertension;
PP, portal pressure; SBP, systolic blood pressure; SO, sham-operated; ST, short-term; TTX, tetrodotoxin.
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[3–6]. In fact, we have previously demonstrated increased
endothelial prostacyclin participation in aorta vasodila-
tion observed in LT (long-term) PH [5]. Nevertheless,
vascular tone is the result of an equilibrium among
several mechanisms, and the adrenergic, cholinergic,
nitrergic, peptidergic and/or sensory innervations play
important functional roles that depend on the vascular
bed being analysed. The rich sympathetic [7], sensory
[8] and nitrergic innervations [9,10] of rat mesenteric
arteries modulate vascular tone by releasing the vasocon-
strictor neurotransmitter NA (noradrenaline), and the
vasodilator neurotransmitters CGRP (calcitonin gene-
related peptide) and NO under electrical stimulation.
We have reported that different physiopathological
situations, such as diabetes [11,12], hypertension
[13,14], cirrhosis [15] or aging [16,17], can modify
the participation of the different innervations in the
vasomotor response to EFS (electrical field stimulation).
In PH, and with regard to adrenergic innervation, both
an increase and a decrease in vasoconstrictor response
to NA have been reported [4,18–21], as well as a down-
regulation of genes related to the adrenergic system and
atrophy ofmesenteric sympathetic innervation [22,23]. In
reference to nitrergic innervation, increased involvement
of neuronal NO in EFS-induced vasodilation [24] and in
nNOS [neuronalNOS (nitric oxide synthase)] expression
[25] has been described.Additionally, an increasedCGRP
participation in periarterial nerve stimulation has been
suggested [24]. In cirrhotic rats, we have reported a
pivotal role by CGRP in the decreased vasoconstrictor
response induced by EFS, mediated by an increase in
CGRP release and vasodilator response [15]. In summary,
few studies have analysed the function of each innervation
in PH or their integrated effect on vascular tone, whereas
the evolution of their participation in a situation of LT
maintenance of PH is also a question of some interest.
Since PH can last for several years in humans, the aim
of this study is to analyse the impact of both STPH
(short-term PH) and LTPH on perivascular innervation
function.
The present study was designed to analyse possible
alterations in adrenergic, nitrergic and sensory function
in mesenteric arteries from rats at 1 and 21 months after
partial portal vein ligation, and the mechanisms involved
in any alterations.
MATERIALS AND METHODS
Animals
The study was conducted in male Wistar rats (250 g;
Harlan Ibe´rica SL), according to the European Union
guidelines for ethical care of experimental animals and
U.S. National Institutes of Health guidelines. Animals
were fed rat chow and water ad libitum. They were
housed in groupsof 3–4 animals in a light/dark-controlled
room, with an average temperature (22+− 2 ◦C) and
humidity (65–70%). Animals were randomly divided
into two groups: SO (sham-operated) rats and rats with
pre-hepatic PH produced by triple partial portal vein
ligation. These animals were maintained for 1 month
(STPH) or 21 months (LTPH).
Surgical techniques
Rats were anaesthetized by intraperitoneal injection of
ketamine (100 mg/kg of body weight) and Xylacine
(12 mg/kg of body weight). The surgical procedure to
produce PH by triple partial ligation of the portal vein
has been described previously [26]. In brief, a midline
abdominal incision was made, the portal vein isolated
and three ligatures, fixed on a sylactic guide, were
performed in its superior, middle and inferior portions.
The stenoses were calibrated by a simultaneous ligation
(4-0 silk) around the portal vein and a 20-gauge blunt-
tipped needle. The midline incision was closed in two
layers with an absorbable suture (polyglycolic acid) and
3-0 silk. Analgesia was maintained during 24 h with
Buprenorphine (0.05 mg/kg, 8 h subcutaneous). In SO
rats, the procedure was the same except for ligature of the
portal vein.
Systolic blood pressure was measured using the tail-
cuff method before killing. Animals were anaesthetized
by intraperitoneal injection of ketamine (100 mg/kg
of body weight) and xylacine (12 mg/kg of body
weight), a midline abdominal incision was made and PP
(portal pressure) was registered and mesenteric venous
vasculopathy and collateral circulation were studied.
At the end of the experiments, each animal was killed
by exanguination through the vena cava at 1 month
(ST) or at 21 months (LT). The superior mesenteric
artery was carefully dissected out, cleaned of connective
tissue, cut into 4-mm-long segments and placed in
KHS (Krebs–Henseleit solution; 115 mmol/l NaCl,
2.5 mmol/l CaCl2, 4.6 mmol/l KCl, 1.2 mmol/l KH2PO4,
1.2 mmol/l MgSO4, 25 mmol/l NaHCO3, 11.1 mmol/l
glucose and 0.03 mmol/l Na2EDTA) at 4 ◦C.
PP measurement
Splenic pulp pressure, an effective indirect measurement
of PP, was measured as described previously [5,15] by
inserting a 23-gauge fluid-filled needle into the spleen
parenchyma. The needle was joined to a PE-50 tube, and
then connected to a pressure recorder (PowerLab 200ML
201) and a transducer (Sensonor SN-844) with a Chart
V4.0 computer program (AD Instruments); the recorder
was re-calibrated before each experiment.
Mesenteric venous vasculopathy and
portosystemic collateral circulation study
methods
The existence of high PP was confirmed by the
development of mesenteric venous vasculopathy and
C© The Authors Journal compilation C© 2012 Biochemical Society
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collateral portal-systemic circulation and was observed
only in PH rats. First, a midline abdominal incision
with a large bilateral subcostal extension was performed.
Mesenteric venous vasculopathy, a characteristic feature
of splanchnic venous congestion, manifests as distension
and tortuosity of the superior mesenteric vein branches
[27]. Portosystemic collateral circulation was studied
by macroscopic examination of the areas in which
the collateral venous circulation had developed, and the
splenorenal, gastroesophageal, colorectal and hepatic
hilumwere carefully studied for the presence of increased
collateral veins [28].
Vascular reactivity
The method used for isometric tension recording has
been described in full elsewhere [10,29]. Briefly, two
parallel stainless steel pins were introduced through
the lumen of the vascular segment: one was fixed to the
bath wall, and the other connected to a force transducer
(Grass FTO3C); this was connected in turn to a model
7D Grass polygraph. For EFS experiments, segments
were mounted between two platinum electrodes 0.5 cm
apart and connected to a stimulator (model S44; Grass)
modified to supply the appropriate current strength.
Segments were suspended in an organ bath containing
5 ml of KHS at 37 ◦C continuously bubbled with
a 95% O2/5% CO2 mixture (pH 7.4). Experiments
were performed in endothelium-denuded segments to
eliminate the main source of vasoactive substances,
including endothelial NO. This avoided possible actions
by different drugs on endothelial cells that could have led
to resultmisinterpretation. Endotheliumwas removed by
gently rubbing the luminal surface of the segments with
a thin wooden stick. The segments were subjected to a
tension of 0.5 gwhichwas readjusted every 15 min during
a 90-min equilibration period before drug administration.
After this, the vessels were exposed to 75 mmol/l KCl
to check their functional integrity. Endothelium removal
did not alter the contractions elicited by 75 mmol/l
KCl. After a washout period, the absence of vascular
endothelium was proven by the inability of 10 μmol/l
ACh (acetylcholine) to relax segments pre-contracted
with NA (995+− 1.29 mg).
Frequency-response curves to EFS (1, 2, 4, 8 and 16
Hz) were performed. The parameters used for EFS were
200 mA, 0.3 ms, 1–16 Hz, for 30 s with an interval of
1 min between each stimulus, the time required to recover
basal tone. A washout period of at least 1 h was necessary
to avoid desensitization between consecutive curves.
Three successive frequency–response curves separated by
1 h intervals produced similar contractile responses. To
evaluate the neural origin of the EFS-induced contractile
response, the nerve impulse propagation blocker TTX
(tetrodotoxin; 0.1 μmol/l) [10] was added to the bath
30 min prior to performing the second frequency–
response curve.
To determine the participation of adrenergic innerv-
ation in the EFS-induced response in segments from
all experimental groups, 1 μmol/l phentolamine [10],
an α-adrenoceptor antagonist, was added to the bath
30 min before performing the frequency–response curve.
Additionally, the vasoconstrictor response of exogenous
NA (1 nmol/l to 10 μmol/l) was tested in segments from
all experimental groups.
To analyse the participation of nitrergic innervation
in the EFS-induced response in segments from all
rat groups, 0.1 mmol/l l-NAME (NG-nitro-l-arginine
methyl ester) [10], a non-specific inhibitor of NOS, was
added to the bath 30 min before performing the second
frequency–response curve. To rule out the inducible
origin of NO, a similar protocol was performed with
the specific iNOS (inducible NOS) inhibitor 1400W
(1 μmol/l) [30]. The vasodilator response to the NO
donor, DEA-NO (diethylamine NONOate; 0.1 nmol/l
to 0.1 mmol/l) was determined in NA-pre-contracted
arteries from all experimental groups.
To study the possible participation of sensitive
innervation in the EFS-induced response in segments
from all experimental groups, 0.5 μmol/l CGRP-(8–37)
[31], a CGRP receptor antagonist, was added to the bath
30 minbefore performing the second frequency–response
curve. The vasodilator response to exogenous CGRP (0.1
nmol/l to 0.1 μmol/l)was analysed inNA-pre-contracted
segments from all animal groups.
NA and CGRP release
Endothelium-denuded mesenteric segments from STSO,
STPH, LTSO and LTPH rats were pre-incubated for
30 min in 5 ml of KHS at 37 ◦C and continuously gassed
with a 95% O2/5% CO2 mixture (stabilization period).
This was followed by two washout periods of 10 min in a
bath of 0.4 ml ofKHS, after which arteries were subjected
to cumulative EFS periods of 30 s at 1, 2, 4, 8 and 16 Hz
at 1 min intervals, as described above.
The release of NA and CGRP was measured by
using an NA research EIA (enzyme immunoassay) kit
(Labor Diagnostica Nord) and a rat CGRP enzyme im-
munoassay kit (Spibio) respectively. The different assays
were performed following manufacturers’ instructions.
Results are expressed as ng of NA/ml per mg of tissue
and pg of CGRP/ml per mg of tissue.
NO release
After an equilibration period of 60 min in Hepes buffer
(119 mmol/l NaCl, 20 mmol/l Hepes, 1.2 mmol/l
CaCl2, 4.6 mmol/l KCl, 1 mmol/l MgSO4, 0.4 mmol/l
KH2PO4, 5 mmol/l NaHCO3, 5.5 mmol/l glucose and
0.15 mmol/l Na2HPO4, pH 7.4) at 37 ◦C, endothelium-
denuded mesenteric segments from each experimental
group were incubated with the fluorescent probe 4,5-
diaminofluorescein (DAF-2; 2 μmol/l) for 45 min. Then,
the medium was collected to measure basal NO release.
C© The Authors Journal compilation C© 2012 Biochemical Society
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Afterwards, cumulativeEFSperiods of 30 s at 1, 2, 4, 8 and
16 Hz were applied at 1 min intervals. The fluorescence
of the medium was measured at room temperature
(22–25 ◦C) using a spectrofluorimeter (LS50 with FL
WINLABSoftware; PerkinElmer)with λex = 492 nm and
λem = 515 nm.
The EFS-induced NO release was calculated by
subtracting basal NO release from that evoked by EFS.
In addition, blank samples were collected in the same
way from segment-free medium in order to subtract
background emission. Some assays were performed in
the presence of 0.1 mmol/l l-NAME, 1 μmol/l 1400W or
0.1 μmol/l TTX to ensure the specificity of the method.
The amount of released NO was expressed as arbitrary
units/mg of tissue.
Western blot analysis
Endothelium-denuded mesenteric segments from all
groups of rats were homogenized in a boiling buffer
composed of 1 mM sodium vanadate, 1% SDS, and
0.01 M Tris/HCl, pH 7.4. Homogenates containing
40 μg of protein were electrophoretically separated by
SDS/PAGE (7.5% gel), and then transferred on to
PVDF membranes (Immun-Blot; Bio-Rad Laboratories)
overnight at 4 ◦C and 230 mA using a Bio-Rad Mini
Protean III system (Bio-Rad Laboratories) containing
25 mM Tris, 190 mM glycine, 20% methanol and
0.05% SDS. The membrane was blocked for 1 h
at room temperature in Tris-buffered saline (100 mM
Tris/HCl, pH 7.4, 0.9%, NaCl and 0.1% SDS) with
5% BSA before being incubated overnight at 4 ◦C
with a rabbit monoclonal antibody against nNOS
(1:1000 dilution; Abcam) or a rabbit polyclonal antibody
against phospho-nNOS (1:1000 dilution; Abcam). After
washing, the membranes were incubated with anti-rabbit
HRP (horseradish peroxidase)-conjugated IgG antibody
(GE Healthcare). The membrane was thoroughly
washed and the immunocomplexes were then detected
using an enhanced HRP/luminol chemiluminescence
system (ECL Plus; GE Healthcare) and subjected to
autoradiography (Hyperfilm ECL, GE Healthcare).
Signals on the immunoblot were quantified using a
computer program (NIH Image version 1.56; National
Institute of Health, Bethesda, MD, U.S.A.). The same
membrane was used to determine α-actin expression, and
the content of the latter was used to correct protein
expression in each sample by means of a monoclonal
anti α-actin antibody (1:2000 dilution; Sigma). Rat brain
homogenate was used as positive control.
Drugs used
l-NA hydrochloride, ACh chloride, DEA-NONOate
diammonium salt, CGRP-(8–37), rat CGRP, TTX, l-
NAME hydrochloride, phentolamine, 1400W, tempol
and DAF-2 were from Sigma. Stock solutions (10
mmol/l) of drugs were made in distilled water, except
for NA which was dissolved in a 0.9% NaCl/0.01%
ascorbic acid. These solutions were kept at − 20 ◦C and
appropriate dilutions were made in KHS on the day of
the experiment.
Data analysis
The responses elicited by EFS or NA are expressed
as a percentage of the initial contraction elicited by
75 mmol/l KCl for comparison between SO and PH
rats. The relaxation induced by DEA-NO or CGRP is
expressed as a percentage of the initial contraction elicited
by NA. Results are given as means+− S.E.M. Statistical
analysis was done by comparing the curve obtained in
the presence of the different substances with the previous
or control curve by means of repeated measure (two-
way ANOVA). The analysis of individual points of each
curve was analysed using Bonferroni post-hoc test. For
the experiments on NO, CGRP and NA release, the
statistical analysis was done using one-way ANOVA,
followed by Newman–Keuls post-hoc test. P< 0.05 was
considered significant.
RESULTS
Animal evolution
STPH and LTPH did not modify SBP (systolic blood
pressure), although it did raise PP (Table 1). Body, spleen
and liver weights were similar in both ST and LT SO and
PH animals (Table 1). All rats in the STPH and LTPH
groups presented portosystemic collateral circulation
(pararectal, paraoesophageal and splenorenal collateral
vessels).
Vascular reactivity
The response induced by 75 mmol/l KCl was similar in
segments from all rat groups (STSO, 1184+− 79.77 mg;
STPH, 1010+− 92.67 mg; LTSO: 1447+− 96.34 mg; LTPH:
1322+− 108.1 mg; P> 0.05; n= 10 animals each group).
The contractions elicitedbyEFSwere lower inmesenteric
segments from STPH rats than those from STSO
rats (P< 0.05; Figure 1A). EFS-induced contractions
were similar in segments from LTSO and LTPH
animals (P> 0.05; Figure 1B). Pre-incubation with the
nerve impulse propagation blocker TTX (0.1 μmol/l)
practically abolished EFS-induced contractions in
segments from all experimental groups (Figure 2).
The contraction elicited by EFS was significantly
reduced by the α-adrenoceptor antagonist, phentolamine
(1 μmol/l), in segments from all rat groups (Figure 3).
This decrease was greater in segments from STSO than
from STPH rats. (Figures 3A and 3B, and Table 2).
Phentolamine decreased EFS-induced vasoconstriction
to a similar extent in segments from both LT groups
(Figures 3C and 3D, and Table 2).
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Table 1 Modification of body weight, SBP, spleen weight and liver weight in STSO, STPH, LTSO and LTPH rats
Results are expressed as means+− S.E.M.; n = 10 animals in each group. ∗P < 0.05 compared with age-matched STSO.
Spleen weight/ Liver weight/
Group Body weight (g) SBP (mmHg) PP (mmHg) body weight (%) body weight (%)
STSO 337.4+− 6.6 123.4+− 1.8 5.45+− 0.77 0.24+− 0.07 2.4+− 0.1
STPH 330.2+− 6.1 119.4+− 1.2 9.90+− 0.64∗ 0.30+− 0.01 2.5+− 0.06
LTSO 617.3+− 83.5 137.1+− 2.2 9.01+− 1.14 0.22+− 0.06 2.56+− 0.31
LTPH 629.9+− 86.4 120.5+− 7.6 12.68+− 1.27∗ 0.18+− 0.07 2.53+− 0.25
Figure 1 Isometric tension recording of the frequency–dependent contractions in denuded mesenteric artery segments
from STSO and STPH rats (A), and LTSO and LTPH rats (B)
Results (means+− S.E.M.) are expressed as a percentage of tone induced by 75 mmol/l KCl; n = 10 animals in each group. ∗P < 0.05 compared with control animals
for each frequency (Bonferroni test).
Figure 2 Effect of 0.1 μmol/L TTX on the frequency–response curves performed in endothelium-denuded mesenteric artery
segments from STSO, STPH, LTSO and LTPH rats
(A and C) Results from SO animals; (B and D) results from PH rats. Results (means+− S.E.M.) are expressed as a percentage of a previous tone with 75 mmol/l KCl;
n = 10 animals in each group. ∗P < 0.05 compared with conditions without specific inhibitor at each frequency (Bonferroni test).
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Table 2 Respective EFS inhibition/potentiation after pre-incubation with 1 μmol/l phentolamine or 0.1 mmol/l L-NAME
Results are expressed as means+− S.E.M. of the percentage inhibition/potentiation of EFS-induced contraction after pre-incubation with 1 μmol/l phentolamine or 0.1
mmol/l L-NAME in STSO, STPH, LTSO and LTPH animals; n = 10 animals in each group. Calculations are performed taking the control EFS-induced contraction as
100 % of the contractile response. ∗P < 0.05 compared with age-matched SO.
EFS inhibition/potentiation (%)
Group 1 Hz 2 Hz 4 Hz 8 Hz
STSO+ phentolamine 100+− 0.1 100+− 0.3 97+− 1.0 93.5+− 2.5
STPH+ phentolamine 100+− 0.2 100+− 0.3 79.7+− 3.2∗ 71.0+− 6.1∗
LTSO+ phentolamine 100+− 0.1 97.7+− 2.3 72.0+− 7.1 51.3+− 4.5
LTPH+ phentolamine 100+− 0.2 96.3+− 3.7 69.3+− 5.3 51.0+− 4.4
STSO+ L-NAME 38.5+− 2.9 99.1+− 7.4 60.4+− 6.9 28.6+− 3.3
STPH+ L-NAME 105.4+− 2.8∗ 152.5+− 9.5∗ 110.3+− 7.3∗ 80.5+− 6.4∗
LTSO+ L-NAME 40.3+− 3.9 96.5+− 7.3 70.3+− 8.1 26.4+− 4.6
LTPH+ L-NAME 39.1+− 2.1 93.8+− 4.9 68.5+− 5.8 30.2+− 3.6
Figure 3 Effect of 1 μmol/l phentolamine on the frequency–response curves performed in endothelium-denuded mesenteric
artery segments from STSO, STPH, LTSO and LTPH rats
(A and C) Results from SO animals; (B and D) results from PH rats. Results (means+− S.E.M.) are expressed as a percentage of a previous tone with 75 mmol/l KCl;
n = 10 animals in each group. ∗P < 0.05 compared with conditions without specific inhibitor at each frequency (Bonferroni test).
The contraction induced by EFS was significantly
increased by pre-incubation with the NOS inhibitor l-
NAME (0.1 mmol/l) in segments from all experimental
groups (Figure 4). This increase was greater in segments
from STPH compared with STSO (Figures 4A and
4B, and Table 2). l-NAME increased EFS-induced
vasoconstriction to a similar extent in segments from
LTSO and LTPH animals (Figures 4C and 4D).
Pre-incubation with specific iNOS inhibitor 1400W
(1 μmol/l) did not modify EFS-induced response in any
experimental group (Figure 4).
The specific CGRP receptor antagonist CGRP-(8–
37) (0.5 μmol/l) did not modify the contractile response
induced by EFS in segments from STSO rats (Figure 5A),
but it increased the response in segments from STPH rats
(Figure 5B). Pre-incubation with CGRP-(8–37) did not
modify the contractile response induced by EFS in LTSO
or LTPH animals (Figures 5C and 5D).
PH did not modify vasoconstrictor responses to
exogenous NA (1 nmol/l to 10 μmol/l) or vas-
odilator responses to NO donor DEA-NO (0.1
nmol/l to 0.1 μmol/l) and exogenous CGRP (0.1
C© The Authors Journal compilation C© 2012 Biochemical Society
Mesenteric innervation function in short- and long-term portal hypertension 343
Figure 4 Effect of 0.1 mmol/l L-NAME or 1 μmol/l 1400W on the frequency–response curves performed in
endothelium-denuded mesenteric artery segments from STSO, STPH, LTSO and LTPH rats
(A and C) Results from SO animals; (B and D) results from PH rats. Results (means+− S.E.M.) are expressed as a percentage of a previous tone with 75 mmol/l KCl.
n = 10 animals in each group. ∗P < 0.05 compared with conditions without specific inhibitor at each frequency (Bonferroni test).
nmol/l to 0.1 μmol/l) in either ST or LT animals
(Figure 6).
NA release
Basal NA release was lower in mesenteric segments
from STPH than from STSO rats (Figure 7A). EFS
increased NA release in STSO and STPH arteries, but
more strongly in segments from SO rats (Figure 7A).
Both basal and EFS-induced NA releases were similar
in segments from LTSO and LTPH animals (Figure 7A).
CGRP release
In ST animals, basalCGRP releasewas higher in segments
from PH rats than in the SO animals (Figure 7B). EFS
increased CGRP levels in both groups of rats, but more
so in segments from PH rats (Figure 7B).
Expression of nNOS and phospho-nNOS
A 155 kDa band was detected in nNOS analysis. nNOS
expression was similar in homogenates from PH rats
and SO rats at 1 month (Figure 7C). Phospho-nNOS
expression was detected as a 160 kDa band, and was
higher in segments from STPH rats compared with SO
rats (Figure 7C).
NO release
Basal NO release was higher in mesenteric segments
from STPH than from STSO rats. EFS increased NO
release in both groups of rats, but more notably in
segments from PH rats (Figure 7D). Both basal and EFS-
inducedNOreleaseswere similar inLTSOandLTPHrats
(Figure 7D). Pre-incubation with 0.1 mmol/l l-NAME
or with 0.1 μmol/l TTX abolished NO release by EFS
in arteries from all experimental groups, whereas 1400W
(1 μmol/l) did not modify NO release (Figure 8).
DISCUSSION
Splanchnic vasodilation is the pathophysiological
hallmark of the development of the hyperdynamic
circulatory syndrome [18,32,33] in PH. This splanchnic
vasodilation has been described to be mainly due to
alterations in endothelial factors, the participation of
which changes over time [3–5]. Despite the important
role of perivascular innervation few studies have been
performed on the possibility that alterations occur in the
adrenergic, nitrergic and sensory innervations, and their
integrated effects on mesenteric vascular tone. Thus, the
objective of the present study was to determine whether
STPH and LTPH could modify the potential functional
influence of the different types of mesenteric innervation.
The vasoconstrictor response to KCl, an indicator of
smooth muscle functional integrity, was not modified by
the development of STPH or LTPH, in contrast with
previous reports. This apparent contradictionmay reflect
the different experimental models used [34,35].
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Figure 5 Effect of 0.5 μmol/l CGRP-(8–37) on the frequency–response curves performed in endothelium-denuded
mesenteric artery segments from STSO, STPH, LTSO and LTPH rats
(A and C) Results from SO animals; (B and D) results from PH rats. Results (means+− S.E.M.) are expressed as a percentage of a previous tone with 75 mmol/l KCl.
n = 10 animals each group.
Our results show that EFS induced a contractile
responses in endothelium-denuded mesenteric segments
from all experimental groups. This vasoconstrictor
response elicited by EFS was practically abolished
by the blocker for nerve impulse propagation TTX,
demonstrating that the response is due to the release of
neurotransmitters from the nerve endings.
Short-term PH
The operated rats had portal hyperpressure and
developed systemic collateral vessels, thus confirming
the validity of triple partial portal vein ligation as an
experimental model to establish PH [27,28].
In STPH rats, the level of vasoconstrictor response
to EFS was lower than in SO animals. This diminished
vasoconstrictor response suggests neural modifications
associated with PH. This effect could be associated with
changes in the release of and/or response to the different
neurotransmitters.
The participation of adrenergic innervation in the EFS-
induced vasoconstriction was analysed by incubation
with the α-adrenoceptor blocker phentolamine. The
vasoconstrictor response was significantly reduced by
phentolamine in STSO and STPH rats, confirming that
this response is at least mediated by NA release from
adrenergic nerve terminals and the subsequent activation
of α-adrenoceptors. The decrease was lower in segments
from PH animals, indicating a lower participation
of adrenergic innervation in these animals. Our next
objectivewas to analysewhether the decreased adrenergic
participation in STPH was associated with a decrease
in NA release and/or vasoconstrictor response to NA.
In our experimental conditions, concentration-response
curves to exogenous NA were similar in segments
from both groups of rats, contrasting with previous
studies reporting both an increase and a decrease of
vasoconstrictor response to NA [4,18–21]; meanwhile,
both basal andEFS-inducedNAreleaseswere diminished
in mesenteric segments from PH rats, as also reported
with reference to circulating NA [18,19]. Therefore these
results explain the decrease of adrenergic function that
results in the diminished vasoconstrictor response to EFS
observed in STPH.
Although the diminished adrenergic function could,
by itself, explain the decreased EFS vasoconstriction,
the participation of other neural components cannot be
ruled out. The NO released from nitrergic innervation
in EFS has been demonstrated to have a vasodilator role
contributing to the vasomotor response to EFS [10–14].
In vascular reactivity experiments, pre-incubationwith 7-
NI (7-nitroindazole) decreases vasoconstrictor response
to NA, making the analysis of EFS-induced contractions
very complex [36,37]. For that reason, we used the
non-selective NOS inhibitor l-NAME in vascular
reactivity experiments. EFS-induced vasoconstriction
was increased in both experimental groups by pre-
incubation with l-NAME. This increase was higher in
mesenteric segments from PH than in SO rats, suggesting
that the participation of nitrergic innervation is increased
in PH; this could be the result of increased NO release
and/or altered smooth muscle cell sensitivity to NO. The
fact that the vasodilator response to the NO analogue
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Figure 6 Vasodilator response to exogenous NA, the NO donor DEA-NO and exogenous CGRP
(A and B) Vasodilator response to exogenous NA in segments from STSO, STPH, LTSO and LTPH rats. Results (mean+− S.E.M.) are expressed as a percentage of a
previous tone with 75 mmol/l KCl; n = 8 animals each group. (C and D) Vasodilator response to NO donor DEA-NO in segments from STSO, STPH, LTSO and LTPH
rats. Results (means+− S.E.M.) are expressed as a percentage of the initial contraction elicited by exogenous NA; n = 7 animals in each group. (E and F) Vasodilator
response to exogenous CGRP in segments from STSO, STPH, LTSO and LTPH rats. Results (means+− S.E.M.) are expressed as a percentage of the initial contraction
elicited by exogenous NA; n = 5 animals each group.
DEA-NO was similar in both experimental groups rules
out differences in smooth muscle sensitivity to NO.
However, we showed directly that both basal and EFS-
induced NO release were increased in PH compared
with SO rats, in agreement with Jurzic et al. [25].
This augmented NO release is abolished by TTX, thus
confirming the neural origin of the NO, and indicating
that neuronal NO also participates in the effect of PH.
Production of NO in neural tissue can have two sources:
nNOS and iNOS [36–38]. However, in the present
study, the specific iNOS inhibitor 1400W did not change
either the vasoconstrictor response to EFS or the NO
release in segments from the two experimental groups,
ruling out the participation of this inducible isoform and
suggesting that NO release was, indeed, dependent on
nNOS expression and/or activity. We found that nNOS
protein expression was not modified by PH, contrasting
with previous reports [25,39], whereas the active form
phospho-nNOSwas increased in PH, suggesting that PH
had increased nNOS activity.
Once the participation of both adrenergic and nitrergic
innervation in the diminished response to EFS in
segments from PH rats had been demonstrated, we
studied the possible role of sensory innervation in this
vasomotor response. We have previously reported that
in this strain sensory innervation does not participate
in vasomotor response induced by EFS in control
animals, but that the participation of this innervation
is increased in several pathological conditions such as
hypertension, cirrhosis and diabetes [12,15,40,41]. In the
present study, we observed that pre-incubation with
the CGRP antagonist CGRP-(8–37) did not modify the
vasoconstrictor response to EFS in mesenteric rings
from SO rats, confirming CGRP non-participation
in vasoconstriction in healthy Wistar rats [10,36,42].
However, CGRP-(8–37) increased the vasoconstrictor
response to EFS in segments from PH rats. These results
indicate that sensory innervation participates in the
vasomotor response to EFS in PH rats, indicating a role
for sensory innervation in the decreased vasoconstrictor
response to EFS in STPH. Thus our next objective was to
analyse whether this participation was associated with
an increase in the CGRP release and/or vasodilatory
response. The vasodilator response to exogenous CGRP
was similar in segments from both experimental groups,
ruling out differences in sensitivity to CGRP due to
PH, meanwhile both basal and EFS-induced CGRP
releases were higher in mesenteric segments from PH
rats, indicating that sensory innervation also contributed
to the diminished vasoconstrictor response to EFS in PH
through an increase in CGRP release.
Altogether, these results confirm that in STPH the
EFS-induced vasoconstrictor response in mesenteric
arteries is decreased as a result of decreased adrenergic
innervation function and increased sensory and nitrergic
innervation function.
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Figure 7 Neurotransmitter release and Western blot analysis
(A) Effect of STPH and LTPH on basal and EFS-induced NA release in endothelium-denuded mesenteric segments; n = 6 animals each group. Results are expressed
as ng of NA/ml per mg of tissue. ∗P < 0.05 compared with basal; #P < 0.05 compared with SO. (B) Effect of STPH on basal and EFS-induced CGRP release in
mesenteric segments. Results are expressed as pg of CGRP/ml per mg of tissue; n = 6 animals. ∗P < 0.05 compared with basal; #P < 0.05 compared with SO. (C)
Western blot for phospho-nNOS and nNOS expression in endothelium-denuded mesenteric artery segments from STSO and STPH rats. The Figure is representative of
preparations from six rats in each group. Lower panel shows relation between densitometric analysis for phospho-nNOS compared with nNOS expression. (D) Effect of
STPH and LTPH on basal and EFS-induced NO release in endothelium-denuded mesenteric segments; n = 6 animals in each group. Results are expressed as arbitrary
units (A.U.)/mg of tissue. ∗P < 0.05 compared with basal; #P < 0.05 compared with STSO.
Figure 8 Effect of 1 μmol/l 1400W, 0.1 mmol/l L-NAME or 0.1 μmol/l TTX on basal and EFS-induced NO release in
endothelium-denuded mesenteric segments from (A) STSO, (B) STPH, (C) LTSO and (D) LTPH rats
Results are expressed as arbitrarial units (A.U.)/ mg of tissue; n = 6 animals in each group. ∗P < 0.05 compared with basal; #P < 0.05 compared with conditions
without specific inhibitor.
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Long-term PH
The operated rats presented portal hyperpressure and had
systemic collateral vessels at 21 months after portal vein
ligation. The persistence in these changes related to PH
indicates that triple partial portal vein ligation in the rat
is an appropriate experimental model that maintains its
validity even during very late stages, making it possible
to establish a correlation with human PH, as previously
suggested [5].
In later stages, an increase in splanchnic blood flow
leads to the hyperdynamic circulation state, which in
turn contributes to the maintenance and aggravation of
many of the complications of PH [43]. In this sense,
we have reported previously that maintenance of PH
for 21 months also maintains the changes in endothelial
function that result from increased prostacyclin release,
and contributes to maintaining the increased vasodilator
response to ACh [5]. Consequently, our next aim was to
determine whether the different innervations also play a
role in the hyperdynamic circulation present in LTPH.
The vasoconstrictor response to EFS is stronger in
LTSO rats than in STSO animals as a consequence
of aging, as we have previously reported [16]. In
contrast with the decrease observed in STPH rats,
the vasoconstrictor response to EFS is not modified
in LTPH rats compared with their age-matched SO
animals. This result indicates a reversion of the decreased
vasoconstrictor effect on innervation in STPH, and
contrasts with its effect on endothelial function [5].
However, a rearrangement of the participation of each
kind of innervation cannot be ruled out.
In both experimental groups, phentolamine reduced
the vasoconstrictor response to EFS to a similar extent,
and both the vasoconstrictor response to NA and NA
release were similar in both SO and PH rats, indicating
a restored function of the adrenergic innervation at
21 months. EFS-induced vasoconstriction was similarly
increased by l-NAME in both experimental groups.
Additionally, neither the basal and the EFS-induced NO
release nor vasodilator response to the NO analogue
DEA-NO were modified by LTPH. These results
indicate that the participation of nitrergic innervation is
also restored in LTPH. The fact that pre-incubation with
CGRP-(8–37) did not alter vasoconstrictor response to
EFS in SO confirms the non-participation of CGRP in
aging [16], and indicates that, in contrast to STPH, the
influence of sensory innervation is attenuated in LTPH.
Taken together, the present results indicate that the
innervations of mesenteric arterial vessels may well
participate in the development of the characteristic
hyperdynamic circulation observed in STPH through the
combined actions of a decrease in the influence of the
adrenergic innervation and an increase in the influences
of the nitrergic and sensory innervations. By contrast, we
suggest that the influences of each type of innervation
normalizes under the conditions of LTPH.
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BACKGROUND AND PURPOSE
We have reported that exposure to a diabetic intrauterine environment during pregnancy increases blood pressure in adult
offspring, but the mechanisms involved are not completely understood. This study was designed to analyse a possible role of
perivascular sympathetic and nitrergic innervation in the superior mesenteric artery (SMA) in this effect.
EXPERIMENTAL APPROACH
Diabetes was induced in pregnant Wistar rats by a single injection of streptozotocin. Endothelium-denuded vascular rings
from the offspring of control (O-CR) and diabetic rats (O-DR) were used. Vasomotor responses to electrical field stimulation
(EFS), NA and the NO donor DEA-NO were studied. The expressions of neuronal NOS (nNOS) and phospho-nNOS
(P-nNOS) and release of NA, ATP and NO were determined. Sympathetic and nitrergic nerve densities were analysed by
immunofluorescence.
KEY RESULTS
Blood pressure was higher in O-DR animals. EFS-induced vasoconstriction was greater in O-DR animals. This response was
decreased by phentolamine more in O-DR animals than their controls. L-NAME increased EFS-induced vasoconstriction more
strongly in O-DR than in O-CR segments. Vasomotor responses to NA or DEA-NO were not modified. NA, ATP and NO
release was increased in segments from O-DR. nNOS expression was not modified, whereas P-nNOS expression was increased
in O-DR. Sympathetic and nitrergic nerve densities were similar in both experimental groups.
CONCLUSIONS AND IMPLICATIONS
The activity of sympathetic and nitrergic neurons is increased in SMA from O-DR animals. The net effect is an increase in
EFS-induced contractions in these animals. These effects may contribute to the increased blood pressure observed in the
offspring of diabetic rats.
Abbreviations
DAF-2, 4, 5-diaminofluorescein; DEA-NO, diethylamine nonoate diammonium salt; EFS, electrical field stimulation;
O-CR, control offspring; O-DR, diabetic offspring; SMA, superior mesenteric artery
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Introduction
A growing body of evidence during the last decade suggests
that adverse environmental conditions during crucial periods
of development may cause profound structural and bio-
chemical changes in the body, resulting in modifications
that, in later life, can become threats to health (Barker, 2004;
Visentin et al., 2014). In line with this, maternal diabetes is a
common medical complication in pregnancy that has been
rapidly increasing worldwide. Both epidemiological investi-
gations and animal studies have shown that intrauterine
exposure to a hyperglycaemic environment can affect embry-
onic and fetal life, predisposing the offspring to develop
metabolic disorders, including diabetes and hypertension in
adult life (Simeoni and Barker, 2009).
The molecular mechanism underlying the association
between diabetes during pregnancy and elevated blood pres-
sure in the offspring remains unclear, and the relatively few
existing studies have rarely address vascular function.
Holemans et al. (1999) showed a reduced relaxation to
endothelium-dependent dilators and enhanced constriction
to NA in small mesenteric arteries in the offspring of diabetic
rats. Rocha et al. (2005), in this same model, found early
life hypertension with renal function impairment and
decreased endothelium-dependent vasodilatation in mesen-
teric microvessels. We ourselves have recently demonstrated
an enhanced formation of vasoconstrictor prostanoids in
mesenteric resistance arteries from the offspring of diabetic
rats, which contributes to a hyper-reactivity to NA that may
participate in their hypertension (Ramos-Alves et al.,
2012a,b).
It is well known that vascular tone is determined by an
equilibrium among several mechanisms in which perivascular
innervation plays an important role. Tone regulation involves
sympathetic, cholinergic, nitrergic, peptidergic and/or
sensory neurons that are specific to the vascular bed under
consideration (Loesch, 2002; Sastre et al., 2010). It is well
known that the splanchnic circulation makes an important
haemodynamic contribution to the early development of
hypertension, and an increase in vascular resistance is appar-
ent in various splanchnic organs (Meininger et al., 1985). The
superior mesenteric artery (SMA) regulates around 20% of
total blood flow; thus, changes in mesenteric vascular tone are
involved in total peripheral resistance. The application of
electrical field stimulation (EFS) produces a vasoconstrictor
response that is the integrated result of the release of different
neurotransmitters, including the sympathetic vasoconstric-
tors NA and ATP, NO from nitrergic neurons and CGRP from
sensory nerves (Kawasaki et al., 1988; Li and Duckles, 1992;
Marín and Balfagón, 1998; Blanco-Rivero et al., 2013b).
Alterations in the functional role of these components in rat
mesenteric artery have been associated with several experi-
mental and pathophysiological conditions including hyper-
tension, a high fat diet intake, ageing and portal hypertension
(Marín et al., 2000; Ferrer et al., 2003; Blanco-Rivero et al.,
2011a; Sastre et al., 2012a). Additionally, we have previously
reported that diabetes alters the function of perivascular
neurons in rat mesenteric arteries (Ferrer et al., 2000; del
Campo et al., 2011). These findings suggest that perivascular
neurons in the mesenteric circulation have an important
influence on the development of several kinds of hyperten-
sion, such as angiotensin II-salt hypertension (Osborn and
Fink, 2010), mild DOCA-salt hypertension (Kandlikar and
Fink, 2011) and renovascular hypertension (Koyama et al.,
2010).
Taking into account this information, we considered it
relevant to investigate whether the development of maternal
diabetes during pregnancy could lead to alterations in the
perivascular neurons, which could affect vascular tone in the
adult offspring of diabetic rats. For this purpose, we analysed
the possible functional changes in perivascular neurons in
mesenteric arteries from the offspring of diabetic rats, evalu-
ating any alterations in the activity of sympathetic, nitrergic
or sensory neurons, as well as the mechanisms involved.
Methods
Ethics statement
All animals were obtained from the Animal Quarters of the
Universidad Autónoma de Madrid and housed in the animal
facility of the Universidad Autónoma de Madrid (registration
number EX-021U) in accordance with guidelines 609/86 of
the E.E.C., R.D. 233/88 of the Ministerio de Agricultura, Pesca
y Alimentación of Spain, and Guide for the Care and Use of
Laboratory Animals published by the United States National
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Institute of Health (NIH publication no. 85.23, revised 1985).
The experimental protocol was approved by the Ethics Com-
mittee of the Universidad Autónoma de Madrid. All studies
involving animals are reported in accordance with the
ARRIVE guidelines for reporting experiments involving
animals (Kilkenny et al., 2010; McGrath et al., 2010).
Animals
Virgin female Wistar rats were kept in cages with male rats in
a 3:1 ratio for mating. Evidence of copulation was confirmed
by the presence of sperm in a vaginal smear 24 h after which
was considered to be day 1 of gestation. Seven days after the
onset of pregnancy, diabetes was induced by a single injec-
tion of streptozotocin (50 mg·kg−1, i.p.), as described previ-
ously (Wichi et al., 2005; Ramos-Alves et al., 2012a,b).
Control animals received an equal volume of vehicle (citrate
buffer). Blood glucose was measured 7 days after injecting
either streptozotocin or citrate buffer to confirm whether or
not diabetes had been induced; only rats with severe hyper-
glycaemia above 2 g·L−1 were used. During lactation, the off-
spring were restricted to six animals per rat. This study used
only 6-month-old male offspring from diabetic mothers
(O-DR) and control offspring (O-CR). Rats were weighed and
killed by CO2 inhalation followed by decapitation; the SMA
was carefully dissected out, placed in Krebs–Henseleit solu-
tion (KHS, in mmol·L−1: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4
1.2, MgSO4 0.7, H2O 1.2, NaHCO3 25, glucose 11.1, Na2 EDTA
0.03) at 4°C, cleaned of perivascular fat and connective tissue
and divided into 2 mm long segments using a micrometre
eyepiece mounted on a Euromex Holland binocular lens.
Some samples were immediately frozen in liquid nitrogen
and stored at −70°C. Additionally, some segments were
mounted on 100 μm wires in a small vessel myograph to
measure internal diameter (1–1.2 mm in diameter; Simonsen
et al., 1999). No differences were found between experimental
groups.
Glucose tolerance and insulin sensitivity
The oral glucose tolerance test was performed according to a
standard protocol. After a 10 h fast, a single oral dose (2 g·kg−1
of body weight) of glucose was delivered. Blood glucose was
then measured from the tail vein just before and at 30, 60, 90
and 120 min after glucose injection using test strips and
reader (ACCU-CHEK®, Roche Diagnostics). After 48 h,
animals were subjected to a new 10 h fast for assessment of
insulin sensitivity by an insulin tolerance test. For this,
regular insulin was administered i.p. at a dose of 1.5 U·kg−1
body weight. Blood glucose was determined before and at 15,
30, 45 and 60 min after insulin administration.
Arterial blood pressure measurement
The animals were anaesthetized with a mixture of ketamine,
xylazine and acetylpromazine (64.9, 3.2 and 0.78 mg·kg−1,
respectively, i.p.). The right carotid artery was cannulated
with a polyethylene catheter (PE-50) filled with heparin-
containing saline. After 24 h, mean arterial pressure was
measured in conscious animals by a pressure transducer
(model MLT844; ADInstruments Pty Ltd, Castle Hill, New
South Wales, Australia) and recorded using an interface and
software for computer acquisition (ADInstruments Pty Ltd).
Heart rate was calculated from the pressure signal recorded by
a pressure transducer and connected to a computerized meas-
uring programme (LabChat v7, ADInstruments Pty Ltd).
Serum biochemical parameters
Serum concentrations of total cholesterol, triglycerides and
HDL cholesterol were determined using specific quantitative
enzyme assays (Vitros Chemistry Products) and measured
with a colorimetric spectrophotometer (Vitros Fusion 5.1 FS
Chemistry System, Ortho-Clinical). The assays were per-
formed following the manufacturer’s instructions. Results are
expressed as mg·L−1. Serum concentrations of insulin were
analysed using the Rat/Mouse Insulin ELISA Kit (EMD Milli-
pore Corporation, Billerica, MA, USA). The assay was per-
formed following the manufacturer’s instructions. Results are
expressed as ng insulin·mL−1.
Vascular reactivity study
The method used for isometric tension recording has been
described in full elsewhere (Nielsen and Owman, 1971; Marín
and Balfagón, 1998). Briefly, two parallel stainless steel pins
were introduced through the lumen of the vascular segment:
one was fixed to the bath wall and the other connected to a
force transducer (Grass FTO3C, Quincy, MA, USA); this, in
turn, was connected to a model 7D Grass polygraph. For EFS
experiments, segments were mounted between two platinum
electrodes 0.5 cm apart and connected to a stimulator (Grass,
model S44) modified to supply the appropriate current
strength. Segments were suspended in an organ bath contain-
ing 5 mL of KHS at 37°C continuously bubbled with a 95% O2
to 5% CO2 mixture (pH 7.4). Some experiments were per-
formed in endothelium-denuded segments to eliminate the
main source of vasoactive substances, including endothelial
NO. This avoided possible actions by different drugs on
endothelial cells that could have led to a misinterpretation
of the results. The endothelium was removed by gently
rubbing the luminal surface of the segments with a thin
wooden stick. The segments were subjected to a tension of
4.95 mN, which was readjusted every 15 min during a 90 min
equilibration period before drug administration. After this,
the vessels were exposed to 75 mmol·L−1 KCl to check their
functional integrity. Endothelium removal did not alter the
contractions elicited by KCl. After a washout period, the
presence/absence of vascular endothelium was tested by the
ability of 10 μmol·L−1 ACh to relax segments precontracted
with 1 μmol·L−1 NA. We consider as endothelium-denuded
those arteries that were unable to relax to ACh.
Vasodilator responses to ACh (0.1 nmol·L−1 to
10 mmol·L−1) were obtained in endothelium-intact arteries
from all experimental groups. Frequency–response curves to
EFS (1, 2, 4, 8 and 16 Hz, a range considered to reproduce
physiological situations) were performed in endothelium-
intact and endothelium-denuded mesenteric segments from
all experimental groups. The parameters used for EFS were
200 mA, 0.3 ms, 1–16 Hz, for 30 s with an interval of 1 min
between each stimulus, the time required to recover basal
tone. A washout period of at least 1 h was necessary to avoid
desensitization between consecutive curves. Two successive
frequency–response curves separated by 1 h intervals pro-
duced similar contractile responses. To evaluate the neural
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origin of the EFS-induced contractile response, the nerve
impulse propagation blocker, tetrodotoxin (TTX;
0.1 mmol·L−1), was added to the bath 30 min before the
second frequency–response curve was obtained.
To determine the participation of sympathetic neurons
in the EFS-induced response in endothelium-denuded seg-
ments from O-CR and O-DR rats, 1 μmol·L−1 phentolamine,
an α-adrenoceptor antagonist, or phentolamine plus
0.1 mmol·L−1 suramin, a non-specific purine receptor antago-
nist, was added to the bath 30 min before performing the
frequency–response curve. Additionally, the vasoconstrictor
response to exogenous NA (1 nmol·L−1 to 10 mmol·L−1) was
tested in segments from both experimental groups.
To study the possible participation of sensory neurons in
the EFS-induced response in endothelium-denuded segments
from O-CR and O-DR rats, 0.5 μmol·L−1 CGRP (8–37), a CGRP
receptor antagonist, was added to the bath 30 min before
performing the second frequency–response curve.
To analyse the participation of NO in the EFS-induced
response in endothelium-denuded segments from O-CR and
O-DR rats, 0.1 mmol·L−1 Nω-nitro-L-arginine methyl ester
(L-NAME), a non-specific inhibitor of NOS, was added to
the bath 30 min before performing the second frequency–
response curve. The vasodilator response to the NO
donor, diethylamine NONOate, (DEA-NO, 0.1 nmol·L−1 to
0.1 mmol·L−1), was determined in NA-precontracted arteries
from both experimental groups.
NA and ATP release
Endothelium-denuded segments of rat mesenteric arteries
from O-CR and O-DR animals were pre-incubated for 30 min
in 5 mL of KHS at 37°C and continuously gassed with a 95%
O2 to 5% CO2 mixture (stabilization period). This was fol-
lowed by two washout periods of 10 min in a bath of 0.4 mL
KHS. Then the medium was collected to measure basal neu-
rotransmitter release. Next, the organ bath was refilled and
cumulative EFS periods of 30 s at 1, 2, 4, 8 and 16 Hz were
applied at 1 min intervals. Afterwards, the medium was col-
lected to measure the EFS-induced release. Mesenteric seg-
ments were weighed in order to normalize the results. NA and
ATP release were measured using Noradrenaline Research
EIA (Labor Diagnostica Nord, Gmbh and Co., KG, Nordhon,
Germany) or an ATP colorimetric/fluorometric assay kit
(Abcam, Cambridge, UK). The assays were performed follow-
ing the manufacturer’s instructions. Results are expressed as
ng NA·mL−1 mg−1 tissue, or nmol ATP·mL−1 mg−1 tissue.
NO release
NO release was measured using fluorescence emitted by the
fluorescent probe 4,5-diaminofluorescein (DAF-2) as previ-
ously described (Blanco-Rivero et al., 2011a). Endothelium-
denuded mesenteric arteries from O-CR and O-DR rats were
subjected to a 60 min equilibration period in HEPES buffer [in
mmol·L−1: NaCl 119; HEPES 20; CaCl2 1.2; KCl 4.6; MgSO4 1;
KH2PO4 0.4; NaHCO3 5; glucose 5.5; Na2HPO4 0.15; (pH 7.4)]
at 37°C. Arteries were incubated with 2 μmol·L−1 DAF-2 for
30 min. The medium was collected to measure basal NO
release. Once the organ bath was refilled, cumulative EFS
periods of 30 s at 1, 2, 4, 8 and 16 Hz were applied at 1 min
intervals. Afterwards, the medium was collected to measure
EFS-induced NO release. The fluorescence of the medium was
measured at room temperature (RT) using a spectrofluorom-
eter (LS50 PerkinElmer Instruments, FL WINLAB Software,
Waltham, MA, USA) with excitation wavelength set at
492 nm and emission wavelength at 515 nm.
The EFS-induced NO release was calculated by subtracting
basal NO release from that evoked by EFS. Also, blank samples
were collected in the same way from segment-free medium in
order to subtract background emission. Some assays were
performed in the presence of 0.1 mmol·L−1 TTX or 1 mmol·L−1
1400 W, the specific iNOS inhibitor. The amount of NO
released was expressed as arbitrary units·mg−1 tissue.
Superoxide anion production
Superoxide anion levels were measured using lucigenin
chemiluminescence (Blanco-Rivero et al., 2011b).
Endothelium-denuded mesenteric segments from O-CR
and O-DR animals were rinsed in KHS for 30 min, equili-
brated for 30 min in HEPES buffer at 37°C, transferred to test
tubes that contained 1 mL HEPES buffer (pH 7.4) with luci-
genin (5 μmol·L−1) and then kept at 37°C. The luminometer
was set to report arbitrary units of emitted light; repeated
measurements were collected for 5 min at 10 s intervals and
averaged. 4,5-Dihydroxy-1,3-benzene-disulfonic acid ‘Tiron’
(10 mmol·L−1), a cell-permeant, non-enzymatic superoxide
anion scavenger, was added to quench the superoxide anion-
dependent chemiluminescence. Also, blank samples were col-
lected in the same way without mesenteric segments to
subtract background emission.
Immunofluorescence staining of nerve fibres
SMA was immediately placed in cold PBS (in g·L−1): NaCl 8,
Na2HPO4 1.15, KCl 0.2, KH2PO4 0.2 (pH 7.2). The whole vessel
was fixed (4% paraformaldehyde in PBS, 50 min, RT). After
three 10 min PBS washing cycles, non-specific binding was
blocked by incubating the samples for 1 h in 5% bovine
albumin PBS + 0.3% Tween 20 (PBS-T). The vessels were cut
into segments and incubated with primary antibodies: rabbit
polyclonal anti-dopamine β-hydroxylase (Sigma 1:200) or
rabbit polyclonal anti-neuronal NOS (nNOS; Abcam 1:100)
diluted in 2% bovine albumin PBS-T. Thereafter, tissues were
stained with the nuclear dye DAPI (1:500 dilution, 15 min,
RT) and, after two PBS-T washing cycles, incubation with
Alexa 647 anti-rabbit fluorescent secondary antibodies (1:200
dilution, 1 h, RT) was carried out. Negative controls were
performed by omitting primary antibodies. After four PBS-T
washing cycles, tissue preparations were mounted in a single
well filled with antifading agent (Citifluor AF-2, Citifluor
Ltd).
Preparations were visualized with a Leica SP5 laser scan-
ning confocal microscopy (LSCM) system (Leica Microsys-
tems, Wetzlar, Germany) fitted with an inverted microscope
(×40 oil immersion lens). Stacks of 2 μm thick serial optical
images were captured from the entire adventitial layer,
which was identified by the shape and orientation of the
nuclei (Arribas et al., 1997). Image acquisition was always
performed under the same laser power, brightness and con-
trast conditions.
Two to three different regions were scanned along
each mesenteric artery, and the resulting images were
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reconstructed separately with ImageJ 1.48c software
(National Institutes of Health) to generate extended focus
images. After obtaining the 0 value for the background, the
area fraction parameter was set to determine the areas occu-
pied by fibres defined as percentage of pixels with non-zero.
Data are presented as percentage of area occupied by nerve
fibres.
nNOs and phospho-nNOS
(P-nNOS) expression
Western blot analysis of nNOS and P-nNOS expression was
performed in endothelium-denuded mesenteric segments
from O-CR and O-DR rats as described previously
(Blanco-Rivero et al., 2011a,b). For these experiments, we
used mouse monoclonal nNOS antibody (1:1000, Transduc-
tion Laboratories), rabbit polyclonal P-nNOS antibody
(1:2000, Abcam) and monoclonal anti-β-actin-peroxidase
antibody (1:50 000, Sigma-Aldrich, Madrid, Spain). Rat brain
homogenates were used as positive control.
Drugs used
L-Noradrenaline hydrochloride, ACh chloride, diethylamine
NONOate diethylammonium salt, CGRP (8–37), TTX,
L-NAME hydrochloride, 1400 W, phentolamine, suramin
sodium salt, lucigenin, tiron and DAF-2 (Sigma-Aldrich) were
used. Stock solutions (10 mmol·L−1) of drugs were made in
distilled water, except for NA, which was dissolved in a NaCl
(0.9%) ascorbic acid (0.01% w v−1) solution. These solutions
were kept at −20°C and appropriate dilutions were made in
KHS on the day of the experiment.
Data analysis
The responses elicited by EFS and NA were expressed as a
percentage of the initial contraction elicited by 75 mmol·L−1
KCl for comparison between O-CR and O-DR rats. The relaxa-
tion induced by ACh or DEA-NO was expressed as a percent-
age of the initial contraction elicited by NA (control:
10.36 ± 0.85 mg; O-DR: 10.81 ± 0.55 mg; P > 0.05). For
concentration–response curves, non-linear regression was
performed. Results are given as mean ± SEM. Statistical analy-
sis was carried out by comparing the curve obtained in the
presence of different substances with the previous or control
curve by means of repeated measure ANOVA followed by the
Bonferroni post hoc test. Some results are expressed as differ-
ences in AUC (dAUC). AUCs were calculated from the indi-
vidual frequency–response plots. For dAUC, NO, NA and ATP
release experiments, the statistical analysis was performed
using one-way ANOVA followed by Newman–Keuls post hoc
test. Glucose tolerance, insulin sensitivity, arterial blood pres-
sure, heart rate, results of general characteristics and immu-
nofluorescence staining were analysed using t-test. P < 0.05
was considered significant.
Results
Dams injected with streptozotocin had severe hyperglycae-
mia on gestational days 14 (control 829 ± 31 vs. diabetic 4572
± 337 mg·L−1, t-test: P < 0.05) and 21 (control 872 ± 26 vs.
diabetic 4806 ± 394 mg·L−1, t-test: P < 0.05) compared
with control dams. Blood glucose levels were similar in O-CR
an O-DR in 3-month-old (O-CR 764 ± 37 vs. O-DR 743 ±
28 mg·L−1, t-test: P > 0.05) and 6-month-old animals (O-CR
788 ± 62 vs. O-DR 792 ± 78 mg·L−1, t-test: P > 0.05).
The oral glucose tolerance test revealed that blood glucose
levels were higher in O-DR at 30 min compared with O-CR
(results not shown) and remained increased until 120 min
(O-CR, 1133 ± 97 vs. O-DR, 1568 ± 34 mg·L−1, t-test: P < 0.05).
Results from the insulin sensitivity test demonstrated signifi-
cant insulin resistance in the O-DR as they presented a higher
blood glucose level from 30 to 60 min after an insulin injec-
tion (blood glucose 60 min after the insulin injection: O-CR,
230 ± 15 vs. O-DR, 612 ± 97 mg·L−1; t-test: P < 0.05).
O-DR had a higher blood pressure than O-CR (mean arte-
rial pressure: O-CR: 119 ± 6.5 vs. O-DR: 137 ± 0.5 mmHg;
t-test: P < 0.05). The heart rate was similar in both the O-DR
and the O-CR (O-CR: 392 ± 21 vs. O-DR: 397 ± 32 bpm; t-test:
P > 0.05).
Body weight was decreased in the O-DR group (Table 1).
Serum insulin, total cholesterol, HDL and triglycerides were
similar in both experimental groups (Table 1).
Vasomotor response to KCl
In endothelium-intact mesenteric segments, the vasocon-
strictor response to 75 mmol·L−1 KCl was similar in both
experimental groups (O-CR: 13.8 ± 1.1 mN; O-DR: 15.53 ±
1.18 mN; P > 0.05). Endothelium removal did not alter KCl-
induced vasoconstriction (O-CR: 15.21 ± 1.5 mN; O-DR:
14.59 ± 10.9 mN; P > 0.05).
Vasodilator response to ACh
ACh-induced cumulative concentration- and endothelium-
dependent relaxations in NA-contracted arteries (O-CR: 10.26
± 0.84 mN; O-DR: 10.71 ± 0.55 mN; P > 0.05) from both the
O-CR and O-DR groups. However, the exposure to maternal
diabetes decreased this vasodilator response as compared
with the response in the O-CR group (Figure 1A).
Vascular responses to EFS
The application of EFS induced a frequency-dependent con-
tractile response in endothelium-intact mesenteric segments
from both the O-CR and O-DR groups. This vasoconstriction
Table 1
Body weight and serum biochemical parameters
O-CR O-DR
Body weight (mg) 438.8 ± 17.16 381.3 ± 8.25*
Total cholesterol
(mg·mL−1)
0.80 ± 0.07 0.73 ± 0.04
HDL (mg·mL−1) 0.52 ± 0.04 0.48 ± 0.02
Triglycerides (mg·mL−1) 1.32 ± 0.12 1.27 ± 0.17
Insulin (ng·mL−1) 5.1 ± 0.3 4.8 ± 0.1
At 6 months, body weight was measured, total cholesterol, HDL
cholesterol, triglycerides and insulin in O-CR and O-DR animals.
Data shown are means ± SEM. *P < 0.05 versus O-CR. n = 8
animals per group.
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was greater in segments from O-DR rats compared with O-CR
animals (Figure 1B). Endothelium removal increased EFS-
induced contractile response similarly in segments from
all experimental groups (Figure 1C and D). EFS-induced
contractions were practically abolished in segments from all
experimental groups by the neurotoxin TTX (0.1 mmol·L−1),
indicating the neuronal origin of the factors inducing this
response (Table 2).
Figure 1
(A) ACh-induced vasodilatation in endothelium-intact mesenteric segments from O-CR and O-DR rats. Results (mean ± SEM) are expressed as a
percentage of the previous tone elicited by exogenous NA. ANOVA *P < 0.05 O-CR versus O-DR. n = 12 animals in each group. (B) EFS-induced
vasoconstriction in endothelium-intact mesenteric segments from O-CR and O-DR rats. Results (mean ± SEM) are expressed as a percentage of
the initial contraction elicited by KCl. *P < 0.05 versus O-CR animals at each frequency (Bonferroni test). n = 12 animals per group. Effect of
endothelium removal on the vasoconstrictor response to EFS in mesenteric segments from O-CR (C) and O-DR (D) animals. Results (mean ± SEM)
are expressed as a percentage of the initial contraction elicited by KCl. ANOVA *P < 0.05 endothelium-intact versus endothelium-denuded arteries.
n = 12 animals per group. (E) dAUC in the absence or presence of endothelium.
Table 2
Effect of pre-incubation with TTX (0.1 μmol·L−1) on the frequency–contraction curves performed in mesenteric segments from O-CR and O-DR
1 Hz 2 Hz 4 Hz 8 Hz 16 Hz
O-CR 8.74 ± 2.9 25.45 ± 4.1 41.44 ± 5.7 58.49 ± 6.9 81.92 ± 8.5
TTX 0 0 0 0.4 ± 0.06 0.7 ± 0.1
O-DR 21.61 ± 6.8 37.92 ± 6.4 35.53 ± 6.9 74.05 ± 7.1 100.49 ± 8.5
TTX 0 0 0 0.5 ± 0.04 0.9 ± 0.02
Results (means ± SEM) are expressed as percentages of the response elicited by 75 mM KCl; 0, no contraction was detected. n = 7 animals
for each group.
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Participation of the sympathetic component
of mesenteric vascular neurons
Pre-incubation with the α-adrenoceptor antagonist phen-
tolamine (1 μmol·L−1) decreased the vasoconstrictor response
induced by EFS in endothelium-denuded segments from
both experimental groups (Figure 2A and B). This decrease
was greater in mesenteric segments from O-DR animals
(Figure 2C). NA-induced vasoconstriction was similar in both
experimental groups (Figure 3A). EFS-induced NA release was
higher in mesenteric segments from the O-DR group than in
segments from O-CR animals (Figure 3B). A phentolamine-
resistant contractile response remained, which was greater in
mesenteric segments from O-DR animals (Figure 2D). Pre-
incubation with phentolamine plus 0.1 mmol·L−1 suramin, a
non-specific P2 purine receptor antagonist, decreased the
EFS-induced contraction only in segments from the O-DR
group (Figure 2A and B). In line with this, EFS-induced ATP
release was increased in segments from O-DR animals
(Figure 3C).
LSCM allowed visualization of the sympathetic nerve
network in the adventitial layer of mesenteric arteries
through reconstruction of stacks of images with dopamine
β-hydroxylase immunoreactivity (Figure 4A and B). Quantifi-
cation of nerve fibre density confirmed that there were no
differences between either experimental groups (Figure 4C).
Participation of the sensory component in
vascular responses to EFS
Pre-incubation with the CGRP receptor antagonist CGRP
(8–37) (0.5 μmol·L−1) did not alter the EFS-induced contrac-
tion in any experimental group (Figure 5).
Participation of the nitrergic component in
vascular responses to EFS
Pre-incubation with non-specific NOS inhibitor L-NAME
(0.1 mmol·L−1) significantly increased the EFS–contractile
response in endothelium-denuded segments from both
experimental groups (Figure 6A and B). This increase was
greater in segments from O-DR animals (Figure 6C). EFS
induced NO release in segments from both groups. This
release was higher in O-DR mesenteric segments (Figure 7A).
TTX practically abolished EFS-induced NO release, whereas
1400 W did not modify it in either experimental group
(Figure 7A). The expression of nNOS was not modified,
whereas P-nNOS expression was increased in homogenates
from O-DR arteries compared with that in O-CR segment
homogenates (Figure 7B). Maternal gestational diabetes did
not alter either the vasodilator response to DEA-NO (NA
pre-contraction: control: 10.33 ± 0.74 mN; O-DR: 10.46 ±
0.65 mN; P > 0.05) or the superoxide anion release in the
offspring (Figure 7C and D).
Figure 2
Effect of pre-incubation with 1 μmol·L−1 phentolamine or phentolamine plus 0.1 mmol·L−1 suramin on the vasoconstrictor response induced by
EFS in endothelium-denuded mesenteric segments from O-CR (A) and O-DR animals (B). Results (mean ± SEM) are expressed as a percentage of
the initial contraction elicited by KCl. ANOVA P < 0.05 versus conditions without phentolamine or suramin in both experimental groups. *P < 0.05
versus conditions without phentolamine at each frequency (Bonferroni test). #P < 0.05 conditions phentolamine plus suramin versus conditions
without suramin at each frequency (Bonferroni test). n = 8 animals each group. (C) dAUC in the absence or presence of 1 μmol·L−1 phentolamine.
dAUC values are expressed as arbitrary units. (D) Representation of the vasoconstriction remaining after pre-incubation with 1 μmol·L−1
phentolamine, expressed as AUC (in arbitrary units).
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LSCM allowed visualization of the nitrergic nerve
network in the adventitial layer of mesenteric arteries
through reconstruction of stacks of images with nNOS immu-
noreactivity (Figure 8A and B). Quantification of nerve fibre
density confirmed the absence of differences between both
experimental groups (Figure 8C).
Discussion
This study provides the first evidence that maternal diabetes
alters the participation of different kinds of perivascular mes-
enteric neurons in adult offspring. The results presented here
demonstrate that in utero exposure to maternal hyperglycae-
mia increases EFS-induced vasoconstriction in adulthood.
This increase is endothelium independent, and is the net
effect of an increased participation of sympathetic neurons,
through increased release of NA and ATP, and an augmented
activity of nitrergic neurons, associated with increased NO
production.
The body weight of rats in the O-DR group was signifi-
cantly lower compared with those in the O-CR group. This
result agrees with previous reports showing that maternal
diabetes induced by STZ produces a decrease in offspring
weight (Grill et al., 1991; Holemans et al., 1999; Porto et al.,
2010; Ramos-Alves et al., 2012a) that has been associated
with reduced protein synthesis (Canavan and Goldspink,
1988). However, several studies have found no changes or
even increases in the body weight of the offspring of rats
subjected to this experimental procedure (Rocha et al., 2005;
Nehiri et al., 2008). This apparent contradiction may be due
to differences in the severity of maternal hyperglycaemia
during pregnancy, as previously suggested by Segar et al.
(2009).
Intrauterine exposure to maternal hyperglycaemia is a
significant risk factor for the development of metabolic and
cardiovascular disorders in the offspring. In the current study,
6-month-old male offspring of diabetic mothers exhibited
glucose intolerance, insulin resistance and an elevated blood
pressure, as we (Ramos-Alves et al., 2012a,b) and others have
reported previously (Simeoni and Barker, 2009). Glucose and
insulin levels and lipid profile were similar in both experi-
mental groups, in agreement with Blondeau et al. (2011). The
mechanisms of hyperglycaemia-programmed hypertension
are complex and involve renal, neural and vascular factors
(Rocha et al., 2005; Wichi et al., 2005; Nehiri et al., 2008;
Segar et al., 2009; Chen et al., 2010). The analysis of the
vasoconstrictor response induced by EFS in endothelium-
intact segments showed a frequency-dependent contraction
in segments from both experimental groups. This vasocon-
striction was greater in mesenteric segments from O-DR
than O-CR animals. This increase could not be attributed to
changes in the intrinsic contractile machinery as a similar
vasoconstrictor response to KCl was obtained in both experi-
mental groups. The endothelium has been reported to affect
the response to several substances including neurotransmit-
ters such as NA (Vanhoutte and Houston, 1985; Li and
Duckles, 1992). Because we observed that the relaxation to
ACh was impaired in O-DR compared with O-CR rats, as we
and other groups had previously reported (Holemans et al.,
1999; Rocha et al., 2005; Segar et al., 2009; Ramos-Alves et al.,
2012a), we expected differences in the influence of endothe-
lium on the vasoconstrictor response to EFS in segments
from the two experimental groups. However, endothelium
removal increased this vasoconstriction to the same extent
in both experimental groups. These results indicate that
endothelial dysfunction does not influence the EFS-induced
response in diabetic offspring, similar to reports on this artery
in rats fed a high fat diet (Sastre et al., 2015). One possible
explanation could be that the vasoconstrictor response to
α-adrenoceptor activation has been reported as maintained in
the absence of endothelium (Xavier et al., 2004a) indepen-
dently of the modifications of the vasodilator response to
ACh. In endothelium-denuded segments, the EFS-induced
vasoconstriction was almost abolished in the presence of
the neurotoxin TTX, indicating a neuronal origin for this
Figure 3
(A) Vasoconstrictor response to NA in segments from O-CR and
O-DR. Results (mean ± SEM) are expressed as a percentage of the
initial contraction elicited by KCl. n = 8 animals each group. EFS-
induced NA (B) and ATP (C) release in mesenteric segments from
O-CR and O-DR animals. Results (mean ± SEM) are expressed as
ng NA·mL−1 mg−1 tissue or nmol ATP·mL−1 mg−1 tissue. n = 8 animals
per group.
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response. The remaining contractile response to high-
frequency stimulation could be explained by a direct action
potential produced in smooth muscle cells elicited by EFS. For
that reason, we performed the following experiments in
endothelium-denuded mesenteric segments.
Sympathetic function is essential for blood pressure regu-
lation, and sympathetic hyperactivity has an important role
in the development of hypertension (Lohmeier, 2001). Sym-
pathetic neurons mainly release NA and ATP when electri-
cally stimulated. The activity of these neurons is altered in
Figure 4
Dopamine β-hydroxylase immunoreactivity in the adventitia of mesenteric arteries from O-CR (A) and O-DR (B) animals. Tissues were stained with
primary monoclonal dopamine β-hydroxylase (DβH) antibody and a species-specific secondary Alexa 647 antibody. Bar = 75 μm. All images are
reconstructions from 10 serial optical sections obtained by LSCM. (C) Percentage of area occupied by sympathetic nerve fibres. n = 6 animals per
group. (For a better visualization, brightness and contrast were modified equally in both experimental groups using ImageJ software).
Figure 5
Effect of pre-incubation with 0.5 μmol·L−1 CGRP (8–37) on the vasoconstrictor response induced by EFS in mesenteric segments from O-CR (A)
and O-DR (B) animals. Results (mean ± SEM) are expressed as a percentage of the previous contraction elicited by KCl. n = 8 animals each group.
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different physiological and pathological situations (Sastre
et al., 2010; 2012a). Increased sympathetic activity has been
reported in O-DR (Young and Morrison, 1998; Iellamo et al.,
2006; de Almeida Chaves Rodrigues et al., 2013). This effect
could be associated with an increased NA release and/or vaso-
constrictor response to NA. To the best of our knowledge,
although increased NA release in different tissues has been
suggested (Morriss, 1984; Iellamo et al., 2006), as well as
increases or no modifications in NA vasoconstriction
(Holemans et al., 1999; Ramos-Alves et al., 2012b), an inte-
grated study of both mechanisms has not yet been performed
in arteries. Thus, our next objective was to determine possible
differences in the function of sympathetic neurons between
the O-CR and O-DR experimental groups. The fact that the
α-adrenoceptor antagonist phentolamine significantly
diminished the vasoconstrictor response to EFS in mesenteric
segments from both experimental groups confirms that
this response would be mediated mainly by the release of NA
from sympathetic nerve terminals. Moreover, our study
showed that phentolamine produced a more marked decrease
in EFS vasoconstriction in segments from OD-R rats than
O-CR animals, confirming an increased involvement of sym-
pathetic neurons in this experimental group. This different
participation can be produced by modifications in NA vaso-
constrictor response and/or release. Exogenous NA-induced
vasoconstriction was similar in both experimental groups,
like the vasoconstriction described in endothelium-denuded
mesenteric resistance arteries (Ramos-Alves et al., 2012b),
whereas EFS-induced NA release was higher in segments from
O-DR animals, confirming that the increased adrenergic
activity in O-DR is associated with increased NA release.
It should also be mentioned that both groups showed a
substantial phentolamine-resistant contractile response. This
remaining vasoconstriction was higher in segments from
O-DR animals. We have previously observed that ATP
released from sympathetic nerves caused vasoconstriction in
this vascular bed (Blanco-Rivero et al., 2011a; 2013a,b). Based
on this information, we analysed EFS-induced contraction
after simultaneous pre-incubation with phentolamine plus
the non-specific P2 purine receptor antagonist suramin. In
these conditions, the contractile response to EFS was reduced
only in segments from the O-DR group, indicating that ATP
contributes to this response. In line with these results, EFS-
induced ATP release was higher in mesenteric segments from
O-DR than O-CR rats, as previously described (Rummery
et al., 2007; Sousa et al., 2014), suggesting an increased
contribution of ATP in neurovascular transmission in hyper-
tension. Altogether, these observations indicate that the
increased participation of sympathetic neurons observed in
mesenteric segments from O-DR animals is due to an increase
in NA and ATP release from nerve terminals. Because this
increased release of sympathetic neurotransmitters could be
due to an increase in nerve fibre density, our next objective
was to determine possible differences in the sympathetic
nerve density. Results obtained by immunofluorescence
staining for dopamine β-hydroxylase showed no differences
between either experimental group, ruling out an increase in
sympathetic nerve density and suggest that the augmented
release of NA and ATP could be related to an increase
in enzymatic activity involved in the synthesis of both
neurotransmitters. However, neurotransmitter release by
sympathetic neurons is mediated by several subtypes of
adrenoceptor (Sanchez-Merino et al., 1990; Arribas et al.,
1991; Enero et al., 1997; Kanagy, 2005), so some type of
presynaptic dysfunction cannot be ruled out.
We have previously reported that CGRP released from
sensory neurons does not participate in the vasoconstrictor
response to EFS (Blanco-Rivero et al., 2011a,c), although the
level of CGRP is increased in several pathological situations,
such as hypertension and diabetes (Blanco-Rivero et al.,
2011c; del Campo et al., 2011; Sastre et al., 2012a). Pre-
incubation with the CGRP receptor antagonist CGRP (8–37)
did not modify EFS-induced vasoconstriction in either O-CR
or O-DR mesenteric segments. This observation led us to
Figure 6
Effect of pre-incubation with 0.1 mmol·L−1 L-NAME on the vasocon-
strictor response induced by EFS in mesenteric segments from O-CR
(A) and O-DR (B) rats. Results are expressed as a percentage of the
previous contraction elicited by KCl. ANOVA P < 0.05 versus conditions
without phentolamine or suramin in both experimental groups. *P <
0.05 versus conditions without L-NAME for each frequency (Bonfer-
roni test). n = 8 animals each group. (C) dAUC in the absence or
presence of 0.1 mmol·L−1 L-NAME. dAUC values are expressed as
arbitrary units. *P < 0.05.
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conclude that maternal diabetes did not alter the activity of
sensory neurons in this vascular bed in adulthood.
A decrease in endothelial NO release has been reported to
participate in the development of hypertension (Wu et al.,
1997; Bernatova, 2014). Similar results have been observed in
rat aorta and mesenteric resistance arteries from offspring of
diabetic rats (Holemans et al., 1999; Cavanal Mde et al., 2007;
Ramos-Alves et al., 2012a). However, there are no data study-
ing the possible role of neuronal NO in this model. The fact
that previous studies have reported increases in endothelial
NO release due to ATP-induced activation of P2X4 and P2Y
receptors and augmented NOS activity due to endothelial α2
adrenoceptor activation by NA in rat mesenteric arteries
(Boric et al., 1999; Buvinic et al., 2002; Codocedo et al., 2013),
as well as our earlier report of increased neuronal NO in both
diabetes and hypertension (Ferrer et al., 2000; 2003; Marín
et al., 2000; del Campo et al., 2011), make it necessary to
evaluate whether a hyperglycaemic environment intra utero
could also affect the synthesis of NO from nitrergic neurons.
In our experimental conditions, the involvement of neuronal
NO in the EFS-induced response was demonstrated by the
fact that pre-incubation with the non-specific NOS inhibitor
L-NAME increased the response to EFS in segments from both
experimental groups. The greater effect of L-NAME observed
in segments from O-DR rats suggests an increased role for
neuronal NO in this experimental group, possibly related to
increases in nitric NO and/or increases in smooth muscle
sensitivity to NO.
In our experimental conditions, we observed an increased
EFS-induced NO release in mesenteric segments from O-DR
animals. The fact that pre-incubation with TTX abolished
EFS-induced NO release in segments from both groups of rats,
and that pre-incubation with the specific iNOS inhibitor
1400 W did not alter NO release confirms the neural origin of
NO and rules out the involvement of inducible NOS. We have
previously demonstrated that NO released from nerve
endings in this vascular bed is synthesized through nNOS
(Blanco-Rivero et al., 2011a,b; 2013a,b). The increase in neu-
ronal NO could be due to an increase in nitrergic nerve fibre
density or an increase in the enzymatic activity of nNOS.
Thus, our next objective was to determine possible differ-
ences in nitrergic nerve density. Immunofluorescence stain-
ing for nNOS showed no differences between experimental
groups, suggesting that the differences in NO release could be
Figure 7
(A) EFS-induced NO release in segments from O-CR and O-DR rats. Results (mean ± SEM) are expressed as arbitrary (A.U.)·mg−1 tissue; n = 8
animals per group. (B) Effect of exposure to maternal hyperglycaemia on nNOS and P-nNOS expression. The blot is representative of eight
separate segments from each group. Rat brain homogenates were used as a positive control. Lower panel shows relationship between P-nNOS
or nNOS expression and β-actin. Results (mean ± SEM) are expressed as ratio of the signal obtained for each protein and the signal obtained for
β-actin. (C) Vasodilator response to NO donor DEA-NO in segments from O-CR and O-DR rats. Results (mean ± SEM) are expressed as a percentage
of the previous tone elicited by exogenous NA. n = 8 animals each group. (D) Superoxide anion release in mesenteric segments from O-CR and
O-DR rats. Results (mean ± SEM) are expressed as chemiluminescence U·min−1 mg tissue. n = 8 animals each group.
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due to modifications in the expression and/or activation of
nNOS. We found that nNOS protein expression was similar in
both experimental groups, whereas the active form P-nNOS
was increased in O-DR rats, indicating that increased nNOS
activity is responsible for the increase in NO release observed
in O-DR mesenteric arteries. These results contrast with obser-
vations in endothelium-intact arteries (Holemans et al., 1999;
Rocha et al., 2005; Segar et al., 2009; Porto et al., 2010), where
the NO release from eNOS was decreased. Similar differences
in this vascular bed have been demonstrated previously in
several pathological situations (Wu et al., 1997; Ferrer et al.,
2000; 2003; Favero et al., 2014).
Several observations indicate that diabetic pregnant rats
and their offspring are exposed to increased oxidative stress
induced by the inadequate production of free radical scaven-
gers (Horal et al., 2004; Li et al., 2005; Katkhuda et al., 2012).
Thus, the involvement of reactive oxidative species in the
vascular response to NO cannot be ruled out as these species
could alter the metabolism and consequently affect neuronal
NO bioavailability. Superoxide anion production was similar
in both experimental groups, in contrast to findings from
previous studies (Horal et al., 2004; Li et al., 2005; Katkhuda
et al., 2012). These differences can be attributed to the differ-
ent tissues analysed as well as to the method of inducing
maternal diabetes. As was expected from the earlier results,
the vasodilator response to the NO donor DEA-NO was
similar in segments from both experimental groups, and
similar to responses in aorta and mesenteric resistance arter-
ies (Holemans et al., 1999; Katkhuda et al., 2012; Ramos-Alves
et al., 2012a). Altogether, these results confirm that the
increased activity of the nitrergic neurons is due to increased
neuronal NO release and not to changes in the vasodilator
response and/or metabolism of neuronal NO.
A reciprocal interaction between sympathetic and nitrer-
gic neurons has been demonstrated in several vascular beds
(Lee, 2002; Hatanaka et al., 2006; Koyama et al., 2010).
However, in SMA, we have demonstrated an increase in
nitrergic activity with no change (Xavier et al., 2004b), a
decrease (Sastre et al., 2012a,b) or increase (Ferrer et al., 2000;
2003; Marín et al., 2000; del Campo et al., 2011) in adrenergic
activity, as in the current study. These observations indicate
that modifications in the activity of adrenergic and nitrergic
neurons in OD-R are independent and lead us to consider
them as primary changes.
Based on previous studies, various hypotheses can be
raised about the mechanism/s involved in these effects.
During pregnancy, maternal high blood glucose levels stimu-
late the fetal pancreas to produce high insulin levels
(Dabelea, 2007). Hyperinsulinaemia may cause sympathetic
overactivation due its effects on the CNS (Scherrer and
Figure 8
nNOS immunoreactivity in the adventitia of mesenteric arteries from O-CR (A) and O-DR (B) animals. Tissues were stained with primary polyclonal
nNOS antibody and a species-specific secondary Alexa 647 antibody. Bar = 75 μm. All images are reconstructions from 10 serial optical sections
obtained by LSCM. (C) Percentage of area occupied by nitrergic nerve fibres. n = 6 animals per group.
1bs_bs_query
2bs_bs_query
3bs_bs_query
4bs_bs_query
5bs_bs_query
6bs_bs_query
7bs_bs_query
8bs_bs_query
9bs_bs_query
10bs_bs_query
11bs_bs_query
12bs_bs_query
13bs_bs_query
14bs_bs_query
15bs_bs_query
16bs_bs_query
17bs_bs_query
18bs_bs_query
19bs_bs_query
20bs_bs_query
21bs_bs_query
22bs_bs_query
23bs_bs_query
24bs_bs_query
25bs_bs_query
26bs_bs_query
27bs_bs_query
28bs_bs_query
29bs_bs_query
30bs_bs_query
31bs_bs_query
32bs_bs_query
33bs_bs_query
34bs_bs_query
35bs_bs_query
36bs_bs_query
37bs_bs_query
38bs_bs_query
39bs_bs_query
40bs_bs_query
41bs_bs_query
42bs_bs_query
43bs_bs_query
44bs_bs_query
45bs_bs_query
46bs_bs_query
47bs_bs_query
48bs_bs_query
49bs_bs_query
50bs_bs_query
51bs_bs_query
52bs_bs_query
53bs_bs_query
54bs_bs_query
55bs_bs_query
BJP D B de Queiroz et al.
12 British Journal of Pharmacology (2015) •• ••–••
17
bs_bs_query
Co
lou
r
bs_bs_query
JOBNAME: No Job Name PAGE: 13 SESS: 9 OUTPUT: Fri Jul 31 16:20:23 2015 SUM: 5181AB2C
/Xpp84_Wiley/wiley_journal_B/BPH/bph_v0_i0/bph_13244
Sartori, 1997). In the offspring of diabetic rats, a decrease in
the mean area of neuronal nuclei and neuronal cytoplasm
has been demonstrated in the ventromedial hypothalamic
nucleus, paraventricular hypothalamic nucleus and arcuate
nucleus (Plagemann et al., 1999). These changes were accom-
panied by an increased number of neurons expressing tyros-
ine hydroxylase in the arcuate nucleus. It has been proposed
that this increase in tyrosine hydroxylase-expressing neurons
might activate and overstimulate the differentiation of hypo-
thalamic catecholaminergic systems due to hyperinsulinism.
Previous reports have demonstrated that hyperinsulinaemia
may also increase the phosphorylation of nNOS (Chiang
et al., 2009; Fioramonti et al., 2010; Hinchee-Rodriguez et al.,
2013) and thereby increase neuronal NO release in the off-
spring of diabetic dams. Additionally, fetal leptin levels are
also raised by maternal hyperglycaemia, which may contrib-
ute to central leptin resistance and hypothalamic dysfunction
(Steculorum and Bouret, 2011) in the offspring of diabetic
rats. Thus, it is possible to postulate that hormonal changes
produced by hyperglycaemia during fetal life induce changes
in neuronal activity/development that persist to some extent
into adult life, as observed in the current study.
In conclusion, maternal diabetes increases the contractile
response to EFS in SMA of their adult offspring. This effect is
endothelium-independent and is the net result of increased
levels of sympathetic vasoconstrictors NA and ATP along with
an augmented release of neuronal NO, whereas the activity of
sensory neurons is unaltered. This mechanism could be
involved in the development of hypertension in the adult
offspring of diabetic mothers, reinforcing the concept of fetal
programming of chronic diseases.
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to be changed to bold or italic. 
 
Highlights text in yellow and opens up a text 
box where comments can be entered. 
How to use it 
 Highlight the relevant section of text. 
 Click on the Add note to text icon in the 
Annotations section. 
 Type instruction on what should be changed 
regarding the text into the yellow box that 
appears. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Add sticky note Tool – for making notes at 
specific points in the text. 
Marks a point in the proof where a comment 
needs to be highlighted. 
How to use it 
 Click on the Add sticky note icon in the 
Annotations section. 
 Click at the point in the proof where the comment 
should be inserted. 
 Type the comment into the yellow box that 
appears. 
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For further information on how to annotate proofs, click on the Help menu to reveal a list of further options: 
5. Attach File Tool – for inserting large amounts of 
text or replacement figures. 
 
Inserts an icon linking to the attached file in the 
appropriate pace in the text. 
How to use it 
 Click on the Attach File icon in the Annotations 
section. 
 Click on the proof to where you’d like the attached 
file to be linked. 
 Select the file to be attached from your computer 
or network. 
 Select the colour and type of icon that will appear 
in the proof. Click OK. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Add stamp Tool – for approving a proof if no 
corrections are required. 
 
Inserts a selected stamp onto an appropriate 
place in the proof. 
How to use it 
 Click on the Add stamp icon in the Annotations 
section. 
 Select the stamp you want to use. (The Approved 
stamp is usually available directly in the menu that 
appears). 
 Click on the proof where you’d like the stamp to 
appear. (Where a proof is to be approved as it is, 
this would normally be on the first page). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Drawing Markups Tools – for drawing shapes, lines and freeform 
annotations on proofs and commenting on these marks. 
Allows shapes, lines and freeform annotations to be drawn on proofs and for 
comment to be made on these marks.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How to use it 
 Click on one of the shapes in the Drawing 
Markups section. 
 Click on the proof at the relevant point and 
draw the selected shape with the cursor. 
 To add a comment to the drawn shape, 
move the cursor over the shape until an 
arrowhead appears. 
 Double click on the shape and type any 
text in the red box that appears. 
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91Objective: To study the effect of aerobic exercise training
on sympathetic, nitrergic and sensory innervation function
in superior mesenteric artery from spontaneously
hypertensive rats (SHRs).
Methods: De-endothelized vascular rings from sedentary
and trained SHRs (treadmill 12 weeks) were used.
Vasomotor responses to electrical field stimulation (EFS),
noradrenaline, nitric oxide donor DEA-NO and calcitonin
gene-related peptide (CGRP) were studied. Neuronal nitric
oxide synthase (nNOS) expression and nitric oxide,
superoxide anions (O2
.-), noradrenaline and CGRP levels
were also determined.
Results: Aerobic exercise training decreased
vasoconstrictor response to EFS but increased
noradrenaline response. Phentolamine decreased while
Nv-nitro-L-arginine methyl ester (L-NAME) increased the
response to EFS; the effect of both drugs was greater in
trained animals. Training also decreased noradrenaline
release and O2
.- production and increased nNOS
expression, nitric oxide release and the vasodilator
response to DEA-NO. The O2
.- scavenger tempol increased
DEA-NO-induced vasodilation only in sedentary rats. The
EFS-induced contraction was increased to a similar extent
in both experimental groups by preincubation with CGRP
(8–37). CGRP release and vasodilator response were not
modified by training.
Conclusion: Aerobic exercise training decreases contractile
response to EFS in mesenteric artery from SHRs. This effect
is the net result of decreased noradrenaline release,
increased sensitivity to the vasoconstrictive effects of
noradrenaline and increased neuronal nitric oxide release
and bioavailability. These modifications might contribute to
the beneficial effects of aerobic exercise training on blood
pressure.
Keywords: aerobic exercise, hypertension, neuronal nitric
oxide, nitrergic innervation, noradrenaline, rat mesenteric
artery, sympathetic innervation
Abbreviations: 6-OHDA, 6-hydroxydopamine; CGRP,
calcitonin gene-related peptide; DEA-NO, diethylamineopyright © Lippincott Williams & Wilkins. Unauth
6 www.jhypertension.comNONOate; EFS, electric field stimulation; KHS, Krebs–
Henseleit solution; L-NAME, N nitro-L-arginine methyl ester;
nNOS, neuronal nitric oxide synthase; O2
.-, superoxide
anions; TTX, tetrodotoxinINTRODUCTIONE
vidence from epidemiological prospective follow-
up studies indicates that physical activity and
physiological fitness are inversely related to the
incidence of cardiovascular disease and mortality. Modifi-
cations in lifestyle, including regular exercise, are effective
in the management of hypertension [1] with differences in
the efficiency of the effect depending on levels and kinds of
physical activity. However, the mechanisms underlying
the beneficial cardiovascular effects produced by regular
exercise are little known.
Vascular tone is determined by an equilibrium among
several mechanisms in which perivascular innervation
plays an important role. This regulation involves sym-
pathetic, cholinergic, nitrergic, peptidergic and/or sensory
innervations that are specific to the vascular bed considered
[2,3]. Superior mesenteric artery regulates around 20%
of total blood flow. Therefore, changes in mesenteric
vascular tone participate in total peripheral resistance.
The application of electrical field stimulation (EFS)
produces a vasoconstrictor response which is the integrated
result of the release of different neurotransmitters, mainlyorized reproduction of this article is prohibited.
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from nitrergic innervation and calcitonin gene-related
peptide (CGRP) from sensory nerves [4–7]. Alterations of
the functional role of these components in rat mesenteric
artery have been associated with several experimental and
pathophysiological circumstances including ageing, portal
hypertension, liver cirrhosis and diabetes [8–11].
Exercise has been shown to reduce hypertension by
decreasing the elevated sympathetic activity in blood
vessels by different mechanisms, including pre and post-
synaptic mechanisms and control of the central nervous
system [12]. Training has been described to improve endo-
thelial nitric oxide release in hypertension through an up-
regulation of endothelial nitric oxide synthase expression
and an increase in neuronal nitric oxide synthase (nNOS)
expression in the central nervous system and rat penile
tissues [13,14]. Additionally, growing evidence indicates
that exercise also prevents oxidative damage by reducing
oxidative stress in hypertension [15–19], thus increasing
nitric oxide bioavailability. Regarding the influence of
training on sensory innervation, cutaneous sensory func-
tion can be preserved by maintaining regular exercise
training [20], and changes in the sensory receptors to
resistive exercise have been described [21].
Taking into account this information, we consider it
important to analyze the effect of aerobic exercise training
on the vasomotor response to EFS in mesenteric artery from
spontaneously hypertensive rats (SHRs), studying the kinds
of innervation, sympathetic, nitrergic or sensory, affected,
as well as the mechanisms implicated.
MATERIALS ANDMETHODS
Animals
Three-month-old male SHRs were obtained from the
Animal Quarters of the Universidad Auto´noma de Madrid
(Registration number EX-021U), in accordance with guide-
lines 609/86 of the E.E.C., R.D. 233/88 of the Ministerio de
Agricultura, Pesca y Alimentacio´n of Spain, and Guide for
the Care and Use of Laboratory Animals published by the
United States National Institute of Health [NIH publication
No. 85.23 revised 1985]. All experimental procedures involv-
ing animal usewere approvedby theEthics Committee of the
Universidad Auto´noma de Madrid (RD 1201/2005).
Rats were housed at a constant room temperature,
humidity and light cycle (12 : 12-h light-dark) and had free
access to tap water and standard rat chow ad libitum. Body
weight was controlled weekly and SBP was measured
before the start of the protocol and every 15 days until
the end of the protocol using tail-cuff plethysmography.
Exercise training protocol
Animals were divided in two experimental groups: seden-
tary and trained SHRs. Exercise training was performed on a
motor treadmill (Motor-driven Treadmill LI8706; Letica
Scientific Instruments, Barcelona, Spain) for 12 weeks,
5 times per week for 60min, gradually progressing toward
55–65% of maximal running speed (15–20m/ min),
as described elsewhere [22]. To determine the maximal
exercise capacity rats were subjected to a progressive
exercise test on a treadmill using an incremental speedCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionprotocol of 5m/min every 3min and no grade until
exhaustion. The treadmill exercise test was repeated after
6 weeks of exercise training in order to adjust training
intensity. Rats were considered to be exhausted when they
could no longer run at the treadmill speed. The sedentary
rats were handled at least twice a week for habituation to
the experimental protocols.Tissue samples
At the end of the experimental protocol and 24 h after the
last session of exercise training rats were euthanized by
decapitation. The muscle soleus was removed and immedi-
ately stored at 808C until citrate synthase analysis was
performed. The first branch of the mesenteric artery was
carefully dissected, cleaned out of connective tissue, div-
ided into 2-mm long segments and maintained in cold (48C)
Krebs–Henseleit solution (KHS) (in mmol/l: 115 NaCl, 25
NaHCO3, 4.7 KCl, 1.2 MgSO4.7H2O, 2.5 CaCl2, 1.2 KH2PO4,
11.1 glucose, and 0.01 Na2EDTA) bubbled with a 95% O2–
5% CO2 mixture. For protein expression analysis, some
segments were quickly frozen in liquid nitrogen and
maintained at 808C until the day the experiments were
performed.
Citrate synthase activity
Citrate synthase activity was determined in mixed right
soleus according to the method of Alp et al. [23] and used
as a marker of muscle oxidative activity. The enzyme
activity was measured in whole muscle homogenates,
and the complex resulting from acetyl-CoA and oxaloace-
tate was determined at 412 nm and 258C, at an interval of
10min. Citrate synthase activity was expressed as nmol/min
per mg of protein.
Vascular reactivity
The method used for isometric tension recording has been
described in full elsewhere [7]. Two parallel stainless steel
pins were introduced through the lumen of the vascular
segment: one was fixed to the bath wall, and the other
connected to a force transducer (Grass FTO3C; Quincy,
Massachusetts, USA); this, in turn, was connected to a
model 7D Grass polygraph. For EFS experiments, segments
were mounted between two platinum electrodes 0.5 cm
apart and connected to a stimulator (Grass, model S44)
modified to supply adequate current strength. Segments
were suspended in an organ bath containing 5 ml of KHS at
378C and continuously bubbled with a 95% O2 to 5% CO2
mixture (pH of 7.4). Experiments were performed in endo-
thelium-denuded segments to eliminate the main source
of vasoactive substances, including endothelial nitric
oxide. This avoided possible actions by different drugs
on endothelial cells that could lead to misinterpretation
of results. Endothelium was removed by gently rubbing the
luminal surface of the segments with a thin wooden stick.
The segments were subjected to a tension of 0.5g, which
was readjusted every 15 min during a 90-min equilibration
period before drug administration. After this, the vessels
were exposed to 75 mmol/l KCl, to check their functional
integrity. Endothelium removal did not alter the contrac-
tions elicited by KCl. After a washout period, the absence oforized reproduction of this article is prohibited.
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10mmol/l acetylcholine (ACh) to relax segments pre-
contracted with noradrenaline.
Frequency–response curves to EFS (1, 2, 4, 8 and 16Hz)
were performed. The parameters used for EFS were
200 mA, 0.3 ms, 1–16 Hz, for 30 s with an interval of
1min between each stimulus, the time required to recover
basal tone. A washout period of at least 1 h was necessary
to avoid desensitization between consecutive curves.
Two successive frequency-response curves separated
by 1-h intervals produced similar contractile responses.
To evaluate the neural origin of the EFS-induced contractile
response, the nerve impulse propagation blocker, tetrodo-
toxin (TTX, 0.1mmol/l) was added to the bath 30min
in advance.
To determine the participation of the adrenergic
component of sympathetic innervation in the EFS-induced
response in segments from sedentary and trained rats,
1mmol/l phentolamine, an a-adrenoceptor antagonist,
was added to the bath 30min before performing the
frequency–response curve. Additionally, the vasoconstric-
tor response of exogenous noradrenaline (1 nmol/l–
10mmol/l) was tested in segments from both experimental
groups.
The method used to deplete sympathetic innervation
has been used previously by our group [24]. Briefly,
endothelium-denuded mesenteric segments from both sed-
entary and trained SHRs were incubated at room tempera-
ture for 10min in KHS (NaHCO3 and NaH2PO4 were
omitted, unbuffered solution) containing 0.02 mmol/l
glutathione and 1.46 mmol/l of the neurotoxin 6-hydroxy-
dopamine (6-OHDA). The pH of this solution was adjusted
to 4.9 with 0.05 mmol/l NaOH and then the solution was
covered with paraffin oil. Subsequently, the arteries were
immersed in normal KHS and EFS-induced contraction
experiments were performed.
To analyze the participation of nitric oxide in the
EFS-induced response in segments from both groups of
rats, 0.1 mmol/l Nv-nitro-L-arginine methyl ester (L-NAME),
a nonspecific inhibitor of NOS, was added to the bath
30min before performing the second frequency–response
curve. The vasodilator response to the nitric oxide donor,
diethylamine NONOate (DEA-NO; 0.1 nmol/l–0.1 mmol/l)
was determined in noradrenaline-precontracted arteries
from both experimental groups. Some experiments were
performed in the presence of superoxide anion scavenger
tempol (0.1 mmol/l).
To study the possible participation of sensory
innervation in the EFS-induced response, 0.5mmol/l CGRP
(8–37), a CGRP receptor antagonist, was added to the
bath 30min before performing the second frequency–
response curve. Additionally, the vasodilator response to
exogenous CGRP (0.1 nmol/l–0.1mmol/l) was determined
in noradrenaline-precontracted arteries from both experi-
mental groups.
Noradrenaline and calcitonin gene-related
peptide levels
Noradrenaline and CGRP releases were measured using
commercial kits (Noradrenaline research EIA Kit; LaborCopyright © Lippincott Williams & Wilkins. Unauth
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and Rat CGRP Enzyme Immunoassay Kit; Spibio, Bertin
Group) following the manufacturer’s instructions. Endo-
thelium-denuded segments of rat mesenteric arteries from
both experimental groups were preincubated for 30 min
in 5ml of KHS at 378C and continuously gassed with a
95% O2–5% CO2 mixture (stabilization period). This was
followed by two washout periods of 10min in a bath of
0.4 ml of KHS. Then, the medium was collected to measure
basal release. Afterwards, the organ bath was refilled, and
cumulative EFS periods of 30 s at 1, 2, 4, 8 and 16Hz were
applied at 1-min intervals. Afterwards, the medium was
collected to measure EFS-induced neurotransmitter release.
Samples were immediately frozen in liquid nitrogen and
conserved at 708C until experiments were performed.
To prevent catecholamine degradation, 1 mmol/l EDTA
and 4mmol/l sodium metabisulfite were added to the
samples. Additionally, endothelium-denuded mesenteric
segments from sedentary and trained SHRs were collected
in order to measure noradrenaline content in the vessel
segments. Samples were homogenized in 0.01 N HCl
containing 1mmol/l EDTA and 4 mmol/l sodium meta-
bisulfite, as the manufacturer suggests. Results were
expressed as ng noradrenaline/ml mg tissue (medium
measurements), ng noradrenaline/mg protein (tissue
measurements) and pg CGRP/ml mg tissue.
Nitric oxide measurements
Nitric oxide release was measured using fluorescence
emitted by the fluorescent probe 4,5-diaminofluorescein
(DAF-2), as previously described [25,26]. Endothelium-
denuded mesenteric arteries from sedentary and trained
SHRs were subjected to a 60-min equilibration period in
HEPES buffer (in mmol/l: NaCl 119; HEPES 20; CaCl2 1.2;
KCl 4.6; MgSO4 1; KH2PO4 0.4; NaHCO3 5; glucose 5.5;
Na2HPO4 0.15; pH 7.4) at 378C. Arteries were incubated
with 2mmol/l DAF-2 for 30min. The medium was then
collected to measure basal nitric oxide release. Once the
organ bath was refilled, cumulative EFS periods of 30 s at 1,
2, 4, 8 and 16Hz at 1-min intervals were applied. After-
wards, the medium was collected to measure EFS-induced
nitric oxide release. The fluorescence of the medium was
measured at room temperature using a spectrofluorometer
(LS50 Perkin Elmer Instruments; FL WINLAB Software,
Waltham, Massachusetts, USA) with excitation wavelength
set at 492 nm and emission wavelength at 515 nm.
The EFS-induced nitric oxide release was calculated
by subtracting basal nitric oxide release from that evoked
by EFS. Also, blank sample measures were collected in the
same way from segment-free medium in order to subtract
background emission. Some assays were performed in the
presence of either TTX (0.1mmol/l), the specific nNOS
inhibitor 7-NI (0.1 mmol/l) or the specific iNOS inhibitor
1400 W (1mmol/l) [9,27,28]. The amount of nitric oxide
released was expressed as arbitrary units/mg tissue.
Superoxide anions measurements
Superoxide anion levels were measured using lucigenin
chemiluminescence, as previously described [26]. Endo-
thelium-denuded mesenteric segments from both groupsorized reproduction of this article is prohibited.
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30min in HEPES buffer at 378C, transferred to test tubes
that contained 1ml HEPES buffer (pH 7.4) containing
lucigenin (5mmol/l) and then kept at 378 C. The lumin-
ometer was set to report arbitrary units of emitted light;
repeated measurements were collected for 5min at
10-s intervals and averaged. 4,5-Dihydroxy-1,3-benzene-
disulphonic acid ‘Tiron’ (10 mmol/l), a cell-permeant, non-
enzymatic superoxide anion scavenger, was added to
quench the superoxide anion-dependent chemilumines-
cence. Calculations were performed subtracting the
lucigenin chemiluminescence obtained in the presence
of Tiron from that obtained in its absence. Blank measures
were collected in the same way without mesenteric
segments to subtract background emission.
Neuronal nitric oxide synthase expression
Western blot analysis of nNOS expression was performed
as previously described [25]. For these experiments,
we used mouse monoclonal nNOS antibody (1 : 1000;
Transduction Laboratories) and monoclonal antib-actin-
peroxidase antibody (1 : 50000; Sigma–Aldrich, Spain).
Rat brain homogenates were used as positive control.
Drugs used
L-NA hydrochloride, ACh chloride, diethylamine NONOate
diethilammonium salt, CGRP, CGRP (8–37), TTX, L-NAME
hydrochloride, 7NI, 1400W, phentolamine, lucigenin, Tiron,
6-OHDA and DAF-2 (Sigma-Aldrich, Madrid, Spain) were
used. Stock solutions (10mmol/l) of drugs were made in
distilled water, except for noradrenaline, which was dis-
solved in a NaCl (0.9%)-ascorbic acid (0.01% w/v) solution.
These solutions were kept at 208C and appropriate
dilutions were made in KHS on the day of the experiment.
Data analysis
The responses elicited by EFS and noradrenaline were
expressed as a percentage of the initial contraction elicited
by 75mmol/l KCl for comparison between sedentary and
trained rats. The relaxation induced by DEA-NO or CGRP
was expressed as a percentage of the initial contraction
elicited by noradrenaline (sedentary: 1124.2 6.7 mg;
trained: 1115.9 7.4 mg; P> 0.05). Results are given as
mean SEM. Statistical analysis was done by comparing
the curve obtained in the presence of the different
substances with the control curve by means of ANOVA
for repeated measures, followed by the Bonferroni post-
hoc test, using the GraphPad Prism 5.0 software (San Diego,
California, USA). For nitric oxide, superoxide anion and
noradrenaline release data, the statistical analysis was done
using one-way ANOVA followed by the Newman–Keuls
post-hoc test. P less than 0.05 was considered significant.RESULTS
Animal evolution
No differences in body weight gain were observed between
sedentary and trained SHRs either before or after training
[sedentary: 74.9 13.6 g (n¼ 7); trained: 74.6 9.5 g
(n¼ 15)]. Blood pressure was significantly decreasedCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionby training (sedentary: 219.4 5.0 mmHg; trained:
193.8 1.8 mmHg; P< 0.05; n¼ 6 animals each group).
Citrate synthase activity in mixed soleus was significantly
higher in trained SHRs compared to sedentary animals
(sedentary: 91.8.4 3.7 nmol/min mg protein; trained:
127.2 3.6 nmol/min mg protein; P< 0.05; n¼ 5 animals
per group).
Vascular responses to electrical field
stimulation
In endothelium-denuded mesenteric segments, the vaso-
constrictor response to 75mmol/l KCl was similar in both
experimental groups (sedentary: 722.6 45.64 mg; trained:
723.3 28.23 mg; P> 0.05). The application of EFS induced
a frequency-dependent contractile response in segments
from both experimental groups. This vasoconstriction was
lower in segments from trained rats (Fig. 1a). EFS-induced
contractions were practically abolished in segments from
both experimental groups by the nerve impulse blocker
TTX (0.1mmol/l), indicating the neuronal origin of the
factors that induce this response (Fig. 1 b and 1c)
Effect of training on sympathetic component of
vascular responses to electrical field
stimulation
Preincubation with the a-adrenergic antagonist phentol-
amine (1mmol/l) decreased the vasoconstrictor response in
segments from both experimental groups, but to a greater
extent in segments from sedentary rats (Fig. 2a and 2b,
Table 1). The remnant vasoconstriction induced by EFS
after preincubation with phentolamine was similar in
both experimental groups (Fig. 2a and 2b). Preincubation
with 6-OHDA abolished EFS-induced contraction in
segments from both experimental groups (Table 1).
The contraction elicited by exogenous noradrenaline
(1 nmol/l–10mmol/l) was increased in segments from
trained rats (Fig. 2c). Both basal and EFS-induced nor-
adrenaline releases were decreased in segments from
trained rats (Fig. 2d). Training did not modify noradrenaline
content in mesenteric segments (sedentary: 187.4 11.7 ng
noradrenaline/mg protein; trained: 200.3 25.5 ng nor-
adrenaline/mg protein; P> 0.05; n¼ 9 animals each
group).
Effect of training on nitrergic component of
vascular responses to electrical field
stimulation
Preincubation with unspecific NOS inhibitor L-NAME
(0.1 mmol/l) significantly increased the EFS-contractile
response in segments from both experimental groups. This
increase was greater in segments from trained animals
(Fig. 3a and 3b, Table 1).
Neuronal NOS expression was increased in segments
from trained rats compared to sedentary rats (Fig. 4a).
Training did not modify basal nitric oxide release.
However, EFS-induced nitric oxide release was significantly
greater in segments from trained rats than those from sed-
entary animals (Fig. 4b). Preincubation with 0.1mmol/l TTX
or 0.1 mmol/l of the specific nNOS inhibitor 7-NI abolished
EFS-induced nitric oxide release, whereas preincubationorized reproduction of this article is prohibited.
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FIGURE 1 Vasoconstrictor response to EFS in mesenteric segments from sedentary and trained SHRs. Results (mean SEM) were expressed as a percentage of the initial
contraction elicited by KCl. P<0.05 vs. sedentary animals for each frequency (Bonferroni test). n¼10 animals each group. Effect of preincubation with 0.1mmol/l TTX on
the vasoconstrictor response induced by EFS in mesenteric segments from sedentary (b) and trained SHRs (c). Results (mean SEM) are expressed as a percentage of the
previous contraction elicited by KCl. n¼6–8 animals each group. P<0.05 vs. conditions without specific inhibitor for each frequency (Bonferroni test). EFS, electrical field
stimulation; SHR, spontaneously hypertensive rat; TTX, tetrodotoxin.
Blanco-Rivero et al.with 1mmol/l of the specific iNOS inhibitor 1400 W did not
modify it (Fig. 4c and 4d).
In segments precontracted with noradrenaline
(sedentary: 1124.2 6.7 mg; trained: 1105.9 7.4 mg;
P> 0.05), vasodilator response elicited by exogenous nitric
oxide donor DEA-NO (0.1 nmol/l–10mmol/l) was greater
in mesenteric segments from trained rats than sedentary
animals (Fig. 5a). Preincubation with the superoxide anion
scavenger Tempol (0.1 mmol/l) increased vasodilator
response to DEA-NO only in segments from sedentary rats
(Fig. 5b and 5c). Superoxide anion formation was lower in
segments from trained rats (Fig. 5d).Effect of training on sensory component of
vascular responses to electrical field
stimulation
Preincubation with the CGRP receptor antagonist CGRP
(8–37) (0.5mmol/l) increased the EFS-induced contraction
to a similar extent in segments from both experimental
groups (Fig. 6a and 6b, Table 1). Additionally, in nor-
adrenaline-precontracted mesenteric segments (sedentary:Copyright © Lippincott Williams & Wilkins. Unauth
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vasodilator response to exogenous CGRP was similar in
segments from both sedentary and trained SHRs (Fig. 6c), as
were both basal and EFS-induced CGRP release (Fig. 6d)
DISCUSSION
The present study shows that aerobic exercise training
diminished the vasoconstrictor response due to stimulation
of perivascular innervation in mesenteric artery from SHRs,
possibly contributing to the decreased blood pressure
observed after training. The decreased vasoconstrictor
response is due to a reduction in sympathetic innervation
function mediated by decreased noradrenaline release,
combined with the increased nitrergic function produced
by increased nitric oxide release, as well as a possible
decrease in nitric oxide scavenging by reactive oxygen
species.
In mesenteric rings from both sedentary and trained
SHRs, EFS produced a frequency-dependent contraction
that was abolished in the presence of TTX, indicating that
this vasoconstriction is the result of neurotransmitter releaseorized reproduction of this article is prohibited.
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FIGURE 2 Effect of preincubation with 1mmol/l phentolamine on the vasoconstrictor response induced by EFS in mesenteric segments from sedentary (a) and trained SHRs
(b). Results (mean SEM) are expressed as a percentage of the previous contraction elicited by KCl. n¼6–10 animals each group. P<0.05 vs. conditions without specific
inhibitor for each frequency (Bonferroni test). (c) Vasoconstrictor response to exogenous NA in segments from sedentary and trained SHRs. Results (mean SEM) are
expressed as a percentage of the previous contraction elicited by KCl. P<0.05 vs. control conditions for each dose (Bonferroni test). n¼6–10 animals each group.
(d) Basal and EFS-induced NA release in mesenteric segments from sedentary and trained SHR. Results (mean SEM) are expressed as ng NA/ml mg tissue.  P<0.05 vs.
basal; # P<0.05 vs. sedentary. n¼6–10 animals each group. EFS, electrical field stimulation; NA, noradrenaline; SHR, spontaneously hypertensive rat; TTX, tetrodotoxin.
Aerobic exercise training and perivascular innervation in hypertensionfrom perivascular nerves. KCl vasoconstriction is an
indicator of the integrity of intrinsic contractile machinery.
Previous reports have shown a lower KCl vasoconstriction
in resistance arteries isolated from exercise trained
rats [29,30], whereas others have found no differences
[31]. This discrepancy could be attributed to differences
in the vascular bed analyzed and/or kind of training. The
fact that in our experimental conditions the vasoconstrictor
response to KCl remained unmodified by training indicatesCopyright © Lippincott Williams & Wilkins. Unauth
TABLE 1. EFS inhibition after preincubationwith 1mmol/l phentolamin
with 0.1mmol/l L-NAME or 0.5mmol/l CGRP (8–37) in mesen
1Hz 2Hz
Sedentary þ phentolamine 98.64.4 98.31.7
Trained þ phentolamine 94.44.2 93.23.7
Sedentary þ 6-OHDA 99.90.5 99.80.4
Trained þ 6-OHDA 99.90.1 99.20.6
Sedentary þ L-NAME 37.23.1 33.64.5
Trained þ L-NAME 75.78.4a 81.45.4a
Sedentary þ CGRP (8–37) 44.17.2 48.49.2
Trained þ CGRP(8–37) 38.15.5 47.17.1
CGRP, calcitonin gene-related peptide; EFS, electrical field stimulation; L-NAME, Nv-nitro-L-argin
(%) of inhibition/potentiation of EFS-induced contraction after preincubation with 1mmol/l phen
mesenteric segments from sedentary and trained SHRs. Calculations are performed taking the K
mean SEM.
aP<0.05 vs. sedentary. n¼6–10 animals each group.
Journal of Hypertensionthe maintenance of the capacity for vasoconstriction, and
suggests that the decrease observed in the EFS-induced
contraction in trained rats could be associated with changes
in neurotransmitter/s release and/or vasomotor response.
Sympathetic, sensory and nitrergic innervation are
involved in the vasomotor response to EFS in rat mesenteric
artery [4–7]. Hypertension is known to be particularly
dependent on the activity of the sympathetic system
[2,32] and training can either increase or decreaseorized reproduction of this article is prohibited.
e or 1.46mmol/l 6-OHDA, and EFS potentiation after preincubation
teric segments from sedentary and trained SHRs
4Hz 8Hz 16Hz
86.65.8 77.44.5 55.23.1
73.71.1a 59.32.1a 34.11.9a
99.80.3 99.70.7 99.50.6
99.90.4 99.50.8 99.40.2
36.3214 21.63.1 13.52.1
57.95.2a 46.34.3a 24.83.2
45.77.4 31.75.3 18.93.2
43.57.2 26.74.6 24.85.6
ine methyl ester; SHR, spontaneously hypertensive rat. This table presents the percentage
tolamine, 1.46 mmol/l 6-OHDA, 0.5mmol/l CGRP (8–37) or 0.1 mmol/l L-NAME in
Cl-induced contraction as 100% of the contractile response. Results are expressed as
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FIGURE 3 Effect of preincubation with 0.1 mmol/l L-NAME on the vasoconstrictor response induced by EFS in mesenteric segments from sedentary (a) and trained SHRs (b).
Results (mean SEM) are expressed as a percentage of the previous contraction elicited by KCl. n¼6–10 animals each group. P<0.05 vs. conditions without specific
inhibitor for each frequency (Bonferroni test). EFS, electrical field stimulation; SHR, spontaneously hypertensive rat.
Blanco-Rivero et al.sympathetic activity, depending on the training program
and vascular bed analyzed [33–36]. For this reason, we
analyzed the effect of aerobic exercise training on the
response to EFS in mesenteric artery preincubated withCopyright © Lippincott Williams & Wilkins. Unauth
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922 www.jhypertension.comthe nonselective a-adrenergic antagonist, phentolamine.
This drug reduced vasoconstrictor response to EFS in seg-
ments from both experimental groups, but the effect was
less marked in mesenteric segments from trained animalsorized reproduction of this article is prohibited.
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FIGURE 5 (a) Vasodilator response to NO donor DEA-NO in segments from sedentary and trained SHR. Effect of preincubation with 0.1 mmol/l Tempol on the vasodilator
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Aerobic exercise training and perivascular innervation in hypertensionthan in segments from sedentary SHRs. However, there was
a remaining contractile response which was phentolamine-
resistant. After preincubation with the neurotoxin 6-OHDA,
which depletes sympathetic innervation, EFS-induced
contraction was practically abolished, indicating that the
EFS-induced contraction is due to neurotransmitters
released from sympathetic nerve endings. Additionally,
the fact that there were no significant differences between
the remnant contractions induced by EFS after pre-
incubation with phentolamine in the segments from
either group, indicates that training does not modify the
vasomotor role of this additional sympathetic component,
which could be probably ATP, since we have recently
described in this vascular bed that ATP is the sympathetic
neurotransmitter responsible of the remnant vasocon-
striction obtained after preincubation with phentolamine
[25,37].
The different reductions produced by phentolamine in
the EFS-induced contractions suggests that a decrease in
the role played by the adrenergic component of the sym-
pathetic innervation could be responsible for the decreased
vasoconstrictor response to EFS in trained SHRs, as has
already been reported in the central nervous system [12].
This effect could be due to a decrease in noradrenaline
release and/or the vasoconstrictor response. To determineCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionthis we first analyzed noradrenaline release, observing a
huge drop in both basal and EFS-induced noradrenaline
release in segments from trained SHRs, in agreement
with previous reports describing decreases in plasmatic
noradrenaline [38]. Regarding the effect of exercise,
increase, decrease and no changes in vasoconstrictor
response to alpha-adrenergic agonists have been reported
[29–31]. In our experimental conditions, we observed that
aerobic exercise training increased the vasoconstrictor
response to noradrenaline, possibly due to an up-
regulation process consequent to the decrease in
noradrenaline release. Although both results indicate
opposite effects of training on sympathetic function, the
net effect is a decreased role for sympathetic innervation
in mesenteric segments from trained SHRs. Additionally,
the fact that noradrenaline levels were similar in arteries
from sedentary and trained SHRs confirms that the
reduction in sympathetic function is due to the decreased
noradrenaline release from adrenergic innervation, and
not to modifications in vessel noradrenaline content.
The diminished sympathetic innervation function could,
by itself, explain the decreased EFS vasoconstriction
observed in mesenteric segments from trained SHRs.
However, the participation of other neural components
cannot be ruled out.orized reproduction of this article is prohibited.
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FIGURE 6 (a) Effect of preincubation with 0.5mmol/l CGRP (8–37) on the vasoconstrictor response induced by EFS in mesenteric segments from sedentary (a) and trained
(b) SHRs. Results (meanþ SEM) are expressed as a percentage of previous contraction elicited by KCl. P<0.05 vs. conditions without specific inhibitor for each frequency
(Bonferroni test). n¼6–10 animals each group. (c) Vasodilator response to exogenous CGRP in segments from sedentary and trained SHR. Results (mean SEM) are
expressed as a percentage of a previous contraction elicited by NA. n¼6–10 animals each group. (d) Basal and EFS-induced CGRP release in mesenteric segments from
sedentary and trained SHRs. Results (mean SEM) are expressed as pg CGRP/ml mg tissue. P<0.05 vs. basal. n¼6–10 animals per group. CGRP, calcitonin gene-related
peptide; SHR, spontaneously hypertensive rat, NA, noradrenaline.
Blanco-Rivero et al.The nitric oxide released from nitrergic innervation by
EFS has been demonstrated to have a vasodilator role
contributing to the vasomotor response to EFS [7,11,39–
41]. In vascular reactivity experiments, preincubation with
7-NI decreases vasoconstrictor response to noradrenaline
[25,42], which could lead to misinterpretation of the
results. That is why we used the nonselective NOS inhibitor
L-NAME in the analysis of vasomotor response to EFS.
Vasoconstriction induced by EFS was increased in segments
from both groups of rats incubated with L-NAME, confirm-
ing an involvement by nitric oxide in the EFS-induced
response. The greater effect of L-NAME in segments from
trained rats suggests an increased role of neuronal nitric
oxide in EFS-induced vasoconstriction, possibly related to
increases in nitric oxide release and/or increases in the
vasodilator response. We observed that EFS increased nitric
oxide release, in agreement with previous reports [43,44],
and that exercise training increased this release. The
EFS-induced nitric oxide release was abolished by TTX
in both groups, thus confirming the neural origin of the
nitric oxide, and neuronal nitric oxide could participate in
the effect on the EFS-contraction produced by training.
nitric oxide production in neural tissue can have two
sources: nNOS and iNOS [45,46]. In the present study,
the specific nNOS inhibitor 7-NI, but not the iNOS inhibitorCopyright © Lippincott Williams & Wilkins. Unauth
924 www.jhypertension.com1400 W, decreased EFS-induced nitric oxide release, indi-
cating that nitric oxide release is dependent on nNOS. The
increased nitric oxide release from nNOS correlates with the
increased nNOS expression observed in mesenteric seg-
ments from trained SHRs. In agreement with this possibility,
an increase in nNOS through training has been reported in
the central nervous system and skeletal muscle [13,47,48].
Moderate exercise training improves the vascular
antioxidant defense systems, increasing nitric oxide bio-
availability [15,19,49]. We observed that superoxide anion
production is decreased in mesenteric segments from
trained SHR and that the superoxide anion scavenger
tempol increased the vasodilator response to DEA-NO only
in segments from sedentary rats. In addition, the vasodilator
response to DEA-NO was greater in segments from trained
than from sedentary rats. Taken together these results
suggest that increased neuronal nitric oxide release and
bioavailabiity through diminished superoxide anion
generation could be an important mechanism by which
aerobic exercise mediates the beneficial vascular effects
in hypertension.
Once we had analyzed the participation of sympathetic
and nitrergic innervation in the diminished response to EFS
in mesenteric segments from trained SHRs, we studied the
possible role of sensory innervation in this vasomotororized reproduction of this article is prohibited.
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Aerobic exercise training and perivascular innervation in hypertensionresponse, since exercise has been shown to modulate the
role of sensory innervation in several tissues [20].
Preincubation with the CGRP receptor antagonist CGRP
(8–37) increased EFS-induced vasoconstriction to a similar
extent in both sedentary and trained SHRs. Additionally,
CGRP release and vasodilator response to this peptide were
also similar in both experimental groups. These obser-
vations led us to conclude that training did not alter sensory
innervation function.
In conclusion, the present results demonstrate that
aerobic exercise training affects the function of vascular
innervation in mesenteric artery from SHR, inducing a
decreased contractile response to EFS. This effect is the
net result of decreased noradrenaline release, increased
noradrenaline vasoconstriction and increased neuronal
nitric oxide release and bioavailability. Sensory innervation
function remains unaltered. These modifications might
contribute to the decreased blood pressure in SHRs
observed after aerobic exercise training.
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Exercise training in spontaneously hypertensive rats
reduces the reactivity of proximal mesenteric artery
segments to perivascular nerve stimulation. It is demon-
strated that this is due to NO-dependent reduction
in norepinephrine release from sympathetic nerves. Thesemodifications in sympathetic nerve function could
contribute to exercise-induced reductions in vascular
resistance and arterial pressure. It remains to be clarified
to what extent such exercise-induced changes in the
neural control of vascular function take place in other
vascular beds and in peripheral segments of the arterial
tree which are of great importance for regulating organ
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reserved.Introduction: We investigated whether high-fat diet
(HFD)-induced obesity was associated with modifications in
mesenteric innervation function, the mechanisms involved,
and the possible effects of aerobic exercise training on
these changes.
Materials and methods: :Male Wistar rats were divided
into three groups: rats fed a standard diet (control group);
rats fed a HFD (35% fat) for 8 weeks; and HFD rats
submitted to aerobic exercise training (8 weeks, 5 times
per week for 50 min). Segments of isolated mesenteric
arteries were exposed to electric field stimulation (EFS)
with or without phentolamine, suramin, or Nv nitro-L-
arginine methyl ester. Noradrenaline, ATP, and nitric oxide
release, and total and phosphorylated neuronal nitric oxide
synthase (nNOS, P-nNOS) expression were also measured.
Results: EFS contraction was greater in sedentary HFD
than in control rats. Phentolamine reduced EFS
contractions more markedly in HFD rats. Suramin
decreased EFS contractions only in control rats.
Phentolamine R suramin practically abolished EFS-induced
contraction in control rats, whereas it did not modify it in
the HFD rats. Noradrenaline release was greater and ATP
was lower in HFD rats. Nv nitro-L-arginine methyl ester
increased contractions to EFS only in segments from
control rats. Nitric oxide release and nNOS and P-nNOS
expressions were lower in arterial segments from HFD rats
than from control rats. None of these changes in sedentary
HFD rats was present in the trained HFD rats.
Conclusions: Enhanced sympathetic and diminished
nitrergic components contributed to increased
vasoconstrictor responses to EFS in sedentary HFD rats. All
these changes were avoided by aerobic exercise training,
suggesting that aerobic exercise could reduce peripheral
vascular resistance in obesity.
Keywords: aerobic exercise training, nitrergic innervation,
obesity, superior mesenteric artery, sympathetic innervation
Abbreviations: CGRP, calcitonin gene-related peptide;
DEA-NO, diethylamine NONOate; EFS, electric field
stimulation; KHS, Krebs–Henseleit solution; L-NAME, Nv
nitro-L-arginine methyl ester; nNOS, neuronal nitric oxide
synthase; TTX, tetrodotoxinopyright © 2015 Wolters Kluwer Health, Inc. Unau
Journal of HypertensionINTRODUCTIONT
he combination of obesity and hypertension is
associated with high morbidity and mortality
because it leads to cardiovascular and kidney dis-
ease – effects seen in developed countries, as well as low-
income populations [1]. Therefore, prevention of obesity
becomes an important goal in overall efforts to control
blood pressure and reduce the incidence of hyperten-
sion-related cardiovascular complications. Potential mech-
anisms linking obesity to hypertension include metabolic,
endothelial and vascular dysfunction, neuroendocrine
imbalances, sodium retention, glomerular hyperfiltration,
proteinuria, and maladaptive immune and inflammatory
responses [1–3]. However, the complex interactions
between obesity and hypertension still raise many ques-
tions regarding the exact mechanisms involved and the
proof of their causes and effects.
Arterial tone is regulated by the central nervous system,
perivascular innervations, and myogenic mechanisms, as
well as by endothelial and humoral factors. Perivascular
innervation plays a principal role in the regulation of
vascular tone, specifically in certain vessels such as the
mesenteric vascular bed [4,5], where blood flow is approxi-
mately 20–30% of the total cardiac output [6]. Inadequate
mesenteric blood flow and tissue perfusion can produce
relevant hemodynamic changes [6–8]. This regulation
involves sympathetic, nitrergic, and sensory innervations,
which release mainly noradrenaline or ATP from sympath-
etic nerve terminals, nitric oxide from nitrergic inner-
vations, and calcitonin gene-related peptide (CGRP) from
sensory innervation [5,9–11]. Alterations in the functionalthorized reproduction of this article is prohibited.
DOI:10.1097/HJH.0000000000000627
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Sastre et al.role of these components have been associated with several
pathophysiological circumstances [12–16].
The amount and the kind of dietary fatty acids can
regulate complex intracellular signaling systems, thereby
modulating cellular function [17]. In a previous study, we
had demonstrated that neural control of mesenteric vaso-
motor tone is altered in rats fed a high-fat diet (HFD) for a
short term, increasing the adrenergic and decreasing the
nitrergic components, the effects of which are avoided by
rosuvastatin treatment [18]. Additionally, we have recently
demonstrated, in mesenteric arteries from hypertensive
rats, that moderate aerobic exercise training decreased
sympathetic activity and increased neuronal nitric oxide
release and bioavailability [19].
Taking into account these results, we hypothesized that
an aerobic training program might contribute to avoid the
vascular effects of a HFD intake and consequently the
development of obesity-linked hypertension, thus leading
to a reduction in the administration of any pharmacological
treatment. Thus, our objective was to study the effect of
aerobic exercise training on sympathetic, nitrergic, and
sensory innervation function in superior mesenteric artery
from rats fed with HFD.
METHODS
Animals
Three-month-old male Wistar rats (initial weight
334.6þ 3.9 g) were obtained from the Animal Quarters of
the Universidad Auto´noma de Madrid (Registration number
EX-021U), in accordance with guidelines 609/86 of the
E.E.C., R.D. 233/88 of the Ministerio de Agricultura, Pesca
y Alimentacio´n of Spain, and Guide for the Care and Use of
Laboratory Animals published by the United States National
Institute of Health (NIH publication No. 85.23 revised
1985). All experimental procedures involving animal use
were approved by the Ethics Committee of the Universidad
Auto´noma de Madrid (RD 1201/2005).
Rats were housed at a constant room temperature,
humidity and light cycle (12 : 12-h light–dark) and had free
access to tap water and standard rat chow ad libitum.
Animals were weighed every 2 weeks. Animals were div-
ided in three experimental groups: control group, fed with a
standard chow (3% fat); sedentary HFD rats, fed with HFD
chow (35% fat) for 8 weeks; and trained HFD rats, fed with
the HFD chow and simultaneously subjected to an aerobic
exercise training protocol for 8 weeks. Diets were pur-
chased from Panlab S.A. (Spain).
Exercise training protocol
Exercise training was performed on a motor treadmill
(Motor-driven Treadmill LI8706; Letica Scientific Instru-
ments, Barcelona, Spain) for 8 weeks, five times per week
for 50min each session, gradually progressing towards
55–65% of maximal running speed (15–20m/min), as
described elsewhere [19–21]. To determine the maximal
exercise capacity, the rats were subjected to a progressive
exercise test on a treadmill using an incremental speed
protocol of 5m/min every 3min and no grade until exhaus-
tion. The treadmill exercise test was repeated after 5 weeks
of exercise training in order to adjust training intensity. RatsCopyright © 2015 Wolters Kluwer Health, Inc. Unau
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longer run at the treadmill speed. The sedentary rats were
handled at least twice a week for habituation to the
experimental protocols.
Blood pressure measurements
At the end of the training protocol, and 24 h after the last
exercise session, the mean blood pressure was measured
using the tail-cuff method, as previously described [19].
Tissue samples
At the end of the training protocol, and 24 h after the last
session of exercise training, the rats were euthanized by
decapitation. The soleus muscle was removed and immedi-
ately stored at 808C until citrate synthase analysis was
performed. The superior mesenteric artery was carefully
dissected, cleaned of connective tissue, and divided into
2-mm-long segments. Measurements were taken using a
micrometer eyepiece mounted on a Euromex Holland
binocular lens. Segments were maintained in cold (48C)
Krebs–Henseleit solution (KHS) (in mmol/l: 115 NaCl, 25
NaHCO3, 4.7 KCl, 1.2 MgSO4.7H2O, 2.5 CaCl2, 1.2 KH2PO4,
11.1 glucose, and 0.01 Na2 EDTA) bubbled with a 95%
O2–5% CO2 mixture. Mesenteric adipose tissue was care-
fully dissected and wet weight was measured. For protein
expression analysis, some segments were endothelium-
denuded and quickly frozen in liquid nitrogen, being
maintained at 808C until the day the experiments were
performed.
Some segments were mounted on 100-mm wires in a
small vessel myograph to measure the internal diameter, as
previously described [22]. The effective internal lumen
diameter was 1.5þ 0.2 mm. No differences were found
among the experimental groups.
Citrate synthase activity
Citrate synthase activity was determined in mixed right
soleus as previously reported [19,23] and used as a marker
of muscle oxidative activity. The enzyme activity was
measured in whole muscle homogenates, and the complex
resulting from acetyl-CoA and oxaloacetate was determined
at 412 nm and 258C, at an interval of 10min. Citrate synthase
activity was expressed as nmol/min per mg of protein.
Vascular reactivity
The method used for isometric tension recording has been
described in full elsewhere [11,24]. Two parallel stainless
steel pins were introduced through the lumen of the vas-
cular segment: one was fixed to the bath wall and the other
connected to a force transducer (Grass FTO3C; Quincy,
Massachusetts, USA); this, in turn, was connected to a
model 7D Grass polygraph. For electrical field stimulation
(EFS) experiments, segments were mounted between two
platinum electrodes 0.5 cm apart and connected to a stimu-
lator (Grass, model S44) modified to supply adequate
current strength. Segments were suspended in an organ
bath containing 5ml of KHS at 378C and continuously
bubbled with a 95% O2–5% CO2 mixture (pH of 7.4). Some
experiments were performed in endothelium-denuded seg-
ments to eliminate the main source of vasoactive substan-
ces, including endothelial nitric oxide. This avoidedthorized reproduction of this article is prohibited.
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Aerobic exercise training and perivascular innervation in obese ratspossible actions by different drugs on endothelial cells that
could lead to misinterpretation of results. Endothelium was
removed by gently rubbing the luminal surface of the
segments with a thin wooden stick. The segments were
subjected to an optimal resting tension of 0.5 g, which was
readjusted every 15min during a 90-min equilibration
period before drug administration. After this, the vessels
were exposed to 75mmol/l KCl to check their functional
integrity. Endothelium removal did not alter the contrac-
tions elicited by KCl. After a washout period, the presence/
absence of vascular endothelium was tested by the ability of
10mmol/l acetylcholine (ACh) to relax segments precon-
tracted with noradrenaline. Arteries which relaxed more
than 90% or less than 10% of the previous tone obtained by
noradrenaline were respectively considered as endo-
thelium-intact or endothelium-denuded.
Frequency–response curves to EFS were performed.
The parameters used for EFS were 200 mA, 0.3 ms, at
frequencies ascending from 1 to 16 Hz, for 30 s each fre-
quency, with an interval of 1min between each stimulus,
the time required to recover basal tone. A washout period
of at least 1 h was necessary to avoid desensitization
between consecutive curves. Two successive frequency–
response curves separated by 1-h intervals produced similar
contractile responses. To evaluate the neural origin of the
EFS-induced contractile response, the nerve impulse
propagation blocker, tetrodotoxin (TTX, 0.1mmol/l), was
added to the bath 30min in advance.
To determine the participation of sympathetic inner-
vation in the EFS-induced response in segments from all
experimental groups, 1mmol/l phentolamine, an a-adre-
noceptor antagonist, 0.1 mmol/l suramin, a nonspecific P2
purinergic receptor antagonist, or a combination of phen-
tolamine þ suramin, was added to the bath 30min before
performing the frequency–response curve. Additionally,
the vasoconstrictor response of exogenous noradrenaline
(1 nmol/l–10mmol/l) was tested in segments from both the
experimental groups.
To analyze the participation of nitric oxide in the EFS-
induced response in segments from both groups of rats,
0.1 mmol/l Nv-nitro-L-arginine methyl ester (L-NAME) – a
nonspecific inhibitor of nitric oxide synthase (NOS) – was
added to the bath 30min before performing the second
frequency–response curve. The vasodilator response to the
nitric oxide donor – diethylamine NONOate (DEA-NO,
0.1 nmol/l–0.1 mmol/l) – was determined in noradrena-
line-precontracted arteries from both the experimental
groups.
To study the possible participation of sensory inner-
vation in the EFS-induced response, 0.5mmol/l CGRP
(8–37) – a CGRP receptor antagonist – was added to
the bath 30min before performing the second fre-
quency–response curve.
Noradrenaline and ATP levels
Noradrenaline and ATP releases were measured using
Noradrenaline Research EIA (Labor Diagnostica Nord,
Gmbh and Co., KG, Nordhon, Germany) or an ATP Colori-
metric/Fluorometric Assay kit (Abcam, Cambridge, UK),
following the manufacturers’ instructions. Endothelium-
denuded segments of rat mesenteric arteries from allopyright © 2015 Wolters Kluwer Health, Inc. Unau
Journal of Hypertensionexperimental groups were preincubated for 30min in
5ml of KHS at 378 C and continuously gassed with a
95% O2–5% CO2 mixture (stabilization period). This was
followed by two washout periods of 10min in a bath of
0.4 ml of KHS. Then, the medium was collected to measure
basal release. Afterwards, the organ bath was refilled, and
cumulative EFS periods of 30 s at 1, 2, 4, 8 and 16Hz were
applied at 1-min intervals. Afterwards, the medium was
collected to measure EFS-induced neurotransmitter release.
Samples were immediately frozen in liquid nitrogen and
conserved at 708C until experiments were performed.
Results were expressed as ng noradrenaline/ml mg tissue
or nmol ATP/ml mg tissue.
Nitric oxide measurements
Nitric oxide release was measured using fluorescence
emitted by the fluorescent probe 4,5-diaminofluorescein
(DAF-2), as previously described [18,19,25]. Endothelium-
denuded mesenteric arteries from all experimental groups
were subjected to a 60-min equilibration period in
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) buffer (in mmol/l: NaCl 119; HEPES 20; CaCl2
1.2; KCl 4.6; MgSO4 1; KH2PO4 0.4; NaHCO3 5; glucose
5.5; Na2HPO4 0.15; pH 7.4) at 378C. Arteries were incubated
with 2mmol/l DAF-2 for 30min. The medium was then
collected to measure basal nitric oxide release. Once the
organ bath was refilled, cumulative EFS periods of 30 s
at 1, 2, 4, 8 and 16Hz at 1-min intervals were applied.
Afterwards, the medium was collected to measure
EFS-induced nitric oxide release. The fluorescence of the
medium was measured at room temperature using a spec-
trofluorometer (LS50 Perkin Elmer Instruments, FL WINLAB
Software, Waltham, Massachusetts, USA) with excitation
wavelength set at 492 nm and emission wavelength at
515 nm.
The EFS-induced nitric oxide release was calculated by
subtracting basal nitric oxide release from that evoked by
EFS. Also, blank sample measures were collected in the
same way from segment-free medium in order to subtract
background emission. Some assays were performed in the
presence of either TTX (0.1mmol/l) or the specific nNOS
inhibitor 7-NI (0.1 mmol/l). The amount of nitric oxide
released was expressed as arbitrary units/mg tissue.
Superoxide anions measurements
Superoxide anion levels were measured using lucigenin
chemiluminescence, as previously described [19,25]. Endo-
thelium-denuded mesenteric segments from all groups of
rats were rinsed in KHS for 30min, equilibrated for 30min
in HEPES buffer at 378C, transferred to test tubes that
contained 1 ml HEPES buffer (pH 7.4) with lucigenin
(5mmol/l), and then kept at 378C. The luminometer was
set to report arbitrary units of emitted light; repeated
measurements were collected for 5 min at 10-s intervals
and averaged. 4,5-dihydroxy-1,3-benzene-disulphonic acid
‘Tiron’ (10mmol/l) – a cell-permeant, nonenzymatic super-
oxide anion scavenger – was added to quench the super-
oxide anion-dependent chemiluminescence. Calculations
were performed subtracting the lucigenin chemilumines-
cence obtained in the presence of Tiron from that obtained
in its absence. Blank measurements were performed in thethorized reproduction of this article is prohibited.
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ground emission.
Western blot analysis
Western blot analysis was performed as previously
described [18,25]. For these experiments, we used rabbit
polyclonal antibodies against nNOS (1 : 2000; Abcam),
nNOS phosphorylated in Serine 1177 (P-nNOS, 1 : 2000;
Abcam), a mouse monoclonal antibody against tyrosine
hydroxylase (1 : 500; Santa Cruz Biotechnology, Texas,
USA), and monoclonal anti-b-actin-peroxidase antibody
(1 : 50 000; Sigma-Aldrich, Madrid, Spain). Rat brain hom-
ogenates were used as positive control.
Drugs used
Acetylcholine chloride, CGRP (8–37), DAF-2, DEA-NO,
diethylammonium salt, L-NA hydrochloride, L-NAME
hydrochloride, suramin, 7NI, phentolamine, lucigenin,
Tiron, and TTX (Sigma-Aldrich) were used. Stock solutions
(10 mmol/l) of drugs were made in distilled water, except
for noradrenaline, which was dissolved in a NaCl (0.9%)–
ascorbic acid (0.01% w/v) solution. These solutions were
kept at –208C, and appropriate dilutions were made in KHS
on the day of the experiment.
Data analysis
The responses elicited by EFS and noradrenaline were
expressed as a percentage of the initial contraction elicited
by 75mmol/l KCl for comparison between experimental
groups. The relaxation induced by DEA-NO was expressed
as a percentage of the initial contraction elicited by nor-
adrenaline (control: 1134.6þ 5.6 mg; sedentary HFD:
1243.2þ 7.5 mg; trained HFD: 1254.9þ 9.5 mg; P> 0.05).
Results are given as meanþ SEM. Statistical analysis was
performed by comparing the curve obtained in the pres-
ence of the different substances with the previous or control
curve by means of two-way analysis of variance (ANOVA),
using GraphPad Prism 5.0 software (California, USA). For
nitric oxide, superoxide anion, ATP, and noradrenaline
release data, the statistical analysis was done using one-
way ANOVA followed by the Newman–Keuls post-hoc test.
P less than 0.05 was considered significant.
RESULTS
Animal evolution
We weighed the animals every 2 weeks, observing a
significantly higher increase in HFD rats compared toCopyright © 2015 Wolters Kluwer Health, Inc. Unau
TABLE 1. Animal evolution
Control
Body weight gain (g) 88.18.4
Mesenteric adipose tissue (g/cm tibia) 0.97þ0.04
Food intake (g/day) 21.60.2
Food intake (kcal/day) 64.80.6
Mean blood pressure (mmHg) 123.2þ3.3
Citrate synthase activity (nmol/min/mg protein) 59.53.9
Mesenteric adipose tissue is expressed per tibia length. Food intake was measured every day. A
HFD, high-fat diet.
P<0.05 vs. control.
P<0.05 vs. sedentary HFD.
4 www.jhypertension.comcontrol rats. The increase in body weight was higher in
sedentary compared to trained HFD animals. When
measuring food intake, it was lower in both sedentary
and trained HFD rats compared to controls throughout
the experiment, whereas calorie intake was higher in
sedentary and trained HFD rats than in controls. Mean
blood pressure was similar in all experimental groups.
After sacrifice, we observed that mesenteric adipose
tissue wet weight was higher in sedentary HFD rats than
in control and trained HFD rats. Additionally, citrate syn-
thase activity in mixed soleus was significantly higher in
trained HFD compared to control and sedentary HFD
animals (Table 1).
Vasomotor response to potassium chloride
In endothelium-intact mesenteric segments, the vasocon-
strictor response to 75mmol/l KCl was similar in all exper-
imental groups (control: 1772 129 mg; sedentary HFD:
1797 121 mg; trained HFD: 1699 112 mg; P> 0.05;
n¼ 12–16 animals each group). Endothelium removal
did not alter KCl-induced vasoconstriction (control:
1848 81 mg; sedentary HFD: 1968 100 mg; trained
HFD: 1852 80mg; P> 0.05; n¼ 12–16 animals each
group).
Vasodilator response to acetylcholine
Acetylcholine induced cumulative concentration and endo-
thelium-dependent relaxations in noradrenaline-contracted
arteries from all experimental groups. This vasodilation was
lower in sedentary HFD segments compared to control or to
trained HFD animals (Fig. 1a).Vascular responses to electrical field
stimulation
The application of EFS induced a frequency-dependent
contractile response in endothelium-intact mesenteric
segments from all experimental groups. This vasocon-
striction was greater in segments from sedentary HFD rats
compared to control and trained HFD rats (Fig. 1b).
Endothelium removal increased EFS-induced contractile
response similarly in segments from all experimental
groups (Fig. 1c and d). EFS-induced contractions
were practically abolished in segments from all experi-
mental groups by the neurotoxin TTX (0.1 mmol/l), indi-
cating the neuronal origin of the factors inducing this
response (n¼ 10–12 animals each group; results not
shown).thorized reproduction of this article is prohibited.
Sedentary HFD Trained HFD
164.29.8 125.67.4
2.04þ0.12 1.62þ0.09
18.50.4 16.20.3
99.92.2 87.51.6
122.5þ3.0 122.9þ2.2
48.91.0 69.04.2
ll data are expressed as meanþ SEM. n¼12–16 rats in each group.
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FIGURE 1 Vasodilator response to acetylcholine and vasoconstrictor response to electrical field stimulation. ACh-induced vasodilation in endothelium-intact mesenteric
segments from control, sedentary and trained HFD rats (a). Results (mean SEM) were expressed as a percentage of the previous tone elicited by exogenous NA (n¼8–10
animals in each group). EFS-induced vasoconstriction in endothelium intact (b) and endothelium denuded (c) mesenteric segments from control, sedentary, and trained
HFD rats. Results (mean SEM) were expressed as a percentage of the initial contraction elicited by KCl (n¼12–16 animals in each group). Results (mean SEM) were
expressed as a percentage of the initial contraction elicited by KCl. (d) Differences of area under the curve (dAUC) in the presence or absence of endothelium. ACh,
acetylcholine; EFS, electric field stimulation; HFD, high-fat diet; NA, noradrenaline.
Aerobic exercise training and perivascular innervation in obese ratsParticipation of the sympathetic component of
mesenteric vascular innervation
Preincubation with the a-adrenergic antagonist phentol-
amine (1mmol/l) decreased the vasoconstrictor response
induced by EFS in endothelium-denuded segments from
all experimental groups (Fig. 2a–c). This decrease was
greater in mesenteric segments from sedentary HFD animals
(Fig. 3d). There was a remnant phentolamine-resistant con-
tractile response, which was lower in mesenteric segments
from sedentary HFD (Fig. 2a–c). Preincubation with the
nonspecific P2 purinergic receptor antagonist suramin
(0.1mmol/l) decreased EFS-induced vasoconstriction in seg-
ments from control and trained HFD rats, but did not modify
it in artery segments from sedentary HFD rats (Fig. 3a–c).
Combined preincubation with phentolamine þ suramin
decreased EFS-induced vasoconstriction in segments from
control and trained HFD animals compared to segments
preincubated only with phentolamine, whereas it did not
modify it inmesenteric rings fromsedentaryHFD(Fig. 2a–c).
Noradrenaline-induced vasoconstriction was similar in
all experimental groups (Fig. 3a). Tyrosine hydroxylaseopyright © 2015 Wolters Kluwer Health, Inc. Unau
Journal of Hypertensionexpression was similar in all experimental groups
(Fig. 3b). EFS-induced noradrenaline release was higher
in mesenteric segments from sedentary HFD compared to
control and trained HFD (Fig. 3c). EFS-induced ATP release
was lower in mesenteric segments from sedentary HFD
compared to segments from control or trained HFD animals
(Fig. 3d).
Participation of the nitrergic component of
mesenteric vascular innervation
Preincubation with the unspecific NOS inhibitor L-NAME
(0.1 mmol/l) significantly increased the EFS-contractile
response in endothelium-denuded segments from control
and trained HFD rats, but did not modify EFS-induced
vasoconstriction in arteries from sedentary HFD animals
(Fig. 4). EFS induced nitric oxide release in segments from
all groups. This release was lower in sedentary HFD mes-
enteric segments (Fig. 5a). 7NI practically abolished EFS-
induced nitric oxide release (n¼ 8–10 animals each group;
results not shown). Both nNOS and P-nNOS expressions
were lower in homogenates from sedentary HFD arteriesthorized reproduction of this article is prohibited.
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FIGURE 2 Effect of obesity and aerobic training on sympathetic innervation function. Effect of preincubation with 1mmol/l phentolamine, 0.1 mmol/l suramin, or a
combination of phentolamineþ suramin on the vasoconstriction response induced by EFS in endothelium-denuded mesenteric segments from control (a) sedentary HFD (b)
and trained HFD animals (c). Results (mean SEM) were expressed as a percentage of the initial contraction elicited by KCl (n¼8–12 animals in each group). (d)
Differences of area under the curve (dAUC) in the absence or presence of 1mmol/l phentolamine. dAUC values are expressed as arbitrary units. ACh, acetylcholine; EFS,
electric field stimulation; HFD, high-fat diet.
Sastre et al.compared with control and trained HFD segment hom-
ogenates (Fig. 5b). Neither the vasodilator response to
DEA-NO nor the superoxide anion production were modi-
fied in our experimental conditions (Fig. 5c and d).
Participation of the sensory component in
vascular responses to electrical field
stimulation
Preincubation with the CGRP receptor antagonist CGRP
(8–37) (0.5mmol/l) did not alter the EFS-induced contrac-
tion in any experimental group (Fig. 6).
DISCUSSION
In this study, we observed that moderate aerobic exercise
averts the alterations in perivascular innervation function
induced by HFD administration, since we observed that the
vasoconstrictor response to EFS and the function of sym-
pathetic and nitrergic innervation in mesenteric arteries
from trained HFD rats remained unmodified compared to
the control group.Copyright © 2015 Wolters Kluwer Health, Inc. Unau
6 www.jhypertension.comWe have previously reported that short-term adminis-
tration of a HFD diet induced an increased response to EFS
in mesenteric arteries, with the net effect being an: adre-
nergic hyperactivity associated with an increased release
and vasoconstrictor response to noradrenaline; decreased
ATP release; and diminished neuronal nitric oxide release.
Consequently, HFD produces an increase of peripheral
vascular resistance [18]. Since we have previously reported
that aerobic exercise training decreased EFS-induced vaso-
constriction in mesenteric artery from spontaneously
hypertensive rats, in the present study, we analyzed the
possibility that moderate exercise could avert the neuronal
dysfunction observed in HFD rats.
In the three experimental groups, EFS produced a fre-
quency-dependent contraction that was abolished in the
presence of TTX, indicating that the vasomotor responses
were the result of neurotransmitter release from perivas-
cular nerves. HFD produced an increased response to EFS,
which was not observed in trained rats. This effect was not
attributable to changes in the intrinsic contractile machin-
ery, as demonstrated by the similar vasoconstrictorthorized reproduction of this article is prohibited.
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FIGURE 3 Effect of obesity and aerobic training on NA synthesis and vasoconstriction, and ATP release (a) vasoconstrictor response to NA in segments from control,
sedentary, and trained HFD rats. Results (mean SEM) were expressed as a percentage of the initial contraction elicited by KCl (n¼8–10 animals in each group). (b) TH
expression in endothelium-denuded mesenteric segments from control, sedentary and trained HFD rats. The blots are representative of eight separate segments from each
group. Rat brain homogenates were used as a positive control. Lower panel shows relation between TH expression and b-actin. Results (mean SEM) are expressed as a
ratio of the signal obtained for each protein and the signal obtained for b-actin. EFS-induced NA (c) and ATP (d) releases in mesenteric segments from control, sedentary,
and trained HFD rats. Results (meanþ SEM) were expressed as ng NA/ml mg tissue or nmol ATP/ml mg tissue (n¼8 animals per group). EFS, electric field stimulation; HFD,
high-fat diet; NA, noradrenaline; TH, tyrosine hydroxylase.
Aerobic exercise training and perivascular innervation in obese ratsresponse to KCl in the three experimental groups. The
reported discrepancies regarding KCl response
[18,19,26–32] could be attributed to differences in the
vascular bed analyzed and/or the kind of experimental
models of obesity and training used.
Endothelial factors have been described to modulate the
response to several vasomotor substances, including neuro-
transmitters [9,33]. Additionally, obesity impairs endothelial
function [1,3,34,35], whereas aerobic exercise training
improves or attenuates the progression of endothelial dys-
function observed in obesity [36–40]. Consequently, the
response to EFS could be differentially affected by the
endothelium in the different experimental groups. Our next
objective was to analyze the response to ACh. As has been
reported, endothelial function was impaired in mesenteric
segments from sedentary HFD rats, and this did not occur in
segments from trained HFD animals. However, endo-
thelium removal increased vasoconstrictor response to
EFS to the same extent in the three experimental groups.
Thus, despite the observed differences in endothelial func-
tion, the modulating role of endothelium on EFS response is
not modified in our experimental conditions. So, we canopyright © 2015 Wolters Kluwer Health, Inc. Unau
Journal of Hypertensionconclude that the differences observed in EFS-induced
vasoconstriction are only innervation-dependent. For that
reason, we performed the following experiments in endo-
thelium-removed mesenteric segments.
Obesity is usually accompanied by increased sympath-
etic discharge [18,41–44]. In line with this, several studies
have demonstrated an elevation in renal sympathetic nerve
activity due to adipokine disorders, such as leptin, adipo-
nectin, and resistin-activation of the renin–angiotensin
system [45–48]. Additionally, aerobic exercise training is
associated with reductions in sympathetic activity [19,49].
These evidences, together with the increased mesenteric
adipose tissue observed in sedentary HFD rats compared to
controls, which was lower in trained HFD rats, led us to
explore the possible changes in sympathetic innervation
function induced by exercise in sedentary HFD rats. The
reduction of EFS-induced contractile response in the pres-
ence of alpha adrenergic antagonist phentolamine was
higher in sedentary HFD rats and similar in trained HFD
animals compared to controls, confirming that aerobic
exercise training averts the increased activity by the adre-
nergic component of sympathetic innervation in arteriesthorized reproduction of this article is prohibited.
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FIGURE 4 Effect of obesity and aerobic training on nitrergic innervation function. Effect of preincubation with 0.1 mmol/l L-NAME on the vasoconstrictor response induced
by EFS in mesenteric segments from control (a), sedentary (b), and trained (c) HFD rats. Results (mean SEM) are expressed as a percentage of the previous contraction
elicited by KCl (n¼10–12 animals in each group). EFS, electric field stimulation; HFD, high-fat diet; L-NAME, Nv nitro-L-arginine methyl ester.
Sastre et al.from obese rats [19,49–53]. Vasoconstrictor response to
noradrenaline remained unmodified in all experimental
groups This result contrasts to those observed in spon-
taneously hypertensive rats (SHR) mesenteric segments,
where we observed an increase in noradrenaline vaso-
constriction [19], suggesting that the effect of training is
dependent on the basal situation of the experimental
participant. Additionally, noradrenaline release was
increased in mesenteric rings from sedentary HFD com-
pared to segments from control and trained HFD rats.
An increase in the activation of noradrenergic neurons
resulting from a HFD intake has been described [54], as
well as differential DNA methylation within the promoter
regions of tyrosine hydroxylase [55]. However, to the best
of our knowledge, there are no studies analyzing
possible modifications in the noradrenaline synthesis path-
way in peripheral nervous system. Thus, we analyzed
tyrosine hydroxylase expression in our experimental
conditions, observing a similar expression of this enzyme
in all experimental groups. Thus, the increased noradrena-
line release observed in arteries from obese rats might
be due to an increase in tyrosine hydroxylase activity,
and aerobic exercise training could avert this activation.
Taken together, these results indicate that aerobic exercise
training avoids the alterations in the adrenergic componentCopyright © 2015 Wolters Kluwer Health, Inc. Unau
8 www.jhypertension.comof sympathetic innervation observed in HFD-induced
obesity.
There was a remaining contractile response that was
phentolamine-resistant in all experimental groups and was
lower in sedentary HFD rats compared to control and
trained HFD rats. We have reported that the remnant vaso-
constriction observed after preincubation with phentol-
amine in segments from control rats is due to ATP
release from sympathetic innervation [18,56]. In our exper-
imental conditions, we observed a decreased EFS-induced
vasoconstriction only in mesenteric segments from control
and trained HFD animals after preincubation with suramin,
whereas vasoconstriction was not modified in segments
from sedentary HFD rats. In parallel, the results on ATP
release confirm that HFD feeding reduces this release and
training blocks this reduction. These results contrast with a
previous study by Haddock and Hill [44], which reported an
increased participation of purinergic neurotransmission in
resistance arteries from HFD animals. The differences in the
rat strain, the diet composition and time of administration,
the vascular bed analyzed, and the experimental approach
could explain these differences. Altogether, these results
confirm that the HFD diet increased noradrenaline release
and decreased ATP release, and training avoided these
modifications.thorized reproduction of this article is prohibited.
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FIGURE 5 Effect of obesity and aerobic training on neuronal NO synthesis and vasodilation. (a) EFS-induced NO release in segments from control, sedentary, and trained
HFD rats. Results (mean SEM) were expressed as arbitrary (AU)/mg tissue (n¼6–8 animals per group). (b) P-nNOS and nNOS expressions in endothelium-denuded
mesenteric segments from control, sedentary, and trained HFD rats. The blots are representative of eight separate segments from each group. Rat brain homogenates were
used as a positive control. Lower panel shows relation between protein expression and b-actin. Results (mean SEM) are expressed as ratio of the signal obtained for each
protein and the signal obtained for b-actin. (c) Vasodilator response to NO donor DEA-NO in segments from control, sedentary and trained HFD rats. Results (mean SEM)
are expressed as a percentage of the previous tone elicited by exogenous NA (n¼8–10 animals in each group). (d) Superoxide anion release in mesenteric segments from
control, sedentary and trained HFD rats. Results (mean SEM) are expressed as chemiluminiscence units (u)/min mg tissue (n¼6–8 animals in each group). DEA-NO,
diethylamine NONOate; EFS, electric field stimulation; HFD, high-fat diet; NA, noradrenaline; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; P-nNOS phosphorylated
neuronal nitric oxide synthase.
Aerobic exercise training and perivascular innervation in obese ratsPreviously, we have demonstrated that the decreased
release of nitric oxide from perivascular nitrergic inner-
vation in segments from HFD rats contributed to the
increased vasoconstrictor response to EFS [18]. Our next
objective was to analyze whether, similarly to observations
in sympathetic innervation, moderate exercise training
averted the nitrergic dysfunction induced by a HFD diet.
The nonspecific nitric oxide synthesis inhibitor L-NAME
increased EFS vasoconstriction similarly in segments from
control and trained HFD rats, but this increase was not
present in segments from sedentary HFD animals, as pre-
viously reported [18]. These results indicate that aerobic
exercise training averts the nitrergic innervation dysfunc-
tion observed in superior mesenteric artery from HFD-
induced obese rats. The differences observed among our
experimental groups are possibly related to modifications
in nitric oxide release and/or vasodilator response. Nitricopyright © 2015 Wolters Kluwer Health, Inc. Unau
Journal of Hypertensionoxide release was lower in sedentary HFD segments than in
either control or trained HFD rats, agreeing with the vas-
cular reactivity studies. The fact that the specific nNOS
inhibitor 7NI practically abolished nitric oxide release in
the three experimental groups confirms, as we have dem-
onstrated in this vascular bed, that this isoform is respon-
sible for neuronal nitric oxide synthesis [18,19,24].
Additionally, the decreased nNOS and P-nNOS expressions
observed in sedentary HFD compared to control and
trained HFD rats correlate with the observed nitric oxide
release. In agreement with these results, a decrease in nNOS
expression due to HFD intake has been described in this
vascular bed, and increases in nNOS through training have
been reported in the central and peripheral nervous system
and skeletal muscle [19,57–59].
Obesity has widely been described to be associated with
an increase in oxidative stress [60], and moderate exercisethorized reproduction of this article is prohibited.
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FIGURE 6 Effect of obesity and aerobic training on sensory innervation function. Effect of preincubation with 0.5mmol/l CGRP (8–37) on the vasoconstrictor response
induced by EFS in mesenteric segments from control (a), sedentary (b), and trained (c) HFD rats. Results (mean SEM) are expressed as a percentage of the previous
contraction elicited by KCl (n¼6–8 animals in each group). CGRP, calcitonin gene-related peptide; EFS, electric field stimulation; HFD, high-fat diet.
Sastre et al.training improves the vascular antioxidant defence systems,
thus increasing nitric oxide bioavailability [19,61–63]. In our
experimental conditions, superoxide anion production and
the vasodilator response to DEA-NO were similar in seg-
ments from all experimental groups, suggesting that oxi-
dative stress is not modified in animals fed HFD and/or
subjected to moderate exercise. This result contrasts to
observations in SHR, where the same training model
decreased the superoxide anions [19], indicating that the
antioxidant effect is associated not only to the training
program, but also to the initial conditions of the study
participant. Taken together, these results indicate that
moderate exercise training averts the nitrergic dysfunction
observed in HFD-induced obese rats by avoiding the
described reduction in neuronal nitric oxide release.
We have previously reported that CGRP released
from sensory innervation of this artery does not participate
in the vasoconstrictor response to EFS in a healthy or
obese situation [18,25,56,64]. On the contrary, aerobic
exercise training has been shown to modulate the role
of sensory innervation in several tissues including vascular
tissue [19,65]. However, preincubation with the CGRP
receptor antagonist CGRP (8–37) did not modify EFS-
induced vasoconstriction in any group, indicating thatCopyright © 2015 Wolters Kluwer Health, Inc. Unau
10 www.jhypertension.comsensory innervation is not altered in our experimental
conditions.
The results regarding modifications in blood pressure
following a HFD intake are controversial; both increases
and no modifications in blood pressure have been reported
depending on the diet fat composition and the time the diet
has been given to the animals [66–71]. When measuring
mean blood pressure, we observed no increase in HFD
animals. However, the modifications we described could
increase peripheral vascular resistance, which would
participate in the future genesis of obesity-related hyper-
tension. Additionally, aerobic exercise training did not
modify blood pressure in obese animals, as reported in
normotensive animals [72,73], but it did avoid the enhanced
sympathetic and diminished nitrergic function observed in
HFD-induced obesity. Altogether, these results suggest that
aerobic exercise could reduce peripheral vascular resist-
ance in obesity, thereby contributing to avoiding the future
development of obesity-related hypertension.
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ABSTRACT—The aim of the present study was to investigate the effects of lipopolysaccharide (LPS) on the contractile
response induced by electrical field stimulation (EFS) in rat mesenteric segments, as well as the mechanisms involved.
Effects of LPS incubation for 2 or 5 h were studied in mesenteric segments from male Wistar rats. Vasomotor responses to
EFS, nitric oxide (NO) donor DEA-NO, and noradrenaline (NA) were studied. Phosphorylated neuronal NO synthase protein
expression was analyzed, and NO, superoxide anion (O2I
j), and peroxynitrite releases were also determined. Lipopolysac-
charide increased EFS-induced vasoconstriction at 2 h. This increase was lower after 5-h preincubation. N5-nitro-L-arginine
methyl ester increased vasoconstrictor response only in control segments. Vasodilator response to DEA-NO was increased by
LPS after 5-h preincubation and was decreased by O2I
j scavenger tempol. Basal NO release was increased by LPS.
Electrical field stimulationYinduced NO release was reduced by LPS compared with control conditions. Lipopolysaccharide
exposure increased both O2I
j and peroxynitrite release. Vasoconstriction to exogenous NA was markedly increased by LPS
compared with control conditions after 2-h incubation and remained unchanged after 5-h incubation. Short-term exposure of
rat mesenteric arteries to LPS produced a time-dependent enhanced contractile response to EFS. The early phase (2 h) was
associated to a reduction in NO from neuronal NO synthase and an enhanced response to NA. After 5 h of LPS exposure, this
enhancement was reduced, because of restoration of the adrenergic component and maintenance of the nitrergic reduction.
KEYWORDS—LPS, rat mesenteric artery, adrenergic innervation, nitrergic innervation
INTRODUCTION
Endotoxic shock is characterized by hypotension, vascular
collapse, and multiple organ failure (1). Several mechanisms
have been proposed to account for this syndrome at the vas-
cular level: activation of ATP-sensitive potassium channels in
the plasma membrane of vascular smooth muscle, activation of
the inducible form of nitric oxide (NO) synthase (NOS), vas-
opressin deficiency, altered catecholamine release, and vaso-
motor response (2Y6).
Nitric oxide is a main participant in the hypotension asso-
ciated with vascular collapse in endotoxic shock. Nitric oxide
can be produced from the three major NOS isoforms: neural
NOS (nNOS), endothelial NOS, and inducible NOS (iNOS)
(7, 8). Thus, inhibition of NOS to prevent excessive NO re-
lease presents an experimental therapeutic approach to coun-
teract hypotension in shock (9, 10). It is generally accepted
that NO from iNOS and endothelial NOS plays a main det-
rimental role in sepsis-induced multiple organ dysfunction
(11Y14). Studies investigating effects of lipopolysaccharide
(LPS) on nNOS have been performed in different tissues,
mainly from central nervous system, yielding a variety of
results (15Y17). However, studies on the participation in the
effects of LPS of NO from nNOS in the regulation of vas-
omotor tone are scarce and report different results (18, 19).
Arterial tone is regulated by the central nervous system,
perivascular innervation, myogenic mechanisms, and endo-
thelial and humoral factors, including cytokines. Perivascular
innervation plays a principal role in the regulation of vascular
tone, specifically in certain vessels such as the mesenteric vas-
cular bed (20). Neural control of mesenteric artery is mediated
by adrenergic and nitrergic components (21Y23), which are
affected by several pathophysiological situations (24). It has
been previously shown that exposure of rat mesenteric segments
to LPS results in induction of iNOS associated with increased
NO formation and noradrenaline (NA) hyporeactivity (25).
Induction and activation of nNOS but not iNOS by LPS have
been described in oligodendrocytes (26). This activation resul-
ted in peroxynitrite accumulation and protein tyrosine nitration
in oligodendrocytes, resulting in reduced cell viability. Most of
the studies investigating the role of NO in vascular dysfunc-
tion under LPS exposure are focused on a chronic or late
phase (27, 28), whereas the results obtained in acute or short-
term studies are inconclusive because of the different exper-
imental conditions (29).
Because there is no functional analysis determining inte-
grated effects of adrenergic and nitrergic alterations under
LPS exposure, the aim of the present study was to investigate
the impact of LPS on the neuronal control of mesenteric
vascular tone as well as the mechanisms involved.
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MATERIALS AND METHODS
Animals
Male Wistar rats (3 months old) were obtained from the Animal Quarters
of the Universidad Auto´noma de Madrid and housed in the Animal Facility
of the Universidad Auto´noma de Madrid (registration no. EX-021U) in
accordance with guidelines 609/86 of the E.E.C., R.D. 233/88 of the Minis-
terio de Agricultura, Pesca y Alimentacio´n of Spain, and Guide for the Care
and Use of Laboratory Animals published by the US National Institutes of
Health (NIH publication 85.23, revised 1985). All experimental procedures
involving animal use were approved by the Ethics Committee of the Uni-
versidad Auto´noma de Madrid. Rats were housed at a constant room tem-
perature, humidity, and light cycle (12:12-hour light-dark cycle) with free
access to tap water and fed with standard rat chow ad libitum.
Animals were killed by CO2 inhalation; the first branch of the mesenteric
artery was carefully dissected, cleaned of connective tissue, and placed in
Krebs-Henseleit solution (KHS, in mmol/L: NaCl 115, CaCl2 2.5, KCl 4.6,
KH2PO4 1.2, MgSO4.7H2O 1.2, NaHCO3 25, glucose 11.1, Na2EDTA 0.03) at
4-C. Effects of LPS (10 2g/mL) incubation were studied at two time points: 2 h
(phase 1) or 5 h (phase 2). The dose of LPS was selected from pilot studies in
which 1-, 10-, and 20-2g/mL doses were assayed. The intermediate dose was
chosen because it produced the most reliable response in the alteration of
vasomotor response to electrical field stimulation (EFS).
Vascular reactivity
The method used for isometric tension recording has been described in full
elsewhere (30). Two parallel stainless steel pins were introduced through the
lumen of the vascular segment: one was fixed to the bath wall, and the other
connected to a force transducer (Grass FTO3C; Quincy, Mass); this, in turn,
was connected to a model 7D Grass polygraph. For EFS experiments, segments
were mounted between two platinum electrodes 0.5 cm apart and connected to
a stimulator (Grass, model S44) modified to supply adequate current strength.
Segments were suspended in an organ bath containing 5 mL of KHS at 37-C
and continuously bubbled with a 95% O2 to 5% CO2 mixture (pH 7.4). Ex-
periments were performed in endothelium-denuded segments to eliminate
the main source of vasoactive substances, including endothelial NO. This
avoided possible actions of different drugs on endothelial cells that could lead
to misinterpretation of results. Endothelium was removed by gently rubbing
the luminal surface of the segments with a thin wooden stick. The segments
were subjected to a tension of 0.5 g, which was readjusted every 15 min during
a 90-min equilibration period before drug administration. After this, the vessels
were exposed to 75 mmol/L KCl, to check their functional integrity. Endo-
thelium removal did not alter the contractions elicited by 75 mmol/L KCl.
After a washout period, the absence of vascular endothelium was tested by the
inability of 10 2mol/L acetylcholine to relax segments precontracted with NA.
Frequency-response curves to EFS (1, 2, 4, and 8 Hz) were performed. The
parameters used for EFS were 200 mA, 0.3 ms, 1 to 8 Hz, for 30 s with an
interval of 1 min between each stimulus, the time required to recover basal
tone. A washout period of at least 1 h was necessary to avoid desensitization
between consecutive curves. Three successive frequency-response curves
separated by 1-h intervals produced similar contractile responses.
To analyze the participation of NO in the EFS-induced response in seg-
ments from control and LPS-incubated mesenteric segments, 0.1 mmol/L
N5-nitro-L-arginine methyl ester (L-NAME), a nonspecific inhibitor of NOS,
was added to the bath 30 min before performing the second frequency-
response curve.
The vasodilator response to the NO donor diethylamine NONOate (DEA-NO,
0.1 nmol/L to 0.1 mmol/L) and to peroxynitrite (0.1 2mol/L to 1 mmol/L) and
the vasoconstrictor response of exogenous NA (1 nmol/L to 10 2mol/L) were
also determined in control and LPS-incubated arteries. To assess the partic-
ipation of superoxide anion in DEA-NOYinduced vasodilation, 0.1 mmol/L
tempol, a superoxide anion scavenger, was added to the bath before the
frequency-response curve to DEA-NO was performed.
Noradrenaline release
Endothelium-denuded segments of rat mesenteric arteries from all exper-
imental groups were preincubated for 30 min in 5 mL of KHS at 37-C and
continuously gassed with a 95% O2 to 5% CO2 mixture (stabilization period).
This was followed by two washout periods of 10 min in a 0.4 mL KHS bath.
Then, the medium was collected to measure basal release. Next, the organ bath
was refilled, and cumulative EFS periods of 30 s at 1, 2, 4, and 8 Hz were
applied at 1-min intervals. Afterward, the medium was collected to measure
EFS-induced neurotransmitter release.
Noradrenaline release was measured using Noradrenaline Research EIA
(Labor Diagnostica Nord, GmbH and Co, KG, Nordhon, Germany). Assays
were performed following the manufacturer’s instructions. Results were ex-
pressed as ng NA/mL mg tissue.
NO release
Nitric oxide release was measured using fluorescence emitted by the fluo-
rescent probe 4,5-diaminofluorescein (DAF-2), as previously described (31).
Endothelium-denuded mesenteric arteries from all experimental groups were
subjected to a 60-min equilibration period in HEPES buffer (in mmol/L: NaCl,
119; HEPES, 20; CaCl2, 1.2; KCl, 4.6; MgSO4, 1; KH2PO4, 0.4; NaHCO3, 5;
glucose, 5.5; Na2HPO4, 0.15; pH 7.4) at 37-C. Arteries were incubated with
2 2mol/L DAF-2 for 30 min. The medium was then collected to measure basal
NO release. Once the organ bath was refilled, cumulative EFS periods of 30 s
at 1, 2, 4, and 8 Hz were applied at 1-min intervals. Afterward, the medium
was collected to measure EFS-induced NO release. The fluorescence of
the medium was measured at room temperature using a spectrofluorometer
(LS50, FL WINLAB Software; Perkin Elmer Instruments, Whaltmann, Mass)
with excitation wavelength set at 492 nm and emission wavelength at 515 nm.
The EFS-induced NO release was calculated by subtracting basal NO
release from that evoked by EFS. Also, blank sample measures were collected
in the same way from segment-free medium to subtract background emission.
Some assays were performed in the presence of 0.1 mmol/L L-NAME;
0.1 mmol/L 7NI, the specific nNOS inhibitor; 1 2mol/L 1400 W, the specific
iNOS inhibitor; or 0.1 2mol/L tetrodotoxin (TTX), a nerve impulse blocker.
The amount of NO released was expressed as arbitrary units/mg tissue.
Detection of superoxide anions
Superoxide anion levels were measured using lucigenin chemiluminescence,
as previously described (32). Endothelium-denuded mesenteric segments from
all experimental groups were rinsed in KHS for 30 min, equilibrated for 30
min in HEPES buffer at 37-C, transferred to test tubes that contained 1 mL
HEPES buffer (pH 7.4) containing lucigenin (5 2mol/L), and then kept at
37-C. The luminometer was set to report arbitrary units of emitted light;
repeated measurements were collected for 5 min at 10-s intervals and aver-
aged. 4,5-Dihydroxy-1,3-benzene-disulfonic acid BTiron[ (10 mmol/L), a cell-
permeant, nonenzymatic superoxide anion scavenger, was added to quench the
superoxide anionYdependent chemiluminescence. Calculations were performed
subtracting the lucigenin chemiluminescence obtained in the presence of Tiron
from that obtained in its absence. Blank measures were collected in the same
way without mesenteric segments to subtract background emission.
Peroxynitrite detection
Peroxynitrite levels were measured using fluorescence emitted by the
fluorescent probe dihydrorhodamine 123. Endothelium-denuded mesenteric
arteries from all experimental groups were subjected to a 30-min equilibration
period in phosphate-buffered saline solution (in mmol/L: NaCl, 137; KCl, 2.7;
Na2HPO4 I 2H2O, 10; KH2PO4, 2; pH 7.4) at 37-C. Arteries were incubated
with 5 2mol/L dihydrorhodamine 123 for 30 min. The medium was then col-
lected to measure basal peroxynitrite release. Once the organ bath was refilled,
cumulative EFS periods of 30 s at 1, 2, 4, and 8 Hz were applied at 1-min
intervals. Afterward, the medium was collected to measure EFS-induced
peroxynitrite release. The fluorescence of the medium was measured at room
temperature using a spectrofluorometer (LS50, FL WINLAB Software; Perkin
Elmer Instruments) with excitation wavelength set at 500 nm and emission
wavelength at 536 nm. Some assays were performed in the presence of
0.1 mmol/L tempol or 0.1 2mol/L TTX. The amount of peroxynitrite released
was expressed as arbitrary units/mg tissue. Blank sample measures were col-
lected in the same way from segment-free medium to subtract background emis-
sion. The amount of peroxynitrite released was expressed as arbitrary units/mg tissue.
nNOS and phosphorylated nNOS expression
Western blot analysis of nNOS and phosphorylated nNOS (P-nNOS) ex-
pression was performed as previously described (32). For these experiments,
we used mouse monoclonal nNOS antibody (1:1,000; BD Transduction Lab-
oratories, Madrid, Spain) and rabbit polyclonal P-nNOS antibody (1:2,000;
Abcam, Cambridge, UK).
Drugs used
Lipopolysaccharide serotype 055:B5, L-NA hydrochloride, acetylcholine
chloride, diethylamine NONOate diethylammonium salt, TTX, tempol, L-NAME
hydrochloride, 1400 W, phentolamine, lucigenin, Tiron, and DAF-2 (Sigma-
Aldrich, Madrid, Spain) were used. Stock solutions (10 mmol/L) of drugs were
made in distilled water, except for NA, which was dissolved in a NaCl
(0.9%)Yascorbic acid (0.01% wt/vol) solution. These solutions were kept at
j20-C, and appropriate dilutions were made in KHS on the day of the
experiment.
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Data analysis
The responses elicited by EFS and NA were expressed as a percentage of
the initial contraction elicited by 75 mmol/L KCl for comparison between
control and LPS-treated arteries. The relaxation induced by DEA-NO was
expressed as a percentage of the initial contraction elicited by NA (control:
1,095.546 T 10.5 mg; LPS 2 h: 1,104.97 T 12.7 mg; LPS 5 h: 1,074.23 T
19.54 mg; P 9 0.05). Results are given as mean T SEM. Statistical analysis
was done by comparing the curve obtained in the presence of the different
substances with the previous or control curve by means of repeated-measure
analysis of variance followed by Bonferroni post hoc test, using the Graph-
Pad Prism 5.0 software (GraphPad Software, Inc, San Diego, Calif). For NO,
superoxide anion, peroxynitrite, and NA release data, the statistical analysis
was done using one-way analysis of variance followed by Newman-Keuls
post hoc test for unpaired experiments. P G 0.05 was considered significant.
RESULTS
Response to KCl
Response of mesenteric segments to KCl (75 mmol/L) was
similar in control and segments exposed to LPS (2 and 5 h)
(control: 1,909 T 183 mg; LPS 2 h: 2,105 T 213 mg; LPS 5 h:
1,879 T 189 mg).
Effect of LPS exposure in vasomotor response to EFS
As previously shown (16), EFS induced a frequency-dependent
contraction that was maintained without modifications over the
entire study period (5 h) (Fig. 1A). Two hours of exposure to
LPS induced an increased (P G 0.05) contractile response,
which was observed at all frequencies (1Y8 Hz). In contrast,
after 5 h of LPS incubation, a reduction (P G 0.05; compared
with the 2-h period) in the EFS-induced contraction was
observed at all frequencies (Fig. 1B).
Incubation of mesenteric arteries with the unspecific NOS
inhibitor L-NAME (0.1 mmol/L) increased (P G 0.05) the
contractile response at all frequencies only in control segments
(Fig. 2A). Exposure to LPS in the presence of L-NAME did not
alter vasoconstrictor response at any frequency (1Y8 Hz) or
exposure period (2 and 5 h) (Fig. 2, B and C).
NO relaxation and release
Relaxation of mesenteric segments to exogenous DEA-NO
was not altered in the presence of LPS compared with control
conditions after 2 h of LPS incubation, whereas relaxation was
increased by LPS after 5-h incubation (Fig. 3A). Preincubation
with 0.1 mmol/L tempol did not modify DEA-NO vasodilation
in control or 2 h-incubated LPS segments, (Fig. 3, B and C),
although it decreased after 5-h incubation with LPS (Fig. 3D).
Basal release of NO increased (P G 0.05) in both phases
(Fig. 4A). In contrast, during EFS stimulation, the increase in
NO release was markedly reduced (P G 0.05) compared with
control conditions at both time periods (Fig. 4B).
Basal NO release was markedly reduced in the presence of
the iNOS inhibitor 1400 W over the studied period, but not in
the presence of the nNOS specific inhibitor, 7NI (Fig. 4A).
The EFS-induced NO release was almost abolished in presence
of 7NI (Fig. 4B), the unspecific NOS inhibitor, L-NAME (data
not shown), or the nerve impulse blocker TTX (Fig. 4B). In
contrast, release was not modified after exposure to 1400 W
(Fig. 4B).
nNOS expression
Neural NOS protein expression was not modified by LPS
exposure at any phase. However, P-nNOS expression de-
creased after 2 and 5 h of LPS exposure (Fig. 4C).
Oxidative and nitrosative stress
Lipopolysaccharide exposure produced a progressive in-
crease in superoxide anions, which reached significance after
5 h of exposure (Fig. 5A). Similarly, although basal perox-
ynitrite levels were undetectable, EFS-induced peroxynitrite
levels also increased over the studied period (Fig. 5B) and
were almost abolished in presence of superoxide anion
scavenger tempol (Fig. 5B) or the nerve impulse blocker TTX
(Fig. 5B) in segments from all experimental groups.
Exogenous peroxynitrite induced a concentration-dependent
response that was not altered by LPS at any time of exposure
(Fig. 5C).
NA contraction and release
Contraction of mesenteric segments to exogenous NA in the
presence of LPS was markedly increased (P G 0.05) compared
with control conditions at 2 h and remained unchanged after
5 h of LPS exposure (Fig. 6A).
FIG. 1. Effect of LPS on EFS-induced vasoconstrictor. A, Time-dependent EFS-induced contractile response in mesenteric segments from Wistar
rats. B, Vasoconstrictor response to EFS in control and LPS-incubated (10 2g/mL, 2 and 5 h) mesenteric arteries. Results (mean T SEM) were expressed
as a percentage of the initial contraction elicited by KCl. *P G 0.05 vs. control segments for each frequency (Bonferroni test). n = 10 animals each group.
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Lipopolysaccharide exposure did not modify NA release
during EFS stimulation compared with control conditions at
any exposure time (Fig. 6B).
DISCUSSION
The study shows that short-term exposure of rat mesenteric
arteries to LPS induced an increased contractile response to
EFS that exhibited a time-dependency pattern. In the early
phase (2 h), an enhanced constrictor response was dependent
on a reduction in NO from nNOS and an enhanced response to
NA. After 5 h of LPS exposure, this enhancement was reduced
because of the restoration of the adrenergic component,
although the nitrergic reduction continued.
Perivascular innervation plays a pivotal role in the regulation
of mesenteric blood flow (20, 23). Adrenergic and nitrergic
innervations, among other factors, have been reported in
rat mesenteric artery, where they seem to play a principal role
(21, 23). The interplay between both types of innervation that
has been described in the regulation of blood flow under
different pathological circumstances could have multiple he-
modynamic consequences (33, 34). Endotoxic shock is charac-
terized by hypotension, vascular collapse, and multiple organ
failure including gastrointestinal tract (1, 7). Previous studies
under a variety of experimental conditions have already shown
that NO plays a pivotal role in the consequences of endotoxic
shock (9, 27). Under these conditions, increased NO production
is mainly due to enhanced activity and expression of iNOS in
a variety of tissues, including the vascular wall (7, 25, 27).
In addition, alterations of NO produced in endotoxic shock
by nNOS in several tissues have also been studied, yielding a
variety of results. Reduced nNOS expression produced by
endotoxins in the neurons from the myenteric plexus of rabbit
duodenum has been reported (17), whereas increased nNOS
protein levels in skeletal muscle during sepsis have also been
reported (16). Increases in nNOS and iNOS gene expression,
with different time courses, were observed in the paraven-
tricular nucleus 2 h after LPS injection in rats (15). Systemic
administration of LPS in rats induced a transcriptional upre-
gulation of nNOS in the brainstem dorsal vagal complex (35).
On the contrary, downregulation of nNOS in cardiomyocytes
from rats treated with LPS has also been reported (36).
Effect of 2 h exposure to LPS
Nitric oxide synthesis could be due to the activation of dif-
ferent NOS isoforms in the mesenteric artery wall. In our
study, EFS-induced NO release was almost abolished in the
presence of TTX, confirming its neuronal origin. In the pres-
ence of LPS, basal NO release increased, although EFS-induced
NO release was reduced. Although basal release of NO was not
altered by the specific nNOS inhibitor 7NI, it was reduced by
the inhibitor of iNOS 1400 W, indicating its inducible origin.
This result confirms the important role of NO from iNOS in
the vasodilation induced by LPS. In turn, EFS-stimulated NO
FIG. 2. Influence of neuronal NO on EFS-induced vasoconstriction. Effect of preincubation with 0.1 mmol/L L-NAME on the vasoconstrictor response to
EFS in control (A) and LPS-incubated (10 2g/mL) segments for 2 h (B) and 5 h (C). Results (mean T SEM) were expressed as a percentage of the initial
contraction elicited by KCl. *P G 0.05 vs. control situation for each frequency (Bonferroni test). n = 10 animals each group.
FIG. 3. Effect of LPS on DEA-NO induced vasodilation. A, Vasodilator response to DEA-NO in control and LPS-incubated (10 2g/mL, 2 and 5 h)
mesenteric arteries. Effect of preincubation with 0.1 mmol/L tempol on the vasodilator response elicited by DEA-NO in segments from control (B) and LPS-
incubated (10 2g/mL) segments at 2 h (C) and 5 h (D). Results (mean T SEM) are expressed as a percentage of the initial contraction elicited by exogenous
NA. *P G 0.05 vs. control conditions for each dose (Bonferroni test). n= 8 animals each group.
SHOCK SEPTEMBER 2012 LPS EFFECTS ON MESENTERIC INNERVATION 331
Copyright © 2012 by the Shock Society. Unauthorized reproduction of this article is prohibited.
release in the absence and presence of LPS was abolished by
7NI but was not modified by 1400 W. This indicates that
nNOS is responsible for the NO release induced by EFS and
rules out the participation of iNOS, thus confirming previous
findings (37).
To explore possible mechanisms involved in the reduced
NO release, nNOS expression and activation to its phos-
phorylated form were studied. Neural NOS protein expression
remained unaltered, whereas P-nNOS was markedly dimin-
ished over the study period. Thus, it could be proposed that a
reduction of nNOS activity seems to cause the aforementioned
reduced NO release.
Incubation of mesenteric arteries with the unspecific NOS
inhibitor L-NAME in control conditions produced an increased
EFS-vasoconstrictor response, but this was not observed dur-
ing 2-h LPS exposure. In addition, the participation of other
components different than nitrergic innervation in the increased
contractile response to EFS cannot be ruled out.
Previous studies have already shown differential partic-
ipation of the adrenergic system in the presence of LPS or in
endotoxic shock. Mesenteric arteries from pigs showed an
elevated contractile response to NA 3 h after induction of
endotoxic shock with LPS, a response that is probably asso-
ciated to changes in endothelial factors (38). Enhanced NA
release from sympathetic nerves has been reported, and it may
play a role in the preservation of neurogenic response after
LPS treatment despite evidence of the induction of NOS (5).
Other authors have shown hyporeactivity to NA or methox-
amine in mesenteric arteries exposed to LPS or in arteries from
rats infused with LPS (25, 39). This latter effect was not due to
a generalized inability of the smooth muscle to contract, as
demonstrated by the unaltered response to KCl, and does not
appear to involve abnormalities in calcium mobilization or
entry (39). On the contrary, alterations in calcium handling
and a decreased sensitivity of myofilaments to calcium have
been proposed as another possible mechanism contributing to
the effects of LPS in mesenteric arteries (40). In our study,
dose-response contraction of mesenteric segments to exoge-
nous NA in the presence of LPS was markedly increased at
2 h of LPS exposure. Thus, the observed increase in NA
response could be due to postjunctional modifications (ion
channels, intracellular mediators, etc.). In addition, a facili-
tating prejunctional mechanism has been reported that may
preserve sympathetic function in endotoxemia (5). Thus, the
observed increased contraction to NA does not rule out the
possibility of a modified NA release. The results show that
LPS exposure did not modify NA release at the basal point
or during EFS stimulation compared with control conditions.
Thus, the observed increased contraction to EFS at 2 h seems to
be due to an enhanced NA response together with a reduction
in NO.
Effect of 5-h exposure to LPS
The study also shows that 5-h exposure of rat mesenteric
arteries to LPS induced an increased contractile response to
EFS, a response that was lower than that observed at 2 h, as
previously reported (41). Basal and stimulated NO release at
5 h was similar to that found at 2 h. Incubation with 7NI and
1400 W also showed a similar pattern to the one observed
under both basal and stimulated conditions at 2 h. Similarly
to findings at 2 h, nNOS protein expression remained un-
altered, whereas P-nNOS was markedly diminished over the
FIG. 4. Effect of LPS on NO release and nNOS expression. Effect of preincubation with 0.1 mmol/L 7NI, 1 2mol/L 1400 W, or 0.1 2mol/L TTX on basal (A)
NO release and EFS-induced (B) NO release in control and LPS-incubated mesenteric segments for 2 and 5 h. Results (mean T SEM) are expressed as
arbitrary units (AU)/ mg tissue. *P G 0.05 vs. control segments; #P G 0.05 vs. release without specific inhibitor. n = 8 animals per group. C, Effect of LPS
incubation (10 2g/mL, 2 or 5 h) on nNOS and P-nNOS expression. The blot is representative of six separate segments from each group. Results (mean T
SEM) are expressed as the ratio of the signal obtained for P-nNOS and the one obtained for nNOS. *P G 0.05 vs. control.
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longer study period. Furthermore, L-NAME incubation did
not induce any modification, as had been observed at 2 h.
Collectively, these results indicate that nitrergic innervation
remained unaltered over the studied period, and consequent-
ly the observed reduction compared with the previous early
phase should be due to the adrenergic component. Our results
show a normalization of NA response to levels similar to those
observed under control conditions and reflect the lower incre-
ment observed at 5 h. However, we do not have any feasible
explanation for this effect.
Oxidative and nitrosative stress
Previous studies showed that endotoxemia increased super-
oxide anion formation, possibly contributing to NO degradation
(42, 43). Our results showed a progressive (2 and 5 h) increase
in superoxide anions in mesenteric arteries exposed to LPS.
This effect was accompanied by a parallel increase in perox-
ynitrites, indicating a time-dependent reduction in NO bio-
availability over the course of the study. In addition, when
either neuronal NO release or superoxide anion was eliminated
by the respective presence of either TTX or tempol, the rhod-
amine fluorescent signal dropped. This confirmed that the signal
observed in the absence of these drugs is due to peroxynitrite
formation originated from neuronal NO.
To determine whether superoxide anions could be an addi-
tional mechanism that reduced NO availability in the presence
of LPS, we analyzed the vasodilator response of mesenteric
segments to the NO donor DEA-NO. The results demonstrated
no differences in the response to the NO donor in the presence
or absence of LPS after 2 h. Similarly, Cuzzocrea et al. (44)
showed no difference in vasorelaxation produced by sodium
nitroprusside in aortic rings from LPS-treated rats. How-
ever, LPS increased DEA-NOYinduced vasodilation after a 5-h
preincubation, and the effect was reversed by tempol. The
present results, like previous studies from our group, show a
vasodilatory effect of peroxynitrite in this vascular bed (45).
Consequently, the increase in peroxynitrite levels may contri-
bute to the increase in relaxation induced by DEA-NO.
It is well known that LPS stimulates cytokine production
and release in several tissues and that cytokines are able to
alter adrenergic and nitrergic function similarly to the manner
observed in our results (46). Thus, the effects of LPS observed
in our experimental conditions might also be mediated by
cytokines. Identification of cytokine participation could be
the subject of future studies.
In summary, short-term exposure of rat mesenteric arteries
to LPS produced a time-dependent enhanced contractile re-
sponse to EFS. The early phase (2 h) was associated to a
reduction in NO from nNOS and an enhanced response to NA.
After 5 h of LPS exposure, this enhancement was reduced,
because of restoration of the adrenergic component and
maintenance of the nitrergic reduction.
FIG. 5. Effect of LPS on oxidative and nitrosative stress. A, Superoxide anion release from control and LPS-incubated segments (10 2g/mL, 2 or 5 h).
Results (mean T SEM) are expressed as chemiluminescence units (U)/min mg tissue. *P G 0.05 vs. control. n = 5 animals per group. B, Effect of preincubation
with 0.1 2mol/L TTX or 0.1 mmol/L tempol on peroxynitrite formation in control and LPS-incubated mesenteric segments (10 2g/mL, 2 or 5 h). Results (mean T
SEM) are expressed as arbitrary units (AU)/ mg tissue. *P G 0.05 vs. control segments; #P G 0.05 vs. 2 h-LPS incubated segments; +P G 0.05 vs. release without
specific inhibitor. n = 6 animals per group. C, Vasodilator response to exogenous peroxynitrite in control and LPS-incubated (10 2g/mL, 2 and 5 h) mesenteric
arteries. Results (mean T SEM) are expressed as a percentage of the initial contraction elicited by exogenous NA. n = 5 animals each group.
FIG. 6. Effect of LPS on NA-induced vasoconstriction and release. A, Vasoconstrictor response to exogenous NA in control and LPS-incubated (10
2g/mL, 2 or 5 h) mesenteric arteries. Results (mean T SEM) are expressed as a percentage of the previous contraction elicited by KCl. n = 5 animals each group.
*P G 0.05 vs. control groups (Bonferroni test). B, Electrical field stimulationYinduced NA release in mesenteric segments from control and LPS-incubated
mesenteric segments. Results (mean T SEM) are expressed as ng NA/mL mg tissue. n = 5 animals per group.
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Opposite Effect of Mast Cell Stabilizers Ketotifen and
Tranilast on the Vasoconstrictor Response to Electrical
Field Stimulation in Rat Mesenteric Artery
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Abstract
Objectives: We analyzed whether mast cell stabilization by either ketotifen or tranilast could alter either sympathetic
or nitrergic innervation function in rat mesenteric arteries.
Methods: Electrical field stimulation (EFS)-induced contraction was analyzed in mesenteric segments from 6-month-
old Wistar rats in three experimental groups: control, 3-hour ketotifen incubated (0.1 αmol/L), and 3-hour tranilast
incubated (0.1 mmol/L). To assess the possible participation of nitrergic or sympathetic innervation, EFS contraction
was analyzed in the presence of non-selective nitric oxide synthase (NOS) inhibitor L-NAME (0.1 mmol/L), α-
adrenergic receptor antagonist phentolamine (0.1 µmol/L), or the neurotoxin 6-hydroxydopamine (6-OHDA, 1.46
mmol/L). Nitric oxide (NO) and superoxide anion (O2.-) levels were measured, as were vasomotor responses to
noradrenaline (NA) and to NO donor DEA-NO, in the presence and absence of 0.1 mmol/L tempol. Phosphorylated
neuronal NOS (P-nNOS) expression was also analyzed.
Results: EFS-induced contraction was increased by ketotifen and decreased by tranilast. L-NAME increased the
vasoconstrictor response to EFS only in control segments. The vasodilator response to DEA-NO was higher in
ketotifen- and tranilast-incubated segments, while tempol increased vasodilator response to DEA-NO only in control
segments. Both NO and O2- release, and P-nNOS expression were diminished by ketotifen and by tranilast
treatment. The decrease in EFS-induced contraction produced by phentolamine was lower in tranilast-incubated
segments. NA vasomotor response was decreased only by tranilast. The remnant vasoconstriction observed in
control and ketotifen-incubated segments was abolished by 6-OHDA.
Conclusion: While both ketotifen and tranilast diminish nitrergic innervation function, only tranilast diminishes
sympathetic innnervation function, thus they alter the vasoconstrictor response to EFS in opposing manners.
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Introduction
Arterial tone is regulated by the central nervous system,
perivascular innervation and myogenic mechanisms, as well as
by endothelial and humoral factors. Perivascular innervation
plays a principal role in the regulation of vascular tone,
specifically in certain vessels such as the mesenteric vascular
bed [1,2], where blood flow is approximately 20-30% of the
total cardiac output [3]. Inadequate mesenteric blood flow and
tissue perfusion can produce relevant haemodynamic changes
[3–5]. This regulation involves sympathetic and nitrergic
innervations (1,2), which mainly release mainly noradrenaline
(NA) or ATP from sympathetic nerve terminals [6], and nitric
oxide (NO) from nitrergic innervation [7,8].
An interaction between mast cells and nerve endings has
been observed in the gastrointestinal tract [9] and cardiac
tissue [10]. When stimulated, these cells degranulate,
subsequently releasing a variety of mediators, such as neutral
proteases, growth factors, cytokines and chemokines, as well
as vasoactive substances like serotonin, histamine,
leukotrienes and prostaglandins [11,12], which can affect
perivascular mesenteric innervation function.
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Ketotifen and tranilast are effective mast cell stabilizer
agents widely used in the management of allergic and
inflammatory disorders. Both drugs block a calcium channel
essential for mast cell degranulation, thereby stabilizing the cell
membrane[12–15]. . Additionally, ketotifen and tranilast can
also induce different additional effects apart from mast cell
stabilization, effects that could induce different alterations in
perivascular nerve function [16–18].
Based on these considerations, the aim of this study was to
analyze the possible different effects of ketotifen and tranilast
on sympathetic and nitrergic function in rat mesenteric arteries,
as well as the mechanism/s implicated.
Methods
Ethics Statement
All animals were housed in the Animal Facility of the
Universidad Autónoma de Madrid (Registration number
EX-021U) in accordance with directives 609/86 of the E.E.C.,
R.D. 233/88 of the Ministerio de Agricultura, Pesca y
Alimentación of Spain, and Guide for the Care and Use of
Laboratory Animals published by the USA National Institutes of
Health (NIH publication No. 85.23, revised 1985). The
experimental protocol was approved by the Ethics Committee
of the Universidad Autónoma de Madrid.
Animals
We used 6 month-old male Wistar rats. Rats were sacrificed
by CO2 inhalation followed by decapitation; the first branch of
the mesenteric artery was carefully dissected out, cleaned of
connective tissue and placed in Krebs–Henseleit solution
(KHS, in mmol/L : NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2,
MgSO4. 7H2O 1.2, NaHCO3 25, glucose 11.1, Na 2EDTA 0.03)
at 4°C. Some samples were immediately frozen in liquid
nitrogen and stored at -70 °C.
Perivascular mast cell detection
Mesenteric arteries were fixed in 4% formaldehyde in
phosphate buffered saline solution (PBS, pH=7.4) for 1 hour,
cryoprotected with 30% w/v sucrose in PBS (overnight),
transferred to a cryomold containing Tissue-Tek OCT
embedding medium (20 min) and then immediately frozen in
liquid nitrogen. All samples were kept at -70 °C until the day of
the experiments. Frozen tissue segments were cut into 10 µm
thick sections, placed on glass slides and stained with 0.1%
Toluidine Blue (3 min) for perivascular mast cell detection.
Sections were coverslipped and light microscopy images were
taken (Nikon Eclipse TE2000-S (inverted microscope), Nikon
DXM1200F (digital camera)).
Vascular Reactivity
The method used for isometric tension recording has been
described in full elsewhere [8,19]. Briefly, two parallel stainless
steel pins were introduced through the lumen of the vascular
segment: one was fixed to the bath wall, and the other
connected to a force transducer (Grass FTO3C; Quincy, Mass.,
USA); in turn, this was connected to a model 7D Grass
polygraph. For EFS experiments, segments were mounted
between two platinum electrodes 0.5 cm apart and connected
to a stimulator (Grass, model S44) modified to supply the
appropriate current strength. Segments were suspended in an
organ bath containing 5 mL of KHS at 37°C continuously
bubbled with a 95% O2 -5% CO2 mixture (pH 7.4). Some
experiments were performed in endothelium-denuded
segments to eliminate the main source of vasoactive
substances, including endothelial NO. This avoided possible
actions by different drugs on endothelial cells that could lead to
misinterpretation of results. Endothelium was removed by
gently rubbing the luminal surface of the segments with a thin
wooden stick. The segments were subjected to a tension of 0.5
g, which was readjusted every 15 min during a 90-min
equilibration period before drug administration. After this, the
vessels were exposed to 75 mmol/L KCl to check their
functional integrity. Endothelium removal did not alter the
contractions elicited by KCl. After a washout period, the
presence/absence of vascular endothelium was tested by the
ability of 10 µmol/L acetylcholine (ACh) to relax segments
precontracted with 1 µmol/L noradrenaline (NA).
Frequency-response curves to EFS (1, 2, 4, 8 and 16 Hz)
were performed. The parameters used for EFS were 200 mA,
0.3 ms, 1–16 Hz, for 30 s with an interval of 1 min between
each stimulus, the time required to recover basal tone. A
washout period of at least 1 h was necessary to avoid
desensitization between consecutive curves. Three successive
frequency-response curves separated by 1-hour intervals were
performed in every segment. EFS responses in the presence of
mast cell stabilizers ketotifen (1 µmol/L, 0.1 µmol/L or 10
nmol/L), or tranilast (1 mmol/L, 0.1 mmol/L or 10 µmol/L) were
performed to evaluate the possible effect of these drugs on the
neural control of vasomotor tone. To analyze a possible time-
dependent effect, either ketotifen or tranilast were added to the
bath for different incubation periods: 1, 2, and 3 h, before the
corresponding frequency-response curves. To evaluate
whether the EFS-induced contractile response had a neural
origin, the blocker for nerve impulse propagation tetrodotoxin
(TTX, 0.1 µmol/L) was added to the bath 30 min in advance.
Vasodilator response to ACh (0.1 nmol/L-10 µmol/L) was
tested in endothelium-intact arteries from all experimental
groups.
To determine the participation of NO in the EFS-induced
response in all experimental groups, 0.1 mmol/L N G-nitro-L-
arginine methyl ester (L-NAME), the unspecific nitric oxide
synthase (NOS) inhibitor, or 1 µmol/L 1400W, the specific
inducible NOS inhibitor, were added to the bath 30 min before
performing the frequency–response curve.
To determine the participation of adrenergic component of
sympathetic innervation on the EFS-induced response in
control and ketotifen- or tranilast-incubated segments, 1 µmol/L
phentolamine, an α-adrenoceptor antagonist, was added to the
bath 30 min before performing the frequency-response curve.
The method to deplete sympathetic innervation has been
used previously by our group in this artery [20]. Briefly, control,
and ketotifen-incubated endothelium-denuded mesenteric
segments were incubated at room temperature for 10 minutes
in KHS (NaHCO3 and NaH2PO4 were omitted, unbuffered
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solution) containing 0.02 mmol/L glutathione and 1.46 mmol/L
of the neurotoxin 6-hydroxydopamine (6-OHDA). The pH of this
solution was adjusted to 4.9 with 0.05 mmol/L NaOH and then
the solution was covered with paraffin oil. Subsequently, the
arteries were immersed in normal KHS and EFS-induced
contraction experiments were performed.
The vasoconstrictor response of exogenous NA (1 nmol/L-10
µmol/L), and the vasodilator response to the NO donor
diethylamine NONOate (DEA-NO, 0.1 nmol/L–0.1 mmol/L)
were tested in mesenteric segments from all experimental
groups. The possible participation of superoxide anions (O2.-) in
the vasodilator response to DEA-NO was tested by incubation
with 0.1 mmol/L of the O2. - scavenger tempol.
Histamine and noradrenaline release
To measure histamine and NA release, we used a Histamine
Enzyme Immunoassay kit (Spibio, Berlin) and a Noradrenaline
Research EIA (Labor Diagnostica Nord, Gmbh & Co., KG),
respectively. Endothelium-denuded segments from control,
ketotifen-incubated (0.1 µmo/L, 3 hours) or tranilast-incubated
(0.1 mmo/L, 3 hours) mesenteric arteries were preincubated in
5 mL of KHS at 37°C and continuously gassed with a 95%
O2-5% CO2 mixture (stabilization period). This was followed by
two washout periods of 10 min in a bath of 0.4 mL of KHS.
Then the medium was collected to measure basal histamine or
NA release. Next, the organ bath was refilled, and cumulative
EFS periods of 30 s at 1, 2, 4, 8 and 16 Hz at 1 min intervals
were applied. Afterwards, the medium was collected to
measure EFS-induced histamine or NA release. The assay
was performed following the manufacturer’s instructions.
Results were expressed as nmol Histamine /mL mg tissue or
ng NA/mL mg tissue.
Nitric Oxide Release
Nitric oxide release was determined using the fluorescent
probe 4,5-diaminofluorescein (DAF-2), as previously described
[21]. Briefly, endothelium-denuded arteries were divided into
several experimental groups: control, and segments incubated
with ketotifen (0.1 µmol/L, 3 hours), tranilast (0.1 mmol/L, 3
hours), loratadine (1 µmol/L, 30 min) or famotidine (1 µmol/L,
30 min). After an equilibration period of 60 min in HEPES buffer
(in mmol/L: NaCl 119; HEPES 20; CaCl2 1.2; KCl 4.6; MgSO4
1; KH2PO4 0.4; NaHCO3 5; glucose 5.5; Na2HPO4 0.15; pH 7.4)
at 37°C, arteries were incubated with 2 µmol/L DAF-2 for 45
min. Then the medium was collected to measure basal NO
release. Once the organ bath was refilled, cumulative EFS
periods of 30 s at 1, 2, 4, 8 and 16 Hz at 1 min intervals were
applied. The fluorescence of the medium was measured at
room temperature using a spectrofluorimeter (LS50
PerkinElmer Instruments, FL WINLAB Software) with excitation
wavelength set at 492 nm and emission wavelength at 515 nm.
The EFS-induced NO release was calculated by subtracting
basal NO release from that evoked by EFS. Also, blank
samples were collected in the same way from segment-free
medium in order to subtract background emission. Some
assays were performed in the presence of 0.1 µmol//L TTX, 0.1
mmol/L L-NAME or 0.1 mmol/L 7-NI, a specific nNOS inhibitor,
to ensure the specificity of the method. The amount of NO
released was expressed as arbitrary units/mg tissue.
nNOs and P-nNOS expression
Western blot analysis of nNOS and phosphorylated nNOS
(P–NOS) expression was performed as previously described
[22,23]. Rabbit polyclonal antibody against nNOS (1:1000
dilution, Abcam), rabbit polyclonal antibody against P-nNOS
(1:1000 dilution, Abcam), and monoclonal anti-β-actin-
peroxidase antibody (1:50000, Sigma-Aldrich, Spain) were
used. Rat brain homogenates were used as a positive control.
Detection of O2-
O2- levels were measured using lucigenin
chemiluminescence, as previously described [22,24]. Briefly,
endothelium-denuded segments of control, ketotifen-incubated
(0.1 µmo/L, 3 hours) or tranilast-incubated (0.1 mmo/L, 3
hours) mesenteric arteries were equilibrated for 30 min in
HEPES buffer at 37°C, transferred to test tubes that contained
1 mL HEPES buffer (pH 7.4) containing lucigenin (5 µmol/L)
and then kept at 37 °C. The luminometer was set to report
arbitrary units of emitted light; repeated measurements were
collected during 5 min at 10 s intervals and averaged. 4,5-
Dihydroxy-1,3-benzene-disulphonic acid ‘‘Tiron’’ (10 mmol/L), a
cell permeant, non-enzymatic O2- scavenger-, was added to
quench the O2--dependent chemiluminescence. Some
segments were preincubated with 0.1 mmol/L tempol before
the experimental protocol was performed, in order to ensure
the specificity of the method. Also, blank measures were
collected in the same way without mesenteric segments to
subtract background emission.
3-nitrotyrosine (3-NT) detection
3-NT levels were determined using the Nitrotyrosine ELISA
kit from Abcam (Cambridge, UK). For this assay, frozen
endothelium-denuded segments of control, ketotifen-incubated
(0.1 µmo/L, 3 hours) or tranilast-incubated (0.1 mmo/L, 3
hours) mesenteric arteries were homogenized in PBS and
centrifuged at 600g for 10 min at 4°C. The supernatant was
then collected and used for the assay. 3-NT was measured
following the manufacturer’s protocol. Results were normalized
with protein content, using a DC protein assay kit (Bio-Rad
Laboratories, Hercules, CA, USA). Results are expressed as
ng 3-NT/mg protein.
Drugs used
L-NA hydrochloride, 6-hydroxydopamine (6-OHDA), ACh
chloride, diethylamine NONOate diethylammonium salt, TTX,
1400W, L -NAME hydrochloride, 7- nitroindazole, tempol,
phentolamine, DAF-2, lucigenin and tiron were purchased from
Sigma-Aldrich (Spain). Stock solutions (10 mmol/L) of drugs
were made in distilled water, except for NA, which was
dissolved in NaCl (0.9%)-ascorbic acid (0.01% w/v), and 7NI
and tempol, which were dissolved in DMSO. These solutions
were kept at -20°C and appropriate dilutions were made in
KHS on the day of the experiment.
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Data Analysis
The responses elicited by EFS or NA were expressed as a
percentage of the initial contraction elicited by 75 mmol/L KCl
for comparison between control, ketotifen-incubated and
tranilast-incubated segments. The relaxation induced by DEA-
NO was expressed as a percentage of the initial contraction
elicited by NA (Control: 995.5 + 14.6 mg; ketotifen: 1002.9 +
29.41 mg; tranilast: 946.7 + 28.47 mg, P> 0.05). Results are
given as mean + S.E.M. Statistical analysis was done by
comparing the curve obtained in the presence of the different
substances with the previous or control curve by means of
repeated measure analysis of variance (ANOVA) followed by
the Bonferroni post-hoc test. Some results were expressed as
differences of area under the curve (dAUC). AUC were
calculated from the individual frequency-response plots. For
dAUC, histamine, NO and NA release experiments, the
statistical analysis was done using one-way ANOVA followed
by Newman-Keuls post-hoc test. P< 0.05 was considered
significant.
Results
Perivascular mast cell detection
Mast cells were detected in the adventitial layer of
mesenteric arteries using toluidine blue staining (Figure 1).
Histamine release
Basal histamine release was significantly lower in ketotifen-
incubated and tranilast-incubated segments than in control
arteries. EFS increased histamine release in all experimental
groups, but the increase was greater in control segments.
Preincubation with TTX abolished EFS-induced histamine
release in all experimental conditions (Table 1).
Figure 1.  Mast cell localization by toluidine blue
staining.  Figure is representative of preparations from four
rats. Magnification: 400·X and 600 X.
doi: 10.1371/journal.pone.0073232.g001
Vasomotor Response to KCl
In endothelium-intact mesenteric segments, the
vasoconstrictor response to 75 mmol/l KCl was similar in all
experimental groups (Control, 964.3 ± 59.9 mg, 0.1 µmol/L
ketotifen, 913.6 ± 74.5 mg, 0.1 mmol/L tranilast ; 917.8 ± 65.2
mg; P > 0.05; n= 10 each group). Endothelium removal did not
alter KCl-induced vasoconstriction (Control, 976.3 ± 67.6 mg,
0.1 µmol/L ketotifen, 912.8 ± 62.7 mg, 0.1 mmol/L tranilast ;
915.5 ± 54.4 mg; P > 0.05; n= 10 each group).
Vascular responses to EFS
The application of EFS induced a frequency-dependent
contractile response in endothelium-intact mesenteric
segments. Four consecutive EFS curves were performed at 1-h
intervals in control mesenteric segments, and induced similar
contractions (Figure 2A). Preincubation with 10 nmol/L
ketotifen did not modify EFS-induced contractions, while
preincubation with 0.1 µmol/L or 1 µmol/L ketotifen for 1, 2 and
3 hours increased the contraction induced by EFS to a similar
extent (Figure 2B–2D). Preincubation with 0.1 mmol/L or 1
mmol/L tranilast for 1 or 2 hours induced a progressive
decrease in EFS-induced contractions that was stabilised after
3 hours. Preincubation with 10 µmol/L tranilast did not modify
EFS-induced contractions (Figure 2E–2G). For this reason, we
performed the following experiments preincubating with either
0.1 µmol/L ketotifen or 0.1 mmol/L tranilast during 3 hours.
Endothelium removal increased EFS-induced contractile
response similarly in segments from all experimental groups
(Figure 3A–3C). EFS-induced contractions were practically
abolished in segments from all experimental groups by the
blocker for nerve impulse propagation, TTX (0.1 µmol/L; table
2).
Vasodilator response to ACh
The vasodilator response to ACh was similar in all
experimental groups (Figure 3D, table 3).
Effect of ketotifen or tranilast on the nitrergic
component of vascular responses to EFS
Basal NO release was higher in control than in ketotifen- or
tranilast-incubated mesenteric segments (Figure 4A). EFS
Table 1. Effect of 0.1 µmol/L ketotifen and 0.1 mmol/L
tranilast on basal and EFS-induced histamine and NA
release.
 Histamine release NA release
 Basal EFS Basal EFS
Control 0.51 + 0.15 1.19 + 0.27* 6.65 + 0.99 9.25 + 1.13*
Ketotifen 0.15 + 0.03# 0.38 + 0.16*# 6.67 + 0.60 9.33 + 0.88*
Tranilast 0.19 + 0.02# 0.52 + 0.11*# 6.55 + 0.65 8.89 + 1.05*
TTX 0.58 + 0.09 0.66 + 0.17# 6.37 + 0.74 6.45 + 0.87#
This table presents histamine and NA levels released in basal and EFS conditions.
Results (means + SEM) are expressed as nmol histamine /mL mg tissue, or ng
NA/mL mg tissue. *P< 0.05 vs basal conditions. #P< 0.05 vs control. n= 6 animals
each group.
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increased NO release in all experimental groups, but the
increase was greater in control arteries (Figure 4A).
Preincubation with L-NAME (0.1 mmol/L), 7NI (0.1 mmol/L) or
TTX (0.1 µmol/L) practically abolished EFS-induced NO
release in arteries from either treatment group (table 4).
Additionally, preincubation with either the H1 receptor
antagonist loratadine (1 µmol/L) or the H2 receptor antagonist
famotidine (1 µmol/L) for 30 minutes did not modify basal or
EFS-induced NO release (table 4).
The expression of nNOS was not modified by incubation with
either ketotifen or tranilast (Figure 4B). P-nNOS expression
was decreased in homogenates from ketotifen- or tranilast-
incubated arteries compared to expression in control segment
homogenates (Figure 4B).
In NA-precontracted mesenteric segments (Control: 995.5 +
14.6 mg; ketotifen: 1002.9 + 29.41 mg; tranilast: 946.7 + 28.47
mg), DEA-NO (0.1 nmol/L–0.1 mmol/L) induced a
concentration-dependent relaxation that was greater in
segments preincubated with either mast cell stabilizer than in
control segments (Figure 4C, table 5). The O2- scavenger
tempol increased vasodilator response to DEA-NO in control
segments, but not in ketotifen- or tranilast- incubated segments
(Figure 5, table 5). Additionally, after subtracting the lucigenin
chemiluminescence obtained in the presence of tiron from that
obtained in its absence, the calculated tiron-quenchable
chemoluminescence was significantly lower in ketotifen-
incubated and tranilast-incubated segments than in control
Figure 2.  Vasoconstrictor response to EFS.  (A) Isometric
tension recording of the frequency-dependent contractions in
intact mesenteric artery segments from Wistar rats. Effect of
preincubation with 10 nmol ketotifen (B), 1 µmol/L ketotifen (C),
0.1 µmol/L ketotifen (D), 10 µmol/L tranilast (E), 0.1 mmol/L
tranilast (F) or 1 mmol/L tranilast (G) for 1, 2 and 3 hours on
frequency dependent contraction in mesenteric segments from
Wistar rats. Results (means ± S.E.M.) are expressed as a
percentage of tone induced by 75 mmol/L KCl. n= 10 animals
each group.
doi: 10.1371/journal.pone.0073232.g002
mesenteric segments. Preincubation of segments with tempol
strongly decreased the tiron-quenchable chemiluminescence
(Table 6). Additionally, 3-NT levels were decreased in
Figure 3.  Endothelium influence on vasoconstrictor
response to EFS.  Effect of endothelium removal on the
vasoconstrictor response to electrical field stimulation in control
(A), ketotifen-incubated (B) or tranilast-incubated (C)
mesenteric segments from Wistar rats. Results (means ±
S.E.M.) are expressed as a percentage of tone induced by 75
mmol/L KCl. n= 10 animals each group. Insert graph shows
differences of area under the curve (dAUC) in the absence or
presence of 01 μmol/L phentolamine, expressed as arbitrary
units. * P< 0.05 control vs. tranilast. (D) ACh-induced
vasodilation in endothelium-intact control, ketotifen-incubated
or tranilast-incubated mesenteric segments. Results (mean +
S.E.M.) were expressed as a percentage of the previous tone
elicited by exogenous NA. n = 6 animals each group.
doi: 10.1371/journal.pone.0073232.g003
Table 2. Effect of preincubation with tetrodotoxin (TTX, 0.1
µmol/L) or 6-hydroxydopamine (6-OHDA, 1.46 mmol/L) on
the frequency–contraction curves performed in control,
ketotifen-incubated (0.1 µmol/L) and tranilast-incubated (0.1
mmol/L) mesenteric segments.
 1 Hz 2 Hz 4 Hz 8 Hz 16 Hz
Control 9.2 + 1.7 27.6 + 3.5 45.9 + 3.4 62.6 + 3.3 79.1 + 3.7
TTX 0 0 0 0.5 + 0.04 0.9 + 0.2
6-OHDA 0 0 0.1 + 0.03 0.2 + 0.05 0.4 + 0.1
Ketotifen 17.8 + 1.7 34.9 + 4.1 53.5 + 4.8 69.6 + 3.8 90.1 + 2.6
TTX 0 0 0 0.2 + 0.01 0.6 + 0.1
6-OHDA 0 0 0.2 + 0.06 0.5 + 0.1 0.9 + 0.2
Tranilast 2.5 + 1.1 7.0 + 3.1 21.3 + 6.1 39.9 + 8.2 61.5 + 8.7
TTX 0 0 0 0 0.1 + 0.01
Results (means ± S.E.M.) are expressed as percentages of the response elicited
by 75 mM KCl; zeros are used when contraction was not detected. n = 5–7
animals.
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ketotifen-incubated and tranilast-incubated segments (In ng 3-
NT/mg protein: Controla: 1.71 + 0.31; 0.1 µmol/L ketotifenb:
0.92 + 0.06; 0.1 mmol/L tranilastc: 0.98 + 0.11; a-b, a-c P< 0.05; n
= 6 animals each group).
In line with these results, the contraction induced by EFS
was significantly increased by preincubation with the unspecific
NOS inhibitor L-NAME (0.1 mmol/L) in control segments, but it
did not have any effect in either ketotifen- or tranilast-treated
segments (Figure 6). The specific iNOS inhibitor 1400W did not
Table 3. Emax and log EC50 values of vasodilator responses
to ACh in control, ketotifen-incubated (0.1 μmo/L) or
tranilast-incubated (0.1 mmol/L) mesenteric arteries from
Wistar rats.
 Emax log EC50
Control 91.88 + 2.62 -6.98 + 0.09
Ketotifen 97.22 + 3.83 -7.07 + 0.13
Tranilast 90.64 + 3.68 -7.02 + 0.15
Results are expressed as means + S.E.M. n=6 animals each group.
Figure 4.  Effect of ketotifen and tranilast on neuronal NO
synthesis and vasodilation (A) Effect of preincubation with
ketotifen or tranilast on basal and EFS-induced NO release
in mesenteric segments.  n = 5 animals each group. Results
(means + S.E.M.) are expressed as arbitrary units (A.U.)/mg
tissue.
*P< 0.05 vs basal; # P< 0.05 vs control. (B) Western blot for
nNOS and P-nNOS expression in control, ketotifen- and
tranilast-incubated mesenteric segments. Figure is
representative of preparations from six samples in each group.
Lower panel shows relation between densitometric analyses for
P-nNOS vs. nNOS expression. * P< 0.05. (C) Vasodilator
response to DEA-NO in control, ketotifen- incubated and
tranilast-incubated mesenteric segments. Results (means +
S.E.M.) are expressed as a percentage of the inhibition of
contraction induced by NA. n = 6 animals each group.
doi: 10.1371/journal.pone.0073232.g004
modify EFS-induced contraction in any experimental group
(Figure 6).
Effect of preincubation with ketotifen or tranilast on
sympathetic innervation
Preincubation with 0.1 µmol/L ketotifen did not modify the NA
contractile response (0.1 nmol/L–10 µmol/L) (Figure 7A), while
the response was decreased in 0.1 mmol/L tranilast-
preincubated segments (Figure 7A). Both basal and EFS-
induced NA releases were not modified by preincubation with
either 0.1 µmol/L ketotifen or 0.1 mmol/L tranilast (Table 1).
The contraction elicited by EFS was significantly reduced by
the α-adrenoceptor antagonist, phentolamine (1 µmol/L), in
segments from control, ketotifen-incubated and tranilast-
incubated segments. The decrease was lower in tranilast-
incubated than in control mesenteric segments (Figure 7B–7D).
Preincubation with 6-OHDA practically abolished the EFS-
Table 4. Effect of preincubation with L-NAME (0.1 mmol/L),
7-nitroindazol (7-NI, 0.1 mmol/L), loratadine 7-NI, 1 mmol/L
loratadine, 1 mmol/L famotidine or 0.1 mmol/L TTX on
basal and EFS-induced NO release in control, ketotifen-
incubated (0.1 mmol/L) and tranilast-incubated (0.1 mmol/L)
mesenteric segments.
 Basal EFS
Control 0.28 + 0.05 0.95 + 0.09*
L-NAME 0.26 + 0.04 0.29 + 0.07#
7-NI 0.27 + 0.09 0.31 + 0.06#
Loratadine 0.32 + 0.07 0.92 + 0.13*
Famotidine 0.27 + 0.12 0.94 + 0.17*
TTX 0.25 + 0.03 0.28 + 0.11#
Ketotifen 0.07 + 0.01 0.23 + 0.11*
L-NAME 0.05 + 0.03 0.07 + 0.04#
7-NI 0.09 + 0.04 0.11 + 0.04#
TTX 0.06 + 0.03 0.07 + 0.03#
Tranilast 0.07 + 0.02 0.38 + 0.16*
L-NAME 0.06 + 0.01 0.09 + 0.04#
7-NI 0.06 + 0.02 0.08 + 0.03#
TTX 0.04 + 0.01 0.04 + 0.01#
Results (means ± S.E.M.) are expressed in arbitrary units (A.U.)/mg tissue. n =
6-10 animals each group. *P < 0.05 compared with the respective basal NO
release. #P < 0.05 compared with conditions without specific inhibitor.
Table 5. Emax and log EC50 values of vasodilator responses
to DEA-NO in control, ketotifen-incubated (0.1 µmol/L) or
tranilast-incubated
 Untreated Tempol-treated
 Emax log EC50 Emax log EC50
Control 101.5 + 2.16 -5.39 + 0.04 94.76 + 7.52 -6.10 + 0.18#
Ketotifen 99.11 + 8.40 -6.14 + 0.18* 101.10 + 2.38 -5.95 + 0.15
Tranilast 98.02 + 2.44 -6.33 + 0.07* 98.62 + 3.03 -6.38 + 0.08
Results are expressed as means + S.E.M. n= 6 animals each group. *P < 0.05 vs.
control segments. #P< 0.05 tempol incubated vs. unincubated segments.
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induced contraction in segments from control and ketotifen-
incubated mesenteric segments (Table 2).
Discussion
The results of the present study demonstrate for the first time
that the mast cell stabilizers ketotifen and tranilast modify EFS-
induced vasoconstriction differently in rat mesenteric arteries.
Ketotifen increased EFS-induced vasoconstriction, an effect
that seems to be mediated at least by a decrease in neuronal
NO release, while tranilast, although also decreasing neuronal
NO release, diminished EFS-induced contraction through a
decreased vasoconstrictor response to NA. The effect of these
drugs on neuronal NO release is mediated by a decrease in
nNOS phosphorylation.
Figure 5.  Effect of superoxide anions on NO-dependent
vasodilation.  Effect of 0.1 mmol/L tempol on the
concentration–response curves to DEA-NO in control (A)
ketotifen-incubated (B) and tranilast-incubated (C)
mesenteric segments.
Results (means + S.E.M.) are expressed as a percentage of
the inhibition of the contraction induced by NA. n=6 animals
each group.
doi: 10.1371/journal.pone.0073232.g005
Table 6. Effect of 0.1 µmol/L ketotifen or 0.1 mmol/L
tranilast on O2. - release. Effect of preincubation with 0.1
mmol/L tempol on O2. - release in control, ketotifen-
incubated and tranilast-incubated mesenteric segments.
 Untreated Tempol-treated
Control 103.4 + 8.2 5.4 + 1.3#
Ketotifen 54.2 + 1.6* 2.1 + 1.8#
Tranilast 39.1 + 2.8* 3.1 + 1.0#
Results (means + S.E.M.) are expressed in chemoluminescence units/ min mg
tissue. *P < 0.05 compared with control group. #P < 0.05 compared with conditions
without tempol. n= 6-10 animals each group.
The remarkable connection between innervation and mast
cells has attracted much interest. This aspect has been widely
studied in the abdominal cavity, where mast cell activation
modulates various gastrointestinal functions [9,25–28]. In the
current study, we have observed that mast cells are located in
the adventitial layer, and that histamine is released under basal
conditions indicating, that perivascular mast cells are tonically
activated. Neurotransmitter release has been described to alter
mast cell activation and their release of multiple mediators,
including histamine [11,12]. In the current study, histamine
release was enhanced by EFS. The fact that preincubation with
TTX abolishes EFS-induced histamine release reveals for the
first time that neurotransmitter release from mesenteric artery
innervation activates mast cell degranulation. Both basal and
EFS-induced histamine release were decreased by ketotifen or
tranilast incubation, confirming the stabilizing role of these
drugs.
The interplay of mast cells with perivascular neuronal
function and the possible functional consequences are highly
interesting when examining aspects of hemodynamic changes
when mast cells are stabilized. Thus, the current study was
designed to analyze the effect of mast cell stabilization on
perivascular innervationfunction. For this purpose, we studied
the effect of ketotifen and tranilast on the vasomotor response
produced by EFS in rat superior mesenteric arteries.
We first analyzed whether ketotifen and tranilast modified the
EFS-induced contraction observed in mesenteric segments. As
we showed in the Results section, after performing a time-
course pilot study, we considered it appropriate to perform
experiments with either 0.1 µmol/L ketotifen or 0.1 mmol/L
tranilast for 3 hours. EFS produced a frequency-dependent
Figure 6.  Effect of ketotifen or tranilast on nitrergic
innervation function.  Effect of preincubation with 0.1 mmol/L
L-NAME or 1 µmol/L 1400W on the frequency-response curves
in control (A) ketotifen-incubated (B) or tranilast-incubated (C)
mesenteric segments. Results (means + S.E.M.) are expressed
as a percentage of tone induced by 75 mmol/L KCl. n = 6
animals each group.
doi: 10.1371/journal.pone.0073232.g006
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contraction in endothelium-intact mesenteric segments from all
the experimental groups as reported in previous reports by our
group [22,23,29,30]. We observed that ketotifen and tranilast
had opposite effects: while preincubation with ketotifen
increased the contraction induced by EFS, tranilast decreased
that contraction. These modifications were not attributable to
changes in the intrinsic contractile machinery as was
demonstrated by the similar vasoconstrictor response to KCl in
all experimental groups. Endothelium removal increased
vasoconstrictor response to EFS to the same extent in the
three experimental groups, indicating that the modulating role
of endothelium is not modified by either ketotifen or tranilast.
The fact that ACh-induced vasodilation was not modified in any
experimental group reinforces this observation. Therefore,
these results indicate that the modifications observed after
preincubation with either ketotifen or tranilast are due to
modifications in perivascular innervation function, as was
confirmed by the abolishment of EFS-induced vasoconstriction
in the presence of TTX.
Superior mesenteric artery possesses different innervations,
mainly vasodilator nitrergic and vasoconstrictor sympathetic
innervations, which are implicated in the control of vascular
tone [6–8]. We analyzed the participation of each kind of
innervation in the vasoconstriction induced by EFS, and the
possible modifications in this participation that were induced by
either ketotifen or tranilast.
Figure 7.  Effect of ketotifen or tranilast on sympathetic
innervation function.  (A) Effect of preincubation with
ketotifen or tranilast on the vasocostrictor response curves to
noradrenaline. Effect of 0.1 µmol/L phentolamine on the
frequency-response curve in control (B), ketotifen-incubated
(C) or tranilast-incubated (D) segments. Results (means +
S.E.M.) are expressed as a percentage of tone induced by 75
mmol/L KCl.
n = 5-6 animals each group. Insert graph shows
differences of area under the curve (dAUC) in the absence
or presence of 01 μmol/L phentolamine, expressed as
arbitrary units. * P< 0.05 control vs. tranilast.
doi: 10.1371/journal.pone.0073232.g007
Ketotifen and tranilast have been reported to alter eNOS and
iNOS activity in several tissues [31–33]. However, to our
knowledge, there are no reports about possible alterations in
nNOS expression and/or activity in perivascular nerve endings.
Therefore, our next objective was to analyze the possible effect
of ketotifen and tranilast on neuronal NO release from nitrergic
nerve endings. Preincubation with ketotifen or tranilast
diminished both basal and EFS-induced NO release. The fact
that, in all cases, EFS-induced NO release was abolished by
preincubation with TTX, L-NAME, the non-specific NOS
inhibitor, or 7-nitroindazol (7-NI), the specific nNOS inhibitor,
confirms the neural origin of the NO release.
Besides its role as a mast cell membrane stabilizer, it has
been clearly demonstrated that ketotifen also possesses
powerful and sustained non-competitive histamine blocking
properties, as it antagonizes both the H1 and H2 histamine
receptors. The fact that neither the selective H1 antagonist
loratadine nor the selective H2 antagonist famotidine modified
either basal or EFS-induced NO release rules out the
participation of histamine receptors in this response.
NO released from nerve endings is biosynthesized by nNOS
[8,22,23,30]. Since preincubation with either ketotifen or
tranilast decreased both basal and EFS-induced NO release,
our next objective was to determine if these decreases
produced by ketotifen and tranilast were due to modifications in
nNOS expression and/or activity. We found that nNOS protein
expression was not modified. nNOS must be phosphorylated in
order to be activated. P-nNOS expression was decreased by
treatment with either ketotifen or tranilast. These results
indicate that the decreased NO release observed after
preincubation with either ketotifen or tranilast is due to a
decrease in nNOS activation. To our knowledge this is the first
study to demonstrate the actions of ketotifen and tranilast on
neuronal NO release from perivascular innervation in
mesenteric bed.
Previously, we have demonstrated in this rat strain that both
the non-selective NOS inhibitor L-NAME and the specific nNOS
inhibitor 7-NI decrease EFS-induced NO release to a similar
extent [30]. However, in vascular reactivity experiments,
preincubation with 7-NI also decreased vasoconstrictor
response to NA, making the analysis of EFS-induced
contractions very complex, and leading to result
misinterpretation [29,30]. For that reason, we used L-NAME in
vascular reactivity experiments. L-NAME did not modify EFS-
induced contractions in ketotifen or tranilast-incubated
segments, in contrast to the increase observed in control
segments, thus suggesting that both ketotifen and tranilast
decrease nitrergic innervation function. Preincubation with the
specific iNOS inhibitor 1400W did not modify vasoconstrictor
response to EFS, ruling out an iNOS participation in the effects
of ketotifen and tranilast.
Possible alterations in smooth muscle sensitivity to NO
cannot be ruled out. A decrease in O2- was observed in
ketotifen- and tranilast-incubated mesenteric segments, in
agreement with the previously described antioxidant effect of
both mast cell stabilizers [34,35]. Additionally, 3-NT detection,
used as a stable marker of peroxynitrite detection [36], showed
a marked decrease in segments preincubated with either
Mast Cell Stabilizers and Mesenteric Innervation
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ketotifen or tranilast. Therefore, both ketotifen and tranilast
could alter NO metabolism and bioavailability. The vasodilator
response to DEA-NO was increased by preincubation with
either ketotifen or tranilast. Preincubation with the O2-scavenger
tempol increased vasodilator response to DEA-NO in control
segments, but not in ketotifen or tranilast-incubated segments,
thus confirming a decreased NO metabolism through
decreased O2-release.
Therefore, ketotifen and tranilast induce two opposite effects:
a decrease in neuronal NO release, and an increase in NO
bioavailability due to a decrease in O2- formation. The net effect
is a decreased role for nitrergic innervation.
The fact that both ketotifen and tranilast exert the same
effect on neuronal NO release does not explain why they
produce opposite effects in the EFS-induced contractile
response. Therefore, different influences by ketotifen and
tranilast on the function of other innervations cannot be ruled
out. Given the principal role played by sympathetic innervation
in EFS-induced vasoconstriction [2,8], we analyzed the
possible influence of ketotifen and tranilast on EFS-induced
vasoconstriction. Vasoconstriction elicited by EFS was strongly
reduced by phentolamine in segments from all experimental
groups, indicating that this response was mediated mainly by
NA release from the adrenergic component of sympathetic
nerve terminals, with subsequent activation of α-adrenoceptors.
This decrease was similar in control and ketotifen-incubated
mesenteric segments. However, the decrease in EFS-induced
contraction obtained by preincubation with phentolamine was
lower in tranilast-preincubated segments, suggesting different
influences by ketotifen and tranilast on the adrenergic
component of sympathetic innervation. These differences could
be due to modifications in either NA release or vasoconstrictor
response to exogenous NA. When analysing NA release, we
observed that it was not modified by mast cell stabilization with
either ketotifen or tranilast. This result shows that the effect of
these drugs on EFS-induced vasoconstriction is not mediated
by changes in NA release. When concentration–response
curves to exogenous NA were performed, we observed that
ketotifen did not modify the vasoconstrictor response, while
tranilast decreased it. Taken together, these results confirm
that the adrenergic component of sympathetic innervation is
not affected by ketotifen in the mesenteric artery, as also
reported in other tissues [37]. However, although tranilast did
not affect NA release, it did reduce the contractile response, as
observed with other vasoconstrictor agents [18,38]. This effect
can be attributed to inhibition of the Ca2+ influx from the
extracellular environment and Ca2+ release from intracellular
Ca2+ stores, as previously reported [39,40]. The fact that
vasoconstriction produced by KCl remained unmodified in the
presence of tranilast suggests that this drug interferes with the
Ca2+ movement coupled to receptor activation, but not to the
movement induced by depolarization. This differential influence
on adrenergic innervation seems to be implicated in the
opposite results obtained when incubating with one mast cell
stabilizer or the other.
After preincubation with phentolamine, we observed a
remnant contractile response to EFS in control and ketotifen-
incubated segments, but not after tranilast treatment. This
result indicates that tranilast abolished the function of another
vasoconstrictor factor. The depletion of sympathetic innervation
in control and ketotifen treated segments by preincubation with
the neurotoxin 6-OHDA abolished the remant vasoconstriction,
thereby confirming that this contractile neurotransmitter has a
sympathetic origin in control and ketotifen-incubated segments.
This neurotransmitter could probably be ATP, as we have
previously observed in other experimental conditions [21,30].
Taken together, these results indicate that both ketotifen and
tranilast alter the vasoconstrictor response to EFS in rat
mesenteric artery, but in an opposite manner: ketotifen
increases EFS-induced contraction, while tranilast decreases it.
This fact is due to different actions by these drugs on the
sympathetic and nitrergic innervations: both ketotifen and
tranilast diminish nitrergic innervation function through a
decrease in nNOS activation, while tranilast also decreases
sympathetic innervation function, mainly through decreased NA
vasoconstriction. These results indicate that the election of the
mast cell stabilizer could be relevant, since it could induce
important hemodynamic changes.
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Abstract
Background and Purpose: Tranilast, in addition to its capacity to inhibit mast cell degranulation, has other biological
effects, including inhibition of reactive oxygen species, cytokines, leukotrienes and prostaglandin release. In the current
study, we analyzed whether tranilast could alter endothelial function in rat mesenteric resistance arteries (MRA).
Experimental Approach: Acetylcholine-induced relaxation was analyzed in MRA (untreated and 1-hour tranilast treatment)
from 6 month-old Wistar rats. To assess the possible participation of endothelial nitric oxide or prostanoids, acetylcholine-
induced relaxation was analyzed in the presence of L-NAME or indomethacin. The participation of endothelium-derived
hyperpolarizing factor (EDHF) in acetylcholine-induced response was analyzed by preincubation with TRAM-34 plus apamin
or by precontraction with a high K+ solution. Nitric oxide (NO) and superoxide anion levels were measured, as well as
vasomotor responses to NO donor DEA-NO and to large conductance calcium-activated potassium channel opener NS1619.
Key Results: Acetylcholine-induced relaxation was greater in tranilast-incubated MRA. Acetylcholine-induced vasodilation
was decreased by L-NAME in a similar manner in both experimental groups. Indomethacin did not modify vasodilation.
Preincubation with a high K+ solution or TRAM-34 plus apamin reduced the vasodilation to ACh more markedly in tranilast-
incubated segments. NO and superoxide anion production, and vasodilator responses to DEA-NO or NS1619 remained
unmodified in the presence of tranilast.
Conclusions and Implications: Tranilast increased the endothelium-dependent relaxation to acetylcholine in rat MRA. This
effect is independent of the nitric oxide and cyclooxygenase pathways but involves EDHF, and is mediated by an increased
role of small conductance calcium-activated K+ channels.
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Introduction
Mesenteric blood flow can constitute up to 20–30% of total
cardiac output [1] and is regulated by different mechanisms in
which endothelial factors like nitric oxide (NO), prostanoids and
endothelium-derived hyperpolarizing factor (EDHF) play a pivotal
role. Modifications in the release and/or participation of these
vasoactive substances can alter peripheral vascular resistance, with
the role of resistance vessels being especially relevant.
Mast cells play an important role in several physiological and
pathological situations such as intestinal motility, angiogenesis and
atherosclerosis [2–4]. When activated, mast cells secrete numerous
vasoactive and proinflammatory mediators, such as histamine,
serotonin, bradykinin, endothelin, NO, leukotrienes, prostaglan-
dins, or cytokines [5], which could alter vascular endothelial and
smooth muscle function [6]. These consequences are highly
interesting, particularly aspects of hemodynamic changes when
mast cells are stabilized. Tranilast was initially used to treat allergic
diseases due to its capacity to inhibit mast cell degranulation [7]
and has also been suggested in the treatment of multiple
inflammatory processes, including various pathologies where
blood flow is altered, such as in the vasodilation induced by
allergic processes [8–11].
Previously our group has described that lipopolysaccharide, a
model of endotoxic shock, influences vascular tone by modifying
both endothelial and neuronal factors [12,13]. Additionally, we
have studied the effect of tranilast on the vasoconstrictor response
produced by electrical field stimulation (EFS) in rat superior
mesenteric arteries, demonstrating that it diminished the vaso-
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e100356
constrictor response to EFS by decreasing noradrenaline-induced
vasoconstriction [14] although it did not influence endothelial
function in this artery, as similarly reported by Yang et al [15] in
rat aorta. However, mesenteric resistance arteries play a pivotal
role in the regulation of vascular resistance, and differences in
endothelial function have been previously described in different
vascular beds under the same experimental conditions [16,17].
With this in mind, the possible effect of tranilast on endothelial
function in resistance vessels may help induce hemodynamic
changes that could be relevant in the treatment of pathologies like
allergy.
Since total peripheral resistance mainly depends on resistance
vessels, and the role that mesenteric resistance arteries play in this
is very relevant, we consider it very important to analyze the
possible alterations tranilast may produce in the endothelial
function of these vessels.
Materials and Methods
Ethics Statement
All animals were housed in the Animal Facility of the
Universidad Auto´noma de Madrid (Registration number EX-
021U) in accordance with directive 609/86 of the E.E.C., R.D.
233/88 of the Ministerio de Agricultura, Pesca y Alimentacio´n of
Spain, and Guide for the Care and Use of Laboratory Animals
published by the USA National Institutes of Health [NIH
publication No. 85.23, revised 1985]. The experimental protocol
was approved by the Ethics Committee of the Universidad
Auto´noma de Madrid.
Animals
We used 6 month-old male Wistar rats. Rats were sacrificed by
CO2 inhalation followed by decapitation; the mesenteric vascular
bed was removed and placed in cold (4uC) Krebs-Henseleit
solution (KHS; in mmol/L: 115 NaCl, 2.5 CaCl2, 4.6 KCl, 1.2
KH2PO4, 1.2, MgSO4.7H2O, 25 NaHCO3, 11.1 glucose, and
0.03 EDTA).
Perivascular mast cell detection
The third-order branches from mesenteric resistance arteries
were fixed in 4% formaldehyde in phosphate buffered saline
solution (PBS, pH = 7.4) for 1 hour, cryoprotected with 30%w/v
sucrose in PBS (overnight), transferred to a cryomold containing
Tissue-Tek OCT embedding medium (20 min) and then imme-
diately frozen in liquid nitrogen. All samples were kept at 270uC
until the day of the experiments. Frozen tissue segments were cut
into 10 mm thick sections, placed on glass slides and stained with
0.1% Toluidine Blue (3 min) for perivascular mast cell detection,
as previously described [14]. Sections were coverslipped and light
microscopy images were taken (Nikon Eclipse TE2000-S [inverted
microscope], Nikon DXM1200F [digital camera]).
Vascular reactivity study
For reactivity experiments the third-order branch of the
mesenteric arcade was dissected and cut in segments of
approximately 2 mm in length. Segments of mesenteric resistance
arteries were mounted in a small vessel chamber myograph
(Danish Myo Technology A/S, A¨arhus, Denmark) to measure
isometric tension according to the method described by Mulvany
and Halpern [18]. After a 15-min equilibration period in
oxygenated KHS at 37uC and pH 7.4, segments were stretched
to their optimal lumen diameter for active tension development.
Optimal lumen diameter was determined based on the internal
circumference/wall tension ratio of the segments by setting the
internal circumference, L 0, to 90% of what the vessels would have
if they were exposed to a passive tension equivalent to that
produced by a transmural pressure of 100 mmHg [18]. Optimal
lumen diameter was determined using specific software for
normalization of resistance arteries (DMT Normalization Module;
ADInstruments Pty Ltd, Castle Hill, Australia). Segments were
washed with KHS and left to equilibrate for 30 min. Vessel
contractility was then tested by an initial exposure to a high-K+
(120 mmol/L) solution.
After washout, segments were contracted with a concentration
of noradrenaline that induced approximately 50%–70% of the
maximum contraction elicited by KCl, and then acetylcholine
(1 mmol/L) was added to assess the integrity of the endothelium.
Some segments were subjected to mechanical endothelium
removal. The absence of endothelium was confirmed by the
inability of acetylcholine (1 mmol/L) to induce relaxation.
Endothelium removal did not modify KCl- (120 mmol/L) induced
contraction.
Since the level of smooth muscle constriction can itself
antagonize the extent of the endothelium-dependent relaxation,
we performed the following experiments adjusting the dose of NA
or KCl to a concentration which allowed us to reach a 50–70% of
the maximum contraction elicited by KCl.
Experimental protocols
The segments were rinsed with KHS for 1 h and then a
cumulative concentration-response curve to ACh (0.1 nmol/L to
3 mmol/L) was obtained in noradrenaline-precontracted segments
preincubated or not with tranilast (100 mmol/L, 1 hour, time and
dose obtained from previous pilot studies). The concentration of
tranilast used and the time of incubation were from previous pilot
studies, performed similarly to our previous study [14]. Addition-
ally, vasoconstrictor responses to alpha-adrenergic agonist nor-
adrenaline (10 nmol/L to 0.1 mmol/L) were performed in both
control and tranilast-incubated segments.
The possible role of NO in ACh-induced relaxation was
investigated in tranilast-treated and untreated segments by
preincubation with 100 mmol/L L-NAME (a non-selective nitric
oxide synthesis inhibitor) before performing concentration-re-
sponse curves to ACh. Additionally, endothelium-independent
relaxation was studied by evaluating relaxation to NO donor
DEA-NO (10 nmol/L to 300 mmol/L) in arteries previously
contracted with noradrenaline.
The role of EDHF in the ACh-induced relaxation was analyzed.
For this purpose, the vasodilator response to ACh in segments
precontracted high K+ solution (at a concentration that produced
approximately 50–70% of the contraction induced by 120 mM
KCl) was studied. Additionally, the effect of a calcium-activated
potassium channel blockade, produced by apamin (1 mmol/L) plus
TRAM-34 (0.1 mmol/L), on the ACh response was analyzed in
NA-precontracted arteries pretreated or not with tranilast. In
another set of experiments, the effect of L-NAME plus TRAM-34
plus apamin on ACh-induced relaxation was studied. To
determine whether tranilast modified the participation of each
potassium channel individually, concentration response curves to
acetylcholine were performed in the presence of L-NAME plus
apamin or L-NAME plus TRAM-34. All drugs were added
30 min before the concentration-response curve to ACh. Addi-
tionally, to rule out an effect of tranilast on NO mediated
hyperpolarization, concentration-response curves to DEA-NO
were performed in control and tranilast-incubated mesenteric
segments precontracted with a high K+ solution.
The effect of tranilast on the smooth muscle calcium-activated
potassium channels was analyzed. For this purpose, the relaxation
Effect of Tranilast on Endothelial Function
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e100356
produced by NS1619 (10 nmol/L-100 mmol/L), a large conduc-
tance calcium-activated potassium channel opener, was analyzed
in NA-precontracted endothelium-denuded arteries preincubated
or not with tranilast.
The participation of COX-derived metabolites was investigated
in tranilast-treated and untreated segments. Arteries were prein-
cubated with the non-specific COX inhibitor indomethacin
(10 mmol/L) before performing concentration-response curves to
ACh.
Nitric Oxide release
Nitric oxide release was determined using the fluorescent probe
4,5-diaminofluorescein (DAF-2), as previously described [19].
Briefly, the second, third and fourth branches of mesenteric artery
were divided in two experimental groups: control and tranilast-
incubated segments (100 mmol/L, 1 hour). After an equilibration
period of 30 min in HEPES (in mmol/L: 119 NaCl, 20 HEPES,
46 KCl, 1 MgSO4.7H2O, 0.15 Na2HPO4.12H2O, 0.4 KH2PO4,
5 NaHCO3, 1.2 CaCl2.2H2O, 5.2 glucose) at 37uC, arteries were
incubated with 2 mmol/L DAF-2 for 45 min and medium was
collected to measure basal NO release. Once the organ bath was
refilled, ACh-induced NO release was measured after an ACh
concentration-curve (0.1 nmol/L - 3 mmol/L) was applied at 2-
min intervals each dose. The fluorescence of the medium was
measured at room temperature using a spectrofluorimeter (LS50
Perkin Elmer Instruments, FL WINLAB Software) with excitation
wavelength set at 492 nm and emission wavelength at 515 nm.
The stimulated NO release was calculated by subtracting the basal
NO release from that evoked by ACh. Also, blank measurement
samples were collected from medium without mesenteric segments
in order to subtract background emission. Some assays were
performed in the presence of L-NAME in order to assure assay
specificity. The amount of NO released was expressed as arbitrary
units/mg tissue.
Detection of superoxide anions
Superoxide anions levels were measured using lucigenin
chemiluminescence, as previously described [20]. Briefly, the
second, third and fourth branches of mesenteric artery, divided in
two experimental groups, control and tranilast-incubated segments
(100 mmol/L, 1 hour), were equilibrated for 30 min in HEPES
buffer at 37uC, transferred to test tubes that contained 1 mL
HEPES buffer (pH 7.4) containing lucigenin (5 mmol/L) and then
kept at 37uC. The luminometer was set to report arbitrary units of
emitted light; repeated measurements were collected during 5 min
at 10 s intervals and averaged. 4,5-dihydroxy-1,3-benzene-dis-
ulphonic acid ‘‘Tiron’’ (10 mmol/L), a cell permeant, non-
enzymatic superoxide anion scavenger, was added to quench the
superoxide anion-dependent chemiluminescence. Also, blank
samples were collected in the same way without mesenteric
segments to subtract background emission.
Drugs
Drugs used were tranilast, atropine, noradrenaline hydrochlo-
ride, acetylcholine chloride, DEA-NO, indomethacin, apamin,
tiron, TRAM-34, NS1619 (Sigma; St. Louis, MO, U.S.A.). Stock
solutions of acetylcholine, apamin, tiron, TRAM-34 and DEA-
NO were made in distilled water, noradrenaline was dissolved in a
NaCl (0.9%)-ascorbic acid (0.01% wv-1) solution; indomethacin
was dissolved in ethanol;tranilast, NS1619 was dissolved in
dimethyl sulfoxide. These solutions were kept at 220uC and
appropriate dilutions were made on the day of the experiment.
Statistical analysis
Contractions to noradrenaline were expressed as the percentage
of contraction of the maximum contractile response induced by a
previous contraction of KCl. Relaxation to ACh, DEA-NO and
NS1619 were expressed as a percentage of the level of
preconstriction induced by noradrenaline or KCl. For each
concentration-response curve the maximum effect (Emax) and
the concentration of agonist that produced half of the Emax (log
EC50) were calculated using non-linear regression analysis
(GraphPad Prism Software, San Diego, CA). The sensitivity of
the agonists is expressed as pD2 (2log EC50).
All values are expressed as means 6 S.E.M. of the number of
animals used in each experiment. Statistical analysis was done by
comparing the curve obtained in the presence of the different
substances with the control curve by means of a non-repeated
measure analysis of variance (ANOVA) followed by the Bonferroni
post-hoc test. Some results were expressed as differences of area
under the curve (dAUC). AUC were calculated from the
individual concentration-response plots. For dAUC, NO and
superoxide anion release experiments, the statistical analysis was
done using one-way ANOVA followed by Newman-Keuls post-
hoc test. P,0.05 was considered significant.
Results
Mast cells were detected in the adventitial layer of mesenteric
arteries using toluidine blue staining (Figure 1).
Preincubation with 100 mmol/L tranilast did not modify
vasoconstrictor response to 120 mmol/L KCl (Control:
14.561.5 mN; Tranilast: 15.161.3 mN/mm; p.0.05), while it
shifted the noradrenaline-induced contractile curve to the right
(Figure 2A). Cumulative addition of ACh evoked endothelium-
dependent relaxations in noradrenaline-contracted arteries.
10 mmol/L and 1 mmol/L tranilast concentrations did not
produce any modification on ACh-induced vasodilation in 1–3
hours incubations (Results not shown), while 1 hour-preincubation
with 100 mmol/L tranilast shifted the concentration response
curve to ACh to the left (Figure 2B and Table 1).
NO synthase inhibitor L-NAME decreased ACh-induced
relaxation to a similar extent in both control and tranilast-
incubated mesenteric segments (Figures 3A and 3B, Table 1).
Relaxation to DEA-NO was not changed by tranilast either in
NA-precontracted or in KCl-precontracted mesenteric arteries
(Figures 3C, Table 2). In line with this, both basal and ACh-
Figure 1. Mast cell localization by toluidine blue staining. Figure
is representative of preparations from four rats. Magnification: 400X
(general vision) and 600X (inset).
doi:10.1371/journal.pone.0100356.g001
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stimulated NO releases were similar in tranilast-treated and
untreated mesenteric resistance arteries (Figure 3D). Preincubation
with L-NAME abolished NO release in all experimental groups
(results not shown). Superoxide anion release was similar in both
tranilast-treated and untreated segments (In chemiluminiscence
units/min mg tissue: Control: 10.9263.5; Tranilast: 12.0363.7;
P,0.05.).
The concentration response curve to ACh was shifted to the
right in KCl-precontracted segments after preincubation with
100 mmol/L tranilast (Figure 4A and 4B). Similarly, preincubation
with apamin plus TRAM-34 shifted the ACh-induced relaxation
leftward to a greater extent in tranilast-incubated segments than in
control segments (Figure 4C and 4D). Combined preincubation
with L-NAME plus TRAM-34 reduced ACh-induced relaxation
similarly in both control and tranilast-incubated segments.
However, preincubation with both L-NAME and apamin shifted
the ACh-induced relaxation to the left more markedly in tranilast-
incubated segments. The remnant vasodilation observed after
preincubation with L-NAME plus TRAM-34 was higher in
tranilast-incubated compared to control segments, while it was
similar in both experimental conditions after preincubation with
L-NAME plus apamin. (Figure 5). Vasodilator response to
NS1619 remained unmodified in presence of tranilast. (Figure 6).
In tranilast-treated and untreated segments, ACh-induced
vasodilation was not modified by indomethacin (Figure 7,
Table 1). In line with this, the combined inhibition of NO and
EDHF through preincubation with L-NAME plus apamin plus
TRAM-34 abolished the increase in relaxation to ACh produced
by tranilast (Figure 7, Table 1).
Discussion
The present results show that tranilast increased the endothe-
lium-dependent relaxation to ACh in rat mesenteric resistance
arteries. This effect is independent of the NO or COX pathways
and seems to be mediated by an increase in EDHF contribution.
Under physiological conditions, mast cells have been identified
in several locations in the mesentery, including around the
mesenteric vessels [14,21]. When activated, mast cells secrete
numerous vasoactive and proinflammatory mediators, such as
histamine, serotonin, bradykinin, endothelin, NO, leukotrienes,
prostaglandins, or cytokines [5], which could alter vascular
endothelial and smooth muscle function [22]. Tranilast is a mast
cell stabilizer used in various pathologies where blood flow is
altered [8–11], such as allergy, which produces an intense
vasodilation produced by histamine release from mast cells. In
this study we have located perivascular mast cells around
mesenteric resistance vessels, as has been described in superior
mesenteric artery [14]. Previously, we have described that tranilast
decreases EFS-induced vasoconstriction in superior mesenteric
arteries [14]. Since total peripheral resistance mainly depends on
Table 1. Effect of indomethacin, L-NAME, Apamin plus TRAM-34 or L-NAME plus Apamin plus TRAM-34 on Emax and pD2 to
acetylcholine in untreated and tranilast-treated MRA.
Untreated Tranilast-treated
Emax pD2 Emax pD2
Control 87.662.03 7.4360.04 93.561.64 8.1260.04+
Indomethacin 85.562.51 7.4460.06 97.165.83 8.1160.13+
L-NAME 71.463.09* 7.2760.07 87.162.18+ 7.6960.11*+
Apamin+TRAM-34 43.565.55* 7.2960.12 46.6.562.82* 7.4760.11*
L-NAME+Apamin+TRAM-34 4.3362.60* - 3.8362.21* -
Values represent means 6 S.E.M.
*P,0.05 vs. situation without specific drugs;
+P,0.05, Tranilast-treated vs. untreated.
doi:10.1371/journal.pone.0100356.t001
Figure 2. Effect of tranilast on endothelial function. NA-induced vasoconstriction in control and tranilast-treated mesenteric resistance arteries
(A).Endothelium-dependent relaxation induced by ACh in NA-precontracted control and tranilast-treated rat resistance arteries (B) Results are
expressed as mean 6 S.E.M. *P,0.05 control vs. tranilast. N = 6–7 animals each group.
doi:10.1371/journal.pone.0100356.g002
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resistance vessels, and the role that mesenteric resistance arteries
play in this is very relevant, we consider it very important to
analyze the possible alterations tranilast may produce in the
endothelial function of these vessels. When analyzing endotheli-
um-dependent relaxation induced by ACh in mesenteric resistance
arteries, we observed an increase in this vasodilator response in
segments preincubated with tranilast. Similar changes in the
endothelial function observed in several pathologic situations in
these vessels are associated to decreased vascular resistance and
subsequent hemodynamic changes [19,23]. This outcome con-
trasts with previous studies, in which ACh-induced vasodilation
was not modified by tranilast in superior mesenteric artery or
aorta, despite the longer treatment period used [14,15]. These
results indicate that tranilast can modify endothelial factor release
and/or sensitivity differentially depending on the vascular bed
analyzed, which is not surprising since we have previously
described a similar effect in these vascular beds [24], probably
associated to differences in the composition of endothelial factors.
Previous studies show that endothelial dysfunction is related to
an increase in the vasoconstrictor responses to different agonists
and vice versa [20,25,26]. In our experimental conditions,
vasoconstriction produced by KCl remained unmodified in the
presence of tranilast, similar to observations in superior mesenteric
arteries [14], suggesting that this drug does not modify vascular
contractile capacity. Additionally, when analyzing the vasocon-
strictor response to the alpha-adrenergic agonist noradrenaline, we
observed that response was decreased in tranilast-incubated
segments, similarly to descriptions in superior mesenteric artery
[14], but in contrast to observations in rat aorta [15].
The relaxation evoked by ACh is mediated, depending on the
vascular bed analyzed, by the release of endothelium-dependent
relaxing factors such as NO, prostacyclin, and EDHF [27–29]. In
Table 2. Emax and pD2 values of DEA-NO in untreated and tranilast-treated MRA.
Untreated Tranilast-treated
Emax pD2 Emax pD2
NA-precontracted 96.9565.12 5.7860.13 94.2564.46 5.7360.10
KCl-precontracted 70.8963.31* 5.8760.23 72.9764.07* 5.6160.12
Values represent means 6 S.E.M.
*P,0.05 KCl precontraction vs. NA precontraction.
*P,0.05 NA-precontracted vs. KCl precontracted.
doi:10.1371/journal.pone.0100356.t002
Figure 3. Participation of NO on the vasodilator response to acetylcholine. Effect of L-NAME (100 mM) on the concentration-dependent
relaxation to ACh in control (A) and tranilast-treated (B) mesenteric resistance arteries. Insert graph shows the differences of area under the curve
(dAUC) in control and tranilast-treated arteries pre-treated with L-NAME. Results are expressed as mean 6 SEM. N= 6–7 animals in each group. (C)
Vasodilator response to DEA-NO in control and tranilast-incubated mesenteric resistance arteries, precontracted with either noradrenaline or KCl.
Results are expressed as mean 6 S.E.M. N = 5–6 animals each group. (D) Effect of tranilast on basal and acetylcholine-induced NO release in rat
mesenteric resistance arteries. Results (mean 6 S.E.M.) are expressed as arbitrary fluorescence units (A.U.)/mg tissue. N = 4 animals each group. *P,
0.05 vs. basal.
doi:10.1371/journal.pone.0100356.g003
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Figure 4. Participation of EDHF in the vasodilator response to acetylcholine. Relaxation to acetylcholine in control (A) and tranilast-treated
arteries (B) pre-contracted with KCl. Effect of preincubation with 1 mM apamin plus 0.1 mM TRAM-34 on endothelium-dependent relaxation to
acetylcholine in noradrenaline-pre-contracted control (C) and tranilast-treated arteries (D). Insert graph shows the differences of area under the curve
(dAUC) in control and tranilast-treated arteries either preconstricted with KCl or pre-treated with TRAM-34 plus Apamin. Results are expressed as
mean 6 SEM. *P,0.05 control vs. tranilast. N = 5–7 animals in each group.
doi:10.1371/journal.pone.0100356.g004
Figure 5. Participation of potassium channels in the vasodilator response to acetylcholine. Effect of preincubation with 100 mmol/L L-
NAME plus 1 mM apamin or plus 0.1 mM TRAM-34 on endothelium-dependent relaxation to acetylcholine in noradrenaline-pre-contracted control (A)
and tranilast-treated arteries (B). Results are expressed as mean 6 SEM. *P,0.05 control vs. tranilast N = 5–7 animals in each group. (C) Differences of
area under curve (dAUC) in the absence or presence of 100 mmol/L L-NAME plus 1 mM apamin or plus 0.1 mM TRAM-34. Results are expressed as
mean 6 SEM. dAUC values are expressed as percentage. *P,0.05 control vs. tranilast. N = 5–7 animals each group. (D) Representation of remnant
acetylcholine-induced vasodilation after preincubation with 100 mmol/L L-NAME plus 1 mmol/L apamin or plus 0.1 mM TRAM-34, expressed as mean
6 SEM of percentage of AUC. *P,0.05 control vs. tranilast. N = 5–7 animals each group.
doi:10.1371/journal.pone.0100356.g005
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rat mesenteric resistance arteries this relaxation is mainly mediated
by the release of NO and EDHF [30], but not by COX-derived
products [31]. Contradictory effects of tranilast on NO release
have been described, since both increases [32], decreases
[14,33,34] and no modifications [15] of NO release have been
reported in several tissues after tranilast preincubation. Addition-
ally, multiple studies have described an antioxidant effect of
tranilast treatment in both in vivo and in vitro experimental
procedures [14,32,33,35–39]. With this in mind, the effects
produced by tranilast in ACh-induced vasodilation could be
mediated by changes in NO synthesis and/or bioavailability. In
order to analyze this possibility, we preincubated control and
tranilast-exposed mesenteric resistance segments with the non-
specific NOS inhibitor L-NAME. We observed that, after
preincubation with this drug, ACh-induced relaxation was
decreased to a similar extent in both experimental conditions
indicating that NO does not participate in the effect observed after
preincubation with tranilast. This was confirmed by the fact that
NO release, superoxide anion formation and vasodilator response
to NO donor DEA-NO were not modified after preincubation
with tranilast, similarly to reported in rat aorta [15]. All these
results contrast with our previous results in superior mesenteric
artery, where we observed decreases in neuronal NO and
superoxide anion releases and an increase in the vasodilator
response to DEA-NO after tranilast preincubation [14]. In
conclusion, the results obtained in the present study confirm the
fact that the increased vasodilator response to ACh produced by
tranilast is not due to modifications in the NO pathway.
Hyperpolarizing mechanisms are important regulators of the
membrane potential and hence of vessel tone [29], this mechanism
being particularly important in small arteries and arterioles.
Although controversial, NO has been described to exert a
hyperpolarizing role in several vascular beds [40,41]. This
hyperpolarization produced by NO can be due to an activation
of different potassium channels, including large-conductance
calcium dependent potassium channels and voltage-dependent
potassium channels [42]. Thus, the effects of tranilast on non-
membrane potential-dependent actions of DEA-NO were inves-
tigated in arteries preconstricted with a high K+ solution, thus
blocking hyperpolarization by decreasing the plasma membrane
potassium gradient [43]. The results showed that, in KCl-
precontracted arteries, the vasodilator response induced by
DEA-NO was reduced to a similar extent in control and
tranilast-incubated mesenteric segments, confirming the hyperpo-
larizing role of NO in this vascular bed, and also that this effect is
not altered by tranilast.
EDHF plays, in addition to NO, an important vasodilator role
in resistance vessels. The relaxation induced by EDHF is
endothelium-dependent, insensitive to inhibition by a combination
of NOS and COX inhibitors, and leads to hyperpolarization of
vascular smooth muscle cells [44]. In order to determine whether
the increase in ACh-induced vasodilation induced by tranilast is
due to an increase in EDHF participation, control and tranilast-
incubated mesenteric resistance arteries were precontracted with a
high K+ solution. We observed that, in this experimental
condition, vasodilation to ACh was reduced in both control and
tranilast-incubated segments, but more markedly in segments
exposed to tranilast. Initially, the EDHF-mediated response was
attributed to activation of small, intermediate and large conduc-
tance calcium-activated K+-channels, although the participation of
the latter has been questioned [45–49]. In presence of a
combination of small (SKCa) and intermediate conductance
calcium-activated K+-channel (IKCa) blockers (apamin+TRAM-
34, respectively), we also observed a greater inhibition of the ACh-
induced vasodilation in tranilast-preincubated segments compared
to control segments. However, a differential effect of tranilast on
each type of calcium-activated potassium channel must also be
considered. The fact that a combined preincubation with L-
NAME plus TRAM-34 decreased ACh-induced relaxation
Figure 6. Vasodilator response to K+-channel openers. Effect of
tranilast on the relaxation to the large conductance calcium-activated
K+-channel opener NS1619 in de-endothelized rat mesenteric arteries.
Results are expressed as mean 6 SEM. N= 5–7 animals in each group.
doi:10.1371/journal.pone.0100356.g006
Figure 7. Participation of prostanoids in the vasodilator response to acetylcholine. Effect of preincubation with 10 mM indomethacin or
with 100 mmol/L L-NAME plus 1 mM apamin plus 0.1 mM TRAM-34 on the concentration-dependent relaxation to ACh in control (A) and tranilast-
treated (B) rat mesenteric resistance arteries. Results are expressed as mean 6 S.E.M. *P,0.05 control vs. tranilast. N = 6–7 animals in each group.
doi:10.1371/journal.pone.0100356.g007
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similarly in both experimental conditions, while a combination of
L-NAME plus apamin produced a more marked decrease in ACh-
induced relaxation in tranilast-incubated segments, suggests a
greater participation of SKCa channels through tranilast prein-
cubation. These findings indicate that hyperpolarization produced
by EDHF is responsible for the tranilast-mediated effects on the
ACh-induced dilation in mesenteric resistance arteries, due to an
increased SKCa channel participation after preincubation with
tranilast. Since the importance of the hyperpolarizing mechanism
in endothelium-dependent relaxations increases as the vessel size
decreases [50,51], this result can explain the difference in the effect
of tranilast on ACh-induced vasodilation previously observed in
superior mesenteric artery and aorta, where the role of EDHF in
endothelium-dependent relaxation is essentially absent [14,15].
The greater participation of EDHF in ACh-induced response in
tranilast-incubated arteries may be associated to an increase in
potassium channel activation by EDHF or to an increase in EDHF
generation. The fact that the vasodilation induced by NS1619 (a
large conductance calcium-activated K+-channel opener) was not
altered in the presence of tranilast seems to rule out a greater
activation of these channels by the tranilast effect. However, we
must take into account that these channels are also present in
endothelial cells, whose activation alters the release of several
vasoactive substances [52–56]. Taken together our results indicate
that tranilast increases the vasodilator response to ACh through a
mechanism that implicates a greater participation of EDHF. This
effect seems to be associated with a greater activation of SKCa
channels, without modifying the participation of IKCa channels,
As we have previously reported [31], COX-derived products do
not participate in the relaxation induced by ACh in control
situations in mesenteric resistance arteries. However, in some
pathological situations, such as hyperaldosteronism, we have also
described participation by COX-derived products in vascular
function, including relaxation to ACh [19,31]. In the present
study, the COX inhibitor indomethacin did not affect the
relaxation to ACh in the absence or presence of tranilast,
confirming the non-participation of COX-derived products in
both experimental conditions. The fact that in the presence of L-
NAME plus TRAM-34 plus apamin the relaxation to ACh was
abolished confirmed this observation, since it demonstrates that
the vasodilator response to ACh is only due to NO and EDHF in
these experimental conditions.
In summary, tranilast increased the endothelium-dependent
relaxation to acetylcholine in rat mesenteric resistance arteries.
This effect is independent of the NO and COX pathways but
involves EDHF, and is mediated by an increased role of small
conductance calcium-activated K+ channels. Similar alterations in
endothelial function in this vascular bed have been associated to
altered splanchnic circulation and the development of organ
failure [19]. Therefore, these results lead us to consider it
important to evaluate the hemodynamic conditions of patients
receiving treatment with tranilast.
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La amplitud de resultados obtenidos en esta Tesis doctoral nos permite realizar una serie 
de consideraciones generales. 
A lo largo de los años 70 diversos estudios histoquímicos y funcionales demostraron la 
presencia de inervación adrenérgica en arteria mesentérica de rata (Lindquist 1971; 
Furness y Marshall, 1974). El papel del sistema nervioso simpático en el control de la 
homeostasis cardiovascular y el control del tono vascular, ha sido desde entonces, 
ampliamente estudiado, así como su implicación en el desarrollo de enfermedades 
cardiovasculares (Seravalle y cols., 2014). El neurotransmisor principal de la inervación 
simpática es el vasoconstrictor NA. A partir de mediados de los años setenta diversos 
datos indicaron la existencia en las terminaciones nerviosas adrenérgicas de los 
cotransmisores ATP con un efecto vasoconstrictor y NPY con una función moduladora 
(Burnstock G 1987, 1995) 
La presencia de la denominada inervación no adrenérgica no colinérgica (NANC) en 
diferentes lechos vasculares de distintas especies fue descrita en los años 70 y 80 y se 
postularon múltiples sustancias como mediadores de este tipo de inervación (Toda 
2003). En este sentido en 1990 surgió la hipótesis de que el NO actuaba como 
neurotransmisor vasodilatador en arteria cerebral de perro (Toda 1975). Aunque durante 
años se cuestionó la función de la inervación nitrérgica en distinto lechos vasculares 
incluyendo el mesentérico (Toda 2003; Amerini y cols., 1993), resultados previos de 
nuestro grupo y los obtenidos en esta tesis doctoral demuestran la presencia de 
inervación nitrergica funcional en las distintas cepas de rata analizadas, ya que en 
presencia de L-NAME la respuesta vasoconstrictora inducida por EE se incrementa 
entre un 25-30%. La discrepancia en los resultados referidos por los distintos 
investigadores puede deberse a diferencias experimentales. Mientras que en nuestro 
caso la EE se aplica sobre la arteria con un tono similar al fisiológico y en ausencia de 
tratamiento farmacológico, estos autores utilizan bloqueantes ganglionares y la EE se 
aplica en las arterias precontraídas con una concentración elevada de agonistas α-
adrenérgicos. De acuerdo con los resultados obtenidos en la arteria peneana, esta 
metodología condicionaría la función de la inervación nitrérgica, disminuyendo la 
liberación de NO, ya que se ha descrito que su liberación neuronal se 
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inhibe presinápticamente a través de receptores α2-adrenérgicos (Simonsen y cols.,. 
1997) Nuestra observación de que la participación del NO neuronal disminuya a medida 
que incrementamos la frecuencia de EE, en la cual se libera una cantidad de NA 
dependiente de frecuencia, refuerza esta hipótesis. Recientemente, los mismos autores 
que negaron la existencia de inervación nitrérgica funcional en esta arteria, han 
reconocido su presencia y participación en el desarrollo de hipertensión espontánea e 
hipertensión portal (Toda 2014). 
Mediante la perfusión del árbol mesentérico, diversos autores han puesto de manifiesto 
la existencia de inervación sensitiva, cuyo neurotransmisor principal es el péptido 
vasodilatador CGRP (Kawasaki y cols., 1988; 1991; Ralevic y Burnstock, 1996; Li y 
Duckles, 1992), y su implicación en diversas situaciones fisiopatológicas como la edad, 
gestación e hipertensión. Estos resultados han sido obtenidos mediante la aplicación de 
EE en esta arteria precontraída, produciendo la liberación de CGRP y consecuente 
vasodilatación. Nuestros resultados, obtenidos aplicando la EE sin tono previo, 
confirman que en arteria mesentérica superior se libera CGRP (Artículo 3), aunque no 
observamos vasodilatación. La escasa relajación inducida por CGRP aplicado de forma 
exógena nos indica que esta arteria tiene inervación sensitiva con el CGRP como 
neurotransmisor, y que la cantidad que se libera en condiciones control es insuficiente 
para producir una vasodilatación valorable. Sin embargo, hemos observado su 
liberación y consecuente efecto vasodilatador en distintas situaciones patológicas 
(Blanco-Rivero y cols., 2011; del Campo y cols., 2004 y Artículo 3). Estos resultados 
están de acuerdo con las conclusiones de una exhaustiva revisión en la que se indica que 
a pesar de existir una amplia distribución de este tipo de inervación en los distintos 
vasos sanguíneos, su participación sólo se pondría de manifiesto en eventos 
cardiovasculares adversos como un mecanismo compensador o protector (Russell y 
cols., 2014). 
Mecanismos implicados en las modificaciones de la función perivascular en las 
distintas situaciones analizadas 
La tabla 1 muestra un resumen de los mecanismos implicados en la modificación de la 
función de la inervación perivascular mesentérica. 
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La respuesta vasoconstrictora inducida por EE es el resultado integrado de la función de 
los distintos tipos de inervación. Aunque la respuesta neta se incremente o disminuye, 
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La respuesta vasoconstrictora inducida por EE es el resultado integrado de los distintos 
tipos de inervación. Aunque la respuesta neta se incremente o disminuya, los 
mecanismos que participan en estas modificaciones dependen de la situación analizada.  
Influencia del endotelio 
El endotelio modula la respuesta a diferentes sustancias vasomotoras (Vanhoutte, 
Houston, 1985 Ralevic 2002) y su eliminación produce un incremento en las respuestas 
a diferentes agentes vasoconstrictores, incluida la NA (Moncada y cols., 1991; Dora y 
cols., 2000). Nuestros resultados indican que en los modelos experimentales en los en 
los que la respuesta vasodilatadora a ACh no se modifica, como durante la gestación 
(Artículo 1), lactancia (Artículo 2) y efecto de fármacos estabilizadores de células 
cebadas (Artículo 8), el incremento en la respuesta vasoconstrictora inducida por EE en 
ausencia de endotelio, lógicamente es similar a sus respectivos controles 
experimentales. Sin embargo, es llamativo que en animales alimentados con una dieta 
rica en grasa (Artículo 6) y en descendientes adultos de madres diabéticas (Artículo 4) 
en los que hemos observado disfunción endotelial, se incrementó la respuesta contráctil 
inducida por EE en la misma medida que en sus respectivos controles.  
Esta carencia de efecto sugiere que la disminución en la respuesta vasodilatadora a ACh 
observada no es suficiente para inducir cambios en la respuesta de origen neuronal, ya 
que existe una diferencia cuantitativamente significativa entre la disfunción endotelial y 
la ausencia total de endotelio.  
Interacciones entre los distintos tipos de inervación 
Se ha descrito una  interacción entre los distintos tipos de inervación en diferentes 
lechos vasculares, incluido en mesentérico (Kawasaki y cols., 1990a; Kawasaki y cols., 
1990b; Hatanaka y cols., 2006; Kawasaki y cols., 2011). 
La mayor parte de los resultados publicados indican que el NO inhibe la liberación de 
NA (Kawasaki y cols., 2011; Macarthur y cols., 2011), aunque también se ha descrito 
que el NO de origen neuronal la aumenta (Wang y Golledge, 2013). Establecer 
inequívocamente la existencia o no de interacciones entre la inervación simpática y 
nitrérgica es compleja ya que su función está regulada por neurotransmisores 
moduladores (Macarthur y cols., 2011) cuya modificación no podemos descartar.  
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Nuestros resultados, resumidos en la tabla 2, muestran un incremento en la liberación de 
NA simultáneamente a una disminución en la liberación de NO neuronal en ratas 
alimentadas con una dieta rica en grasa (Artículo 6) así como una disminución en la 
liberación de NA simultáneamente a un incremento en la liberación de NO en 
hipertensión portal (Artículo 3) y durante la gestación (Artículo 1). Estos resultados 
parecen confirmar una interacción entre ambos tipos de inervación en este lecho 
vascular. 
 
Tabla 2: Resumen de las modificaciones en la liberación de NA y NO en arteria 
mesentérica superior en diferentes situaciones fisiopatológicas.  
 Liberación de NA Liberación de NO 
Embarazo ↓ ↑ 
Hipertensión Portal ↓ ↑ 
Dieta rica en grasa ↑ ↓ 
Lactancia = ↓ 
LPS = ↓ 
Ketotifen/Tranilast = ↓ 
SHR ↑ ↑ 
Descendencia Diabetes ↑ ↑ 
 
Sin embargo durante la lactancia (Artículo 2) y el tratamiento con LPS (Artículo 7), 
ketotifen o tranilast (Artículo 8) observamos una disminución en la función nitrérgica 
mientras que la liberación de NA permanece inalterada. En el modelo de hipertensión en 
descendencia de madres diabéticas (Artículo 4) y SHR (Marín y cols., 2000) se observa 
un incremento simultáneo en la función de la inervación adrenérgica y nitrérgica. Estos 
resultados nos llevan a sugerir que las alteraciones observadas en las distintas 
situaciones fisiopatológicas en la función de ambas inervaciones no son fruto de una 
interacción entre las mismas.  
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Los resultados obtenidos en esta tesis doctoral demuestran que: 
1. Las modificaciones en la función perivascular participan en la adaptación del 
organismo durante la gestación y la lactancia: 
 En la gestación disminuye la respuesta contráctil inducida por EE. Este efecto 
está mediado por una disminución tanto en la liberación de NA como en la 
respuesta vasoconstrictora a este neurotransmisor, junto con incremento en la 
liberación de NO neuronal mediado por una mayor activación de nNOS, 
mientras que la respuesta vasodilatadora al DEA-NO no se modifica La 
inervación sensitiva no presenta un papel funcional en este modelo.  
 Durante la lactancia se produce un incremento en la respuesta vasoconstrictora 
inducida por EE. Este incremento está mediado por un incremento en la 
liberación de ATP, mientras que no se modifica el componente adrenérgico; 
junto con una diminución tanto en la expresión como en la actividad de nNOS y 
consecuente liberación de NO, mientras que la respuesta a DEA-NO es similar. 
No se observa participación ni modificación en la inervación sensitiva. 
2. En la vasodilatación esplácnica asociada a la hipertensión portal a corto plazo 
participa la inervación perivascular disminuyendo la respuesta contráctil inducida por 
EE. Este efecto se debe a una disminución en la liberación de NA y al incremento tanto 
en la liberación de NO neuronal mediado por un aumento en la actividad de nNOS, 
como en la liberación de CGRP. Las respuestas vasomotoras a los distintos 
neurotransmisores no se modifican. Sin embargo, a largo plazo hay una adaptación en la 
función neuronal. 
3. En la hipertensión desarrollada por la descendencia adulta de madres diabéticas 
participa la inervación perivascular. En estos animales se incrementa la respuesta 
vasoconstrictora inducida por EE,  este efecto es el resultado neto del incremento en la 
liberación de los vasoconstrictores simpáticos NA y ATP y de un aumento en la 
liberación de NO neuronal mediado por un aumento en la activación de nNOS, mientras 
que las respuestas vasomotoras a NA y DEA-NO no se modifican. La inervación 
sensitiva no presenta un papel funcional en este modelo experimental.  
4. El ejercicio físico moderado es capaz de revertir las alteraciones en la inervación 
perivascular en hipertensión y prevenirlas en un modelo de obesidad inducido con dieta 
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grasa, por lo que en los efectos beneficiosos del ejercicio físico también está implicada 
la regulación neuronal del tono vascular:  
 En SHR disminuye la liberación de NA e incrementa su respuesta contráctil, y 
se incrementa tanto la liberación de NO neuronal, mediado por una mayor 
expresión de nNOS, como su biodisponibilidad. La inervación sensitiva 
participa en la respuesta contráctil aunque no se modifica con el ejercicio. 
 En ratas sometidas a una dieta rica en grasa disminuye la liberación de NA y 
aumenta la de ATP; y se incrementa la liberación de NO debida a un aumento 
tanto en la expresión como en la actividad de nNOS. Las respuestas vasomotoras 
a NA y DEA-NO no se modifican. La inervación sensitiva no presenta un papel 
funcional en este modelo experimental 
5. El LPS parece desencadenar en una fase temprana un efecto compensador al estado 
de vasodilatación característico de la sepsis, la cual no se mantiene a largo plazo. A 
corto plazo, 2 horas, se incrementa la respuesta vasoconstrictora inducida por EE 
mediada por una menor liberación de NO neuronal mediada por una disminución en la 
actividad de nNOS, y una mayor respuesta vasoconstrictora a NA. A largo plazo, 5 
horas, se mantiene la disminución en la liberación de NO y se restaura la función 
adrenérgica.  
6. El ketotifen y tranilast, fármacos que estabilizan la membrana de las células cebadas, 
alteran la respuesta contráctil inducida por EE, de forma opuesta. El ketotifen la 
incrementa a través de la disminución en la actividad de nNOS y por tanto en la 
liberación de NO neuronal, mientas que no modifica la función adrenérgica. El tranilast  
disminuye la respuesta vasoconstrictora disminuyendo tanto la liberación de NO como 
la respuesta vasoconstrictora a NA.  
7. En vasos de resistencia el tranilast también contribuye a facilitar un estado de 
vasodilatación, ya que incrementa la relajación dependiente de endotelio por una mayor 
mayor participación de EDHF cuyo efecto está mediado a través de canales de potasio 
dependientes de calcio de baja conductancia, descartándose la participación del NO y 
prostanoides derivados de COX. Por lo que, la elección de uno u otro fármaco 
estabilizador puede tener efectos hemodinámicos. 
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Estos datos tomados en su conjunto nos permiten realizar diversas consideraciones 
generales:  
 La existencia de inervación nitrérgica funcional en el control del tono 
vascular en la arteria mesentérica superior de todas las cepas analizadas. 
 La inervación sensitiva no participa en la respuesta contráctil inducida por 
EE en situaciones fisiológicas, mientras que en las distintas situaciones 
patológicas analizadas sólo contribuye a la vasodilatación esplácnica 
asociada a la hipertensión portal. 
 Los mecanismos por los cuales se incrementa o disminuye la respuesta 
vasoconstrictora inducida por EE no son homogéneos y difieren en función 
de la situación experimental analizada. 
 El incremento en la respuestas vasoconstrictora inducida por la liberación de 
los distintos neurotransmisores en arteria mesentérica superior no se ve 
afectada por la disfunción endotelial.. 
 No parece existir una interacción entre la inervación nitrérgica y adrenérgica. 
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